No definition available.
Coagulation defects, purpura and other haemorrhagic conditions
EFO MESH Endpoint Browser PheWeb
D3_COAGDEF_PURPUR_HAEMORRHAGIC
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
9448 |
6. Filter based on genotype QC (FinnGen only) |
9095 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Coagulation defects, purpura and other haemorrhagic conditions
based on the number of shared cases.
Similar with more cases:
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 67221 | 35241 | 31460 |
| Only index persons | 56925 | 30781 | 26144 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.94 | 1.01 | 0.88 |
| Only index persons | 1.07 | 1.13 | 1.00 |
| Median age at first event (years) | |||
| Whole population | 51.21 | 48.10 | 54.52 |
| Only index persons | 48.68 | 44.82 | 53.23 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 9095 | 5124 | 3971 |
| Unadjusted period prevalence (%) | 1.82 | 1.82 | 1.82 |
| Median age at first event (years) | 55.33 | 48.73 | 63.85 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 9448
- Matched controls
- 94465
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D69.8
ICD-10 Finland
Other specified haemorrhagic conditions
68.9
323.3
176
26
D69.2
ICD-10 Finland
Other nonthrombocytopenic purpura
206.0
307.7
357
18
D69.0
ICD-10 Finland
Allergic purpura
257.7
307.7
930
40
D68.3
ICD-10 Finland
Haemorrhagic disorder due to circulating anticoagulants
813.1
307.7
538
7
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
401.5
307.7
2975
108
D68.0
ICD-10 Finland
Von Willebrand disease
1290.6
307.7
490
*
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
24.1
307.7
335
144
B01AA03
ATC
warfarin; systemic
3.1
307.7
2630
10541
B01AB05
ATC
enoxaparin; parenteral
2.5
307.7
3726
19691
D69.9
ICD-10 Finland
Haemorrhagic condition, unspecified
126.1
307.7
558
47
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.0
307.7
2016
7806
D68.9
ICD-10 Finland
Coagulation defect, unspecified
305.0
307.7
519
18
D68.2
ICD-10 Finland
Hereditary deficiency of other clotting factors
294.5
307.7
368
13
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
5.3
307.7
881
1791
D69.5
ICD-10 Finland
Secondary thrombocytopenia
791.2
307.7
453
6
D68.8
ICD-10 Finland
Other specified coagulation defects
288.5
307.7
1781
76
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
2993.9
307.7
1107
*
WW500
NOMESCO Finland
Blood transfusion
6.6
307.7
994
1651
129
Kela drug reimbursment
Idiopathic thrombocytopaenia or granulocytopenia
217.8
307.7
275
13
D70.82
ICD-10 Finland
Drug-induced neutropenia
9.8
307.7
444
471
XW000
NOMESCO Finland
Bone marrow biopsy
9.7
307.7
1307
1543
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
306.2
5156
33132
D70.89
ICD-10 Finland
Neutropenic splenomegaly
9.6
301.1
358
385
D64.9
ICD-10 Finland
Anaemia, unspecified
3.0
298.5
1559
5871
H02AB06
ATC
prednisolone; systemic
2.1
261.1
5058
33542
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
18.5
245.8
196
108
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.7
245.7
1493
6054
ZX120
NOMESCO Finland
Intravenous
2.9
242.3
1268
4748
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.6
232.9
1524
6402
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.4
230.9
2002
9585
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
4.8
209.0
491
1071
C03CA01
ATC
furosemide; systemic
2.0
207.8
3166
18820
B01AB04
ATC
dalteparin; parenteral
3.5
205.8
759
2300
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.7
202.4
1210
4836
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.0
201.6
3417
21035
R50.9
ICD-10 Finland
Fever, unspecified
2.3
197.9
1870
9227
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.4
195.9
774
2448
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
4.0
189.4
571
1507
L03AA02
ATC
filgrastim; parenteral
4.5
189.0
474
1089
126
Kela drug reimbursment
Chronic coagulation defects
+∞
188.1
180
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.1
185.5
835
2854
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
174.9
2391
13527
28700
ICD-8 Finland
Purpura and other haemorrhagic conditions, Allergic purpura
+∞
171.3
164
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
4.9
169.0
385
817
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
3.5
168.4
608
1812
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
6.7
167.7
270
414
M04AA01
ATC
allopurinol; systemic
2.3
167.2
1470
6992
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
167.1
2986
18460
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.5
163.2
1120
4764
D69.4
ICD-10 Finland
Other primary thrombocytopenia
+∞
156.7
150
*
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
7.2
154.5
231
327
L04AA06
ATC
mycophenolic acid; systemic
5.0
150.3
333
690
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
3.7
147.6
479
1328
N08.2*D69.0
ICD-10 Finland
Glomerular disorders in Henoch(-Schönlein) purpura
+∞
145.1
139
*
ZXE00
NOMESCO Finland
One hour or less
1.8
144.3
3795
26107
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.0
144.1
1904
10549
JN4AD
NOMESCO Finland
Body CT examination
2.3
143.1
1280
6105
JN4BD
NOMESCO Finland
Extensive body CT
2.4
142.3
1134
5148
J01MA12
ATC
levofloxacin; systemic
2.0
137.1
1893
10628
B02AA02
ATC
tranexamic acid; systemic
2.1
137.0
1516
7858
D69.1
ICD-10 Finland
Qualitative platelet defects
283.5
136.7
139
5
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.1
136.1
389
985
N02AX02
ATC
tramadol; systemic, rectal
1.7
134.2
4090
29137
127
Kela drug reimbursment
Transplant complication
5.4
133.8
268
508
2873A
ICD-9 Finland
Purpura and other haemorrhagic conditions, Primary thrombocytopenia[PURPURA THROMBOCYTOPENICA IDIOPATHICA (ITP)]
+∞
133.6
128
*
B01AB10
ATC
tinzaparin; parenteral
2.2
132.7
1201
5745
28719
ICD-8 Finland
Purpura and other haemorrhagic conditions, Thrombocytopenia NUD
+∞
132.6
127
*
A02BC02
ATC
pantoprazole; systemic
1.7
131.6
6445
52060
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
4.8
131.1
302
646
Z2221
NOMESCO Finland
Medical doctor
1.8
130.8
2726
17417
D69
ICD-10 Finland
Purpura and other haemorrhagic conditions
26.9
128.7
88
33
L04AX01
ATC
azathioprine; systemic
3.1
128.4
553
1833
R4110
NOMESCO Finland
Physiotherapy
1.8
126.3
2734
17630
B03XA02
ATC
darbepoetin alfa; parenteral
4.4
124.8
324
763
L95.8
ICD-10 Finland
Other vasculitis limited to skin
17.3
123.0
101
59
AA1AD
NOMESCO Finland
CT of head and brain
1.8
122.5
2802
18324
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
122.2
2600
16651
WW300
NOMESCO Finland
Transfer of autologic stem cells
14.2
121.9
111
79
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.2
121.4
1173
5749
ZXD05
NOMESCO Finland
Urgent procedure
1.7
121.0
2975
19839
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.5
120.7
857
3681
TK800
NOMESCO Finland
Hemodialysis
4.3
120.4
315
746
R04.0
ICD-10 Finland
Epistaxis
2.4
119.8
869
3770
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
9.3
118.3
142
154
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.6
118.1
403
1154
B02BX05
ATC
eltrombopag; oral
395.7
117.8
118
*
A41.9
ICD-10 Finland
Sepsis, unspecified
3.3
116.8
468
1484
H02AB07
ATC
prednisone; oral
2.0
116.7
1374
7253
Z3231
NOMESCO Finland
Registered nurse
1.7
114.8
2672
17501
XF400
NOMESCO Finland
ECG with 12 standard connections
2.0
114.5
1562
8680
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.9
112.6
1809
10602
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
7.7
112.2
157
206
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.9
112.0
569
2067
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
5.6
111.8
214
389
YNB10
NOMESCO Finland
Collection of stem cells for transplant
25.9
111.0
77
30
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
3.1
110.4
482
1608
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.7
110.3
640
2492
A03FA01
ATC
metoclopramide; systemic, rectal
1.8
109.2
2147
13370
L04AD01
ATC
ciclosporin; systemic
4.4
107.9
276
642
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
107.7
2467
16034
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
10.4
107.2
119
116
ZXE10
NOMESCO Finland
More than one and less than three hours
1.6
105.3
3277
23063
I80.1
ICD-10 Finland
Phlebitis and thrombophlebitis of femoral vein
4.8
105.0
238
502
D65
ICD-10 Finland
Disseminated intravascular coagulation [defibrination syndrome]
+∞
103.3
99
*
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
10.4
102.7
114
111
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.5
101.9
705
2985
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.9
101.9
513
1853
WZC00
NOMESCO Finland
Treatment plan or consultation
1.6
101.4
3573
25866
2870A
ICD-9 Finland
Purpura and other haemorrhagic conditions, Allergic purpura[PURPURA HENOCH-SCHÖNLEIN]
+∞
101.2
97
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
7.2
100.4
149
209
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
5.1
100.1
212
422
WX892
NOMESCO Finland
Monitored bed care
2.3
99.9
816
3719
R06.0
ICD-10 Finland
Dyspnoea
1.7
99.6
2590
17355
N02AA05
ATC
oxycodone; systemic
1.8
97.5
1748
10548
K94
ICPC
Phlebitis/thrombophlebitis
4.6
96.7
234
521
R23.3
ICD-10 Finland
Spontaneous ecchymoses
3.8
96.3
305
830
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.8
95.8
1962
12299
D61.9
ICD-10 Finland
Aplastic anaemia, unspecified
30.2
95.6
63
21
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
4.6
95.0
227
500
D66
ICD-10 Finland
Hereditary factor VIII deficiency
+∞
94.9
91
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
4.5
94.8
233
525
Z3226
NOMESCO Finland
Physiotherapist
1.8
94.2
1729
10495
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
19.1
91.8
72
38
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.6
91.6
568
2281
JN6AD
NOMESCO Finland
CT of torso and neck
4.1
91.5
252
620
3039, ,
Kela drug reimbursment
312.4
91.0
92
*
1517, ,
Kela drug reimbursment
312.4
91.0
92
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
90.9
3396
24751
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
6.4
90.8
150
236
6BA02, ,
NOMESCO Finland
12.1
90.8
91
76
ZX108
NOMESCO Finland
Inhalation
6.7
90.5
144
218
TPH07
NOMESCO Finland
Cathetrisation of artery
2.0
89.6
1128
6061
JN3AD
NOMESCO Finland
Abdominal CT examination
1.9
87.5
1309
7446
ZXE20
NOMESCO Finland
More than three and less than five hours
1.9
86.3
1259
7101
I50.9
ICD-10 Finland
Heart failure, unspecified
1.9
86.2
1335
7675
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
9.1
85.7
105
117
A04AA01
ATC
ondansetron; systemic, rectal
2.1
85.7
845
4148
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.3
84.5
661
2951
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.7
84.5
2157
14285
L04AD02
ATC
tacrolimus; systemic
5.2
84.3
173
335
L03AA14
ATC
lipegfilgrastim; parenteral
4.0
83.2
243
624
L03AA13
ATC
pegfilgrastim; parenteral
2.7
83.1
473
1819
R58
ICD-10 Finland
Haemorrhage, not elsewhere classified
4.4
83.1
212
492
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.3
83.1
661
2972
A46
ICD-10 Finland
Erysipelas
1.8
82.9
1410
8334
C83.1
ICD-10 Finland
Mantle cell lymphoma
10.2
82.9
93
92
C07AB07
ATC
bisoprolol; oral
1.5
81.7
4241
32997
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
6.1
81.0
141
234
H02AB02
ATC
dexamethasone; systemic
1.9
80.8
1075
5874
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.3
80.6
677
3114
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.3
80.1
673
3095
TGC00
NOMESCO Finland
Bronchial lavation
3.3
79.0
304
939
J01DB01
ATC
cefalexin; oral
1.7
78.5
7623
67629
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
3.5
78.4
281
830
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.4
76.3
276
820
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.5
75.5
483
1966
Z51.5
ICD-10 Finland
Palliative care
2.0
75.5
863
4469
I82.9
ICD-10 Finland
Embolism and thrombosis of unspecified vein
3.8
74.9
233
626
C03DA01
ATC
spironolactone; oral
1.9
74.8
1154
6606
WX002
NOMESCO Finland
Sedation and analgesia
1.7
73.6
1715
11040
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
3.7
72.5
233
640
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.4
72.4
512
2183
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
71.9
3401
25745
UJF32
NOMESCO Finland
Coloscopy
1.6
71.0
2306
16085
J01FF01
ATC
clindamycin; systemic
1.6
70.9
2401
16906
H02AB09
ATC
hydrocortisone; systemic
3.1
70.5
300
984
J01MA02
ATC
ciprofloxacin; systemic
1.5
69.4
3426
26108
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.0
68.6
826
4350
A02BC01
ATC
omeprazole; systemic
1.5
68.0
2414
17148
122
Kela drug reimbursment
Aplastic anaemia
31.6
67.6
44
14
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.8
67.3
1025
5832
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.9
67.2
912
5000
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
67.1
1474
9320
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
67.1
1775
11770
R60.0
ICD-10 Finland
Localized oedema
1.8
67.0
1196
7138
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
4.0
66.8
193
492
E0000UV, ,
ATC
1.5
66.8
3779
29521
Z49.1
ICD-10 Finland
Extracorporeal dialysis
4.3
66.7
175
415
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
2.1
66.7
717
3624
N08.2
ICD-10 Finland
Glomerular disorders in blood diseases and disorders involving the immune mechanism
11.4
66.3
69
61
P01BA02
ATC
hydroxychloroquine; oral
2.0
65.8
763
3964
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
65.7
3838
30139
N03AX16
ATC
[U] pregabalin
1.6
65.5
1991
13639
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.4
65.5
240
719
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
2.0
64.9
747
3869
J01MA14
ATC
moxifloxacin; systemic
1.9
64.9
836
4503
Z2446
NOMESCO Finland
Social worker
2.1
64.9
650
3200
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
63.8
1741
11617
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.9
63.4
846
4609
R79.9
ICD-10 Finland
Abnormal finding of blood chemistry, unspecified
5.8
62.7
115
201
1XC02, ,
NOMESCO Finland
5.8
62.5
114
198
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
4.1
61.9
171
422
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
6.9
61.7
95
139
K78
ICPC
Atrial fibrillation/flutter
2.0
61.4
732
3837
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.5
61.0
402
1658
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.6
60.8
372
1481
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
7.2
60.4
89
124
K99
ICPC
Cardiovascular disease other
2.9
60.2
296
1054
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
3.6
60.2
198
553
S97
ICPC
Chronic ulcer skin
2.1
60.0
613
3039
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
59.9
3771
29867
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
59.0
2036
14302
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.6
58.7
365
1464
X59
ICD-10 Finland
Exposure to unspecified factor
1.6
58.6
1710
11567
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
3.3
58.3
229
716
I80.9
ICD-10 Finland
Phlebitis and thrombophlebitis of unspecified site
3.9
58.2
175
459
N02BE01
ATC
paracetamol; systemic, rectal
1.6
58.0
8124
74585
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
7.4
57.5
83
113
Z94.0
ICD-10 Finland
Kidney transplant status
4.3
56.9
147
345
K93
ICPC
Pulmonary embolism
4.4
56.5
141
322
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
2.3
56.4
451
2026
D68.4
ICD-10 Finland
Acquired coagulation factor deficiency
+∞
56.3
54
*
D73.1
ICD-10 Finland
Hypersplenism
19.2
56.2
44
23
N18.8
ICD-10 Finland
Other chronic renal failure
3.0
56.2
259
890
A11CC03
ATC
alfacalcidol; systemic
2.9
56.1
262
907
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
56.0
4650
38515
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.8
55.5
966
5706
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
13.9
55.3
51
37
28799
ICD-8 Finland
Purpura and other haemorrhagic conditions, Other and unspecified
+∞
55.2
53
*
I80.0
ICD-10 Finland
Phlebitis and thrombophlebitis of superficial vessels of lower extremities
2.4
55.2
376
1575
I87.0
ICD-10 Finland
Postthrombotic syndrome
9.1
55.1
67
74
L04AA01
ATC
[U] ciclosporin
3.9
54.8
162
420
H02AB04
ATC
methylprednisolone; systemic
1.7
54.5
1240
7878
K92.1
ICD-10 Finland
Melaena
2.1
54.5
526
2550
A04AA02
ATC
granisetron; systemic, transdermal
2.1
53.6
569
2858
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.7
53.4
1184
7469
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.4
53.2
374
1589
M36.4*D69.0
ICD-10 Finland
Arthropathy in Henoch(-Schönlein) purpura
+∞
53.2
51
*
4511A
ICD-9 Finland
Phlebitis and thrombophlebitis, Of deep vessels of lower extremities
5.0
53.1
114
230
R31
ICD-10 Finland
Unspecified haematuria
1.8
52.9
921
5438
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.8
52.6
874
5088
D62
ICD-10 Finland
Acute posthaemorrhagic anaemia
4.6
52.5
126
279
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.1
52.4
539
2675
ZXA00
NOMESCO Finland
Right side
1.5
52.1
2144
15567
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.8
52.0
273
1006
WX402
NOMESCO Finland
General anaesthesia
1.5
51.0
1965
14071
UJF30
NOMESCO Finland
Ileoscopy through colon
1.7
50.9
944
5670
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
50.8
3622
29064
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
4.0
50.6
143
359
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
50.5
2702
20610
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.5
50.3
1881
13379
WW200
NOMESCO Finland
Immunization
2.6
50.3
287
1104
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
5.6
50.2
95
171
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
2.5
50.1
333
1378
2875A
ICD-9 Finland
Purpura and other haemorrhagic conditions, Thrombocytopenia, unspecified
+∞
50.0
48
*
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.7
49.9
981
5987
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.4
49.5
2565
19434
GD1AD
NOMESCO Finland
Thorax CT examination
2.0
49.3
580
3021
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
5.1
49.3
103
203
R79.8
ICD-10 Finland
Other specified abnormal findings of blood chemistry
4.8
49.1
111
234
ZX112
NOMESCO Finland
Subcutaneous
2.9
48.9
227
783
JMA10
NOMESCO Finland
Transabdominal total splenectomy
6.0
48.7
86
145
6753
FHL
Transabdominal splenectomy
16.5
48.7
41
25
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.5
48.6
327
1362
9989/3-C42.1
ICD-O-3
Myelodysplastic syndrome, NOS, of bone marrow
8.9
48.3
60
68
ZXA05
NOMESCO Finland
Left side
1.5
48.2
1980
14339
O99.4
ICD-10 Finland
Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium
6.3
48.1
80
127
B99
ICD-10 Finland
Other and unspecified infectious diseases
3.0
47.7
213
719
M10.9
ICD-10 Finland
Gout, unspecified
1.9
47.6
629
3407
A41.8
ICD-10 Finland
Other specified sepsis
3.0
47.5
208
694
N05CF01
ATC
zopiclone; oral
1.4
47.3
2660
20421
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
47.3
2391
18007
M79.6
ICD-10 Finland
Pain in limb
1.4
47.1
3819
31182
3AC01, ,
NOMESCO Finland
4.2
46.8
124
297
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.2
46.6
430
2047
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
3.5
46.5
163
475
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
7.3
46.5
68
94
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.7
46.2
845
5050
R06AE07
ATC
cetirizine; oral
1.4
46.2
3764
30722
TK810
NOMESCO Finland
Hemofiltration
5.3
46.1
92
174
D07AB08
ATC
desonide; topical
1.7
46.0
961
5957
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.0
45.8
554
2913
J01CA04
ATC
amoxicillin; systemic
1.4
45.6
7373
67152
M32.0
ICD-10 Finland
Drug-induced systemic lupus erythematosus
11.8
45.4
46
39
A12AA04
ATC
calcium carbonate; oral
3.3
45.4
170
517
R18
ICD-10 Finland
Ascites
3.0
45.3
205
697
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
4.5
45.3
110
246
M31.1
ICD-10 Finland
Thrombotic microangiopathy
16.6
45.3
38
23
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
3.3
45.2
171
523
J05AB11
ATC
valaciclovir; oral
1.6
45.1
1252
8324
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
6.9
44.4
68
99
I26
ICD-10 Finland
Pulmonary embolism
4.2
44.2
117
280
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
7.8
44.1
61
79
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.9
44.0
550
2922
WZC30
NOMESCO Finland
Teaching
1.5
43.8
1401
9609
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
8.5
43.8
56
66
N18.0
ICD-10 Finland
End-stage renal disease
4.0
43.7
125
317
D07AC01
ATC
betamethasone; topical
1.4
43.6
3079
24497
212
Kela drug reimbursment
Gout
2.9
43.5
202
697
R53
ICD-10 Finland
Malaise and fatigue
1.4
43.5
2261
17071
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.5
43.4
1665
11863
A10AB05
ATC
insulin aspart; parenteral
1.8
43.2
678
3873
A05AA02
ATC
ursodeoxycholic acid; oral
3.0
43.1
191
642
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.8
43.1
651
3677
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.6
42.7
1151
7593
WX872
NOMESCO Finland
Intensive care
2.1
42.4
445
2224
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
5.5
42.2
81
148
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
1.9
42.1
593
3276
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
6.1
42.1
73
121
I50.0
ICD-10 Finland
Congestive heart failure
1.8
42.1
636
3592
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.6
41.8
1087
7107
O28.0
ICD-10 Finland
Abnormal haematological finding on antenatal screening of mother
12.5
41.8
41
33
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
4.3
41.7
107
250
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
10.8
41.7
45
42
D59.9
ICD-10 Finland
Acquired haemolytic anaemia, unspecified
10.8
41.7
45
42
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.6
41.3
251
996
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.0
41.1
432
2160
Z71.8
ICD-10 Finland
Other specified counselling
1.4
41.1
2979
23744
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
2.5
41.1
253
1011
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.6
40.7
1133
7524
B02BD02
ATC
coagulation factor VIII; parenteral
+∞
40.6
39
*
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
4.7
40.5
93
199
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
2.7
40.5
221
832
R4120
NOMESCO Finland
Occupational therapy
1.9
40.4
574
3178
A07AA11
ATC
rifaximin; oral
7.4
40.2
58
79
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
3.8
40.0
120
315
L95.0
ICD-10 Finland
Livedoid vasculitis
15.3
39.9
35
23
L04AX03
ATC
methotrexate; systemic
1.7
39.9
812
4989
J02AC03
ATC
voriconazole; systemic
8.5
39.9
51
60
M05BA04
ATC
alendronic acid; oral
1.8
39.9
683
4001
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.8
39.9
594
3338
A06AD11
ATC
lactulose; oral
1.5
39.9
1224
8307
A28
ICPC
Limited function/disability NOS
1.5
39.9
1490
10542
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
8.3
39.8
52
63
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.5
39.7
251
1015
2864A
ICD-9 Finland
Coagulation defects, von Willebrand's disease
+∞
39.6
38
*
3052, ,
Kela drug reimbursment
+∞
39.6
38
*
1524, ,
Kela drug reimbursment
+∞
39.6
38
*
L28
ICPC
Limited function/disability (L)
1.5
39.4
1587
11394
J01AA02
ATC
doxycycline; systemic
1.4
39.3
6670
60218
XF600
NOMESCO Finland
Bloodpressure measurement
1.8
39.3
567
3156
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
9.8
39.1
45
46
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.7
39.1
739
4452
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
3.4
39.0
144
434
WX110
NOMESCO Finland
Infiltration anesthesia
1.3
38.8
6298
56402
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.3
38.7
299
1324
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.1
38.5
354
1682
L81.7
ICD-10 Finland
Pigmented purpuric dermatosis
5.9
38.4
68
115
B03XA01
ATC
erythropoietin; parenteral
4.0
38.3
107
267
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
6.5
38.2
62
96
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
4.9
38.0
84
174
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
37.7
1548
11147
B02BX04
ATC
romiplostim; parenteral
+∞
37.5
36
*
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.4
37.5
253
1055
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.4
37.2
2096
15978
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.8
37.2
618
3588
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
2.9
37.1
181
642
L17
ICPC
Foot/toe symptom/complaint
1.4
37.1
2604
20575
B99
ICPC
Blood/lymph/spleen disease other
5.6
37.1
70
126
Z31.5
ICD-10 Finland
Genetic counselling
1.9
37.0
479
2573
XF404
NOMESCO Finland
Ambulatory ECG
1.7
37.0
717
4345
D89.80
ICD-10 Finland
Immunoglobulin A (IgA) deposits in organisms
8.0
37.0
50
63
B01AF02
ATC
apixaban; oral
1.5
36.9
1099
7402
B01AX05
ATC
fondaparinux; parenteral
4.1
36.8
102
253
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.0
36.7
438
2290
ED1AA
NOMESCO Finland
Mandibular X-ray examination
4.7
36.5
85
184
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.1
36.5
364
1785
3038, ,
Kela drug reimbursment
+∞
36.5
35
*
28710
ICD-8 Finland
Purpura and other haemorrhagic conditions, Thrombocytopenia essentialis (Morbus Werlhof)
+∞
36.5
35
*
1516, ,
Kela drug reimbursment
+∞
36.5
35
*
P01AB01
ATC
metronidazole; oral, rectal
1.3
36.4
3266
26767
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
3.2
36.2
147
470
L01CB01
ATC
etoposide; systemic
5.1
36.2
75
147
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
7.4
36.0
52
71
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
4.0
35.8
102
258
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
35.6
1164
7994
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
2.3
35.6
271
1193
B02BX08
ATC
avatrombopag; systemic
+∞
35.4
34
*
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
5.4
35.4
69
128
M31.9
ICD-10 Finland
Necrotizing vasculopathy, unspecified
8.8
35.4
44
50
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
3.6
35.4
116
324
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
3.9
35.2
103
266
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
3.3
34.9
133
409
J01DA01
ATC
[U] cefalexin
1.3
34.8
5172
45367
PJA10
NOMESCO Finland
Exploration of lymph nodes
3.3
34.8
132
405
M35.1
ICD-10 Finland
Other overlap syndromes
5.4
34.6
68
127
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.6
34.5
796
5045
WX882
NOMESCO Finland
High dependency care
2.3
34.4
273
1223
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
7.0
34.3
52
75
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
2.8
34.1
173
627
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.8
33.9
481
2662
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.6
33.8
754
4740
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.8
33.7
548
3159
A08
ICPC
Swelling
1.8
33.5
493
2758
WVA20
NOMESCO Finland
Medicine administration
2.3
33.5
264
1179
TKC20
NOMESCO Finland
Catheterisation of bladder
1.8
33.4
569
3325
B83
ICPC
Purpura/coagulation defect
55.9
33.2
39
7
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
3.9
33.0
96
247
J01FA06
ATC
roxithromycin; oral
1.3
32.9
3149
25946
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
3.5
32.8
113
326
S16
ICPC
Bruise/contusion
2.2
32.8
288
1345
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
2.5
32.7
213
874
JN4CD
NOMESCO Finland
Very extensive body CT
2.1
32.7
301
1431
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.0
32.6
372
1916
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.4
32.4
1724
12971
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.3
32.4
2514
20087
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.5
32.4
202
813
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
6.4
32.3
53
83
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.9
32.3
396
2089
WW409
NOMESCO Finland
Other aferesis
7.9
32.3
44
56
TFP20
NOMESCO Finland
Cardiodefibrillation
1.7
32.3
563
3312
TAB00
NOMESCO Finland
Lumbar puncture
1.9
32.0
383
2005
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.8
31.9
487
2755
A10AC01
ATC
insulin (human); parenteral
1.7
31.9
612
3696
ZXA10
NOMESCO Finland
Bilateral
1.4
31.9
1453
10637
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.7
31.9
621
3767
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
3.6
31.8
105
295
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.4
31.7
1456
10670
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.6
31.7
814
5291
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
2.5
31.7
208
857
Z3229
NOMESCO Finland
Other healthcare associate professional
1.7
31.6
681
4239
A07AA02
ATC
nystatin; oral
1.8
31.6
470
2639
V03AE01
ATC
polystyrene sulfonate; oral
3.1
31.5
131
425
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.7
31.5
653
4025
W19
ICD-10 Finland
Unspecified fall
1.6
31.5
825
5389
Z94.4
ICD-10 Finland
Liver transplant status
5.9
31.2
56
96
J04BA02
ATC
dapsone; oral
4.6
31.2
74
163
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
2.7
31.1
168
630
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.7
30.9
610
3712
JJC00
NOMESCO Finland
Allogenic transplantation of liver
7.1
30.9
46
65
TPX15
NOMESCO Finland
Removal of vascular injection port
4.9
30.8
67
137
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
8.4
30.8
40
48
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.6
30.6
726
4629
J45.9
ICD-10 Finland
Asthma, unspecified
1.4
30.4
1547
11537
N03AX14
ATC
levetiracetam; systemic
2.2
30.3
257
1183
28630
ICD-8 Finland
Coagulation defects, Vascular haemophilia
+∞
30.2
29
*
I74.3
ICD-10 Finland
Embolism and thrombosis of arteries of lower extremities
3.4
30.2
107
315
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
2.7
30.1
167
635
J05AB01
ATC
aciclovir; systemic
1.4
30.0
1759
13430
D68
ICD-10 Finland
Other coagulation defects
41.2
29.9
37
9
120
Kela drug reimbursment
Hypogammaglobulinaemia
8.0
29.8
40
50
V03AE02
ATC
sevelamer; oral
4.7
29.8
68
145
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
1.9
29.7
370
1962
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.3
29.5
4309
37375
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
3.4
29.3
105
311
NA1AD
NOMESCO Finland
Cervical spine CT examination
1.9
29.3
393
2135
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
7.9
29.3
40
51
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.4
29.3
1307
9516
A12BA01
ATC
potassium chloride; oral
2.0
29.3
330
1691
I81
ICD-10 Finland
Portal vein thrombosis
5.2
29.3
59
113
A40.8
ICD-10 Finland
Other streptococcal sepsis
3.5
29.2
100
288
R60.9
ICD-10 Finland
Oedema, unspecified
1.8
29.2
483
2799
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
4.4
29.1
73
168
S18
ICPC
Laceration/cut
1.3
29.1
3886
33307
R51.80
ICD-10 Finland
Headache
1.4
28.9
1303
9504
XX3DW
NOMESCO Finland
Time consuming IT work
1.5
28.8
828
5519
K70.1
ICD-10 Finland
Alcoholic hepatitis
4.9
28.7
63
130
205
Kela drug reimbursment
Chronic hypertension
1.3
28.7
1997
15654
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
10.7
28.6
31
29
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.4
28.6
195
818
M13.9
ICD-10 Finland
Arthritis, unspecified
1.7
28.5
607
3766
A07AA09
ATC
vancomycin; oral
2.8
28.4
143
517
I80.20
ICD-10 Finland
Phlebitis and thrombophlebitis in the iliac vein
4.6
28.4
66
143
R11
ICD-10 Finland
Nausea and vomiting
1.6
28.3
752
4924
D72.9
ICD-10 Finland
Disorder of white blood cells, unspecified
6.3
28.2
47
75
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
1.8
28.2
416
2330
R03AC02
ATC
salbutamol; inhalant
1.3
28.1
4601
40368
D61.3
ICD-10 Finland
Idiopathic aplastic anaemia
55.2
28.1
33
6
I35.0
ICD-10 Finland
Aortic (valve) stenosis
1.7
28.1
483
2829
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.8
28.0
463
2681
WW400
NOMESCO Finland
Plasmaferesis
7.7
28.0
39
51
I85.0
ICD-10 Finland
Oesophageal varices with bleeding
5.4
28.0
55
103
D64.8
ICD-10 Finland
Other specified anaemias
2.5
27.9
177
719
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
2.1
27.8
272
1325
UKC02
NOMESCO Finland
Cystoscopy
1.4
27.7
1262
9217
J01FA10
ATC
azithromycin; systemic
1.3
27.7
4742
41800
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
2.1
27.7
271
1320
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.3
27.7
221
993
TQW80
NOMESCO Finland
Local dermatologic skincare
2.2
27.7
232
1064
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
27.7
2471
20059
I83.1
ICD-10 Finland
Varicose veins of lower extremities with inflammation
2.4
27.6
182
752
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
1.6
27.5
652
4153
Z01.7
ICD-10 Finland
Laboratory examination
1.4
27.5
1370
10162
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.6
27.5
781
5189
JN5JR
NOMESCO Finland
Extensive PET-CT of upper body metabolism (eyebrows to thighs)
6.1
27.5
47
77
I50
ICD-10 Finland
Heart failure
2.1
27.4
254
1212
R55
ICD-10 Finland
Syncope and collapse
1.5
27.4
884
6038
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
4.2
27.4
72
172
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
1.7
27.4
478
2812
K29
ICPC
Cardiovascular sympt/complt other
1.9
27.4
365
1980
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.1
27.2
263
1275
L01XX05
ATC
hydroxycarbamide; oral
3.0
27.1
118
394
K92.0
ICD-10 Finland
Haematemesis
2.3
27.1
211
939
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
3.0
27.0
116
384
TPH40
NOMESCO Finland
Insertion of a long peripheral venous catheter
3.5
27.0
94
274
137
Kela drug reimbursment
Uraemia requiring dialysis
3.5
26.9
91
260
C08CA01
ATC
amlodipine; oral
1.3
26.8
2971
24800
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
2.2
26.7
219
995
J02AC01
ATC
fluconazole; systemic
1.3
26.7
3086
25889
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.3
26.4
192
829
EBA10
NOMESCO Finland
Operative extraction of tooth
1.4
26.4
1075
7686
C09AA05
ATC
ramipril; oral
1.3
26.3
1863
14612
N19
ICD-10 Finland
Unspecified kidney failure
2.0
26.2
306
1588
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.8
26.2
376
2087
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.1
26.2
265
1307
ZXE40
NOMESCO Finland
More than seven and less than nine hours
2.3
26.2
199
876
2860A
ICD-9 Finland
Coagulation defects, Congenital factor VIII disorder
+∞
26.0
25
*
A02BC05
ATC
esomeprazole; systemic
1.3
26.0
3228
27298
QDA10
NOMESCO Finland
Incision of skin of lower limb
3.8
25.9
78
206
C07AG02
ATC
carvedilol; oral
1.7
25.9
445
2607
M01AE01
ATC
ibuprofen; systemic, rectal
0.8
25.9
7068
75099
XA800
NOMESCO Finland
Neuropsychological investigation
1.9
25.8
342
1852
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
5.0
25.7
55
111
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
2.6
25.7
150
585
ZX121
NOMESCO Finland
Central venous catheter
4.8
25.7
57
119
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.6
25.6
585
3694
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
10.0
25.6
29
29
R4190
NOMESCO Finland
Nutritional therapy
1.9
25.5
349
1909
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
1.9
25.4
305
1598
C01AA05
ATC
digoxin; systemic
1.6
25.4
587
3717
R06
ICPC
Nose bleed/epistaxis
2.2
25.4
211
965
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.3
25.3
1928
15273
J45.1
ICD-10 Finland
Nonallergic asthma
1.6
25.2
565
3551
J47
ICD-10 Finland
Bronchiectasis
2.5
25.1
154
616
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.4
25.0
1446
10981
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.5
25.0
833
5723
C90.0
ICD-10 Finland
Multiple myeloma
3.1
25.0
106
349
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.3
24.9
1666
12941
I48.1
ICD-10 Finland
Persistent atrial fibrillation
1.8
24.9
352
1946
NK1XE
NOMESCO Finland
Other ultrasound examinnation of muscle or tendon
3.2
24.8
97
304
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.6
24.7
661
4333
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
1.9
24.7
342
1879
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
2.4
24.7
163
675
WF049
NOMESCO Finland
Radiotherapy of metastasis
2.0
24.6
282
1455
WX730
NOMESCO Finland
Conventional respirator
2.6
24.6
139
534
O22.3
ICD-10 Finland
Deep phlebothrombosis in pregnancy
7.0
24.5
37
53
A10AE04
ATC
insulin glargine; parenteral
1.5
24.5
741
4988
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
1.7
24.3
485
2958
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.3
24.3
1609
12477
C08CA05
ATC
nifedipine; systemic
1.7
24.3
469
2836
L01AA01
ATC
cyclophosphamide; systemic
4.9
24.3
53
109
N06AX11
ATC
mirtazapine; oral
1.3
24.2
2732
22782
N30.0
ICD-10 Finland
Acute cystitis
1.4
24.2
1390
10539
L01BA01
ATC
methotrexate; systemic
1.9
24.2
288
1506
R42
ICD-10 Finland
Dizziness and giddiness
1.3
24.1
1843
14593
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
2.5
24.1
152
616
K72.9
ICD-10 Finland
Hepatic failure, unspecified
4.3
24.1
62
146
B02BX06
ATC
emicizumab; parenteral
+∞
24.0
23
*
M362, D66,
ICD-10 Finland
+∞
24.0
23
*
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
2.8
23.9
116
412
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
3.3
23.9
89
271
ZZA00
NOMESCO Finland
Split skin graft
2.1
23.9
226
1088
M32
ICD-10 Finland
Systemic lupus erythematosus
9.1
23.8
29
32
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
23.8
3205
27294
A03
ICPC
Fever
1.4
23.7
1433
10955
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
3.1
23.7
96
308
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
2.3
23.6
173
750
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
5.8
23.6
43
75
B34.9
ICD-10 Finland
Viral infection, unspecified
2.0
23.4
258
1313
N05BA04
ATC
oxazepam; oral
1.3
23.4
2080
16806
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
19.5
23.4
35
18
M10.0
ICD-10 Finland
Idiopathic gout
1.9
23.3
277
1447
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
1.9
23.2
277
1449
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.5
23.2
760
5203
Z35.9
ICD-10 Finland
Supervision of high-risk pregnancy, unspecified
2.1
23.2
229
1121
I50.1
ICD-10 Finland
Left ventricular failure
1.8
23.1
374
2154
J20
ICD-10 Finland
Acute bronchitis
1.5
23.0
811
5633
S29
ICPC
Skin symptom/complaint other
1.3
23.0
1652
12954
B28
ICPC
Limited function/disability (B)
4.2
23.0
61
147
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
6.5
23.0
37
57
28600
ICD-8 Finland
Coagulation defects, Haemophilia
+∞
22.9
22
*
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.6
22.9
621
4081
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
5.5
22.8
44
81
306
Kela drug reimbursment
Erythropoietin and darbepoetin
5.7
22.8
42
74
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.5
22.6
673
4514
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
22.6
3352
28824
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
2.4
22.5
161
691
ZX131
NOMESCO Finland
Intrathecal
22.9
22.5
32
14
9673/3-C42.1
ICD-O-3
Mantle cell lymphoma of bone marrow
18.9
22.5
34
18
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
3.5
22.5
78
227
L14
ICPC
Leg/thigh symptom/complaint
1.5
22.4
651
4342
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
2.6
22.3
126
484
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
6.1
22.3
38
62
7100A
ICD-9 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
8.3
22.2
29
35
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.5
22.1
792
5517
N05BA01
ATC
diazepam; systemic, rectal
1.4
22.1
945
6807
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
1.8
22.1
342
1944
I80
ICD-10 Finland
Phlebitis and thrombophlebitis
2.7
22.1
114
419
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
7.6
22.0
31
41
ZX070
NOMESCO Finland
Intensity modified radiotherapy
2.4
22.0
146
606
SPAT1263
SPAT
Sampling
1.2
22.0
3390
29252
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
1.7
21.9
455
2803
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
2.0
21.9
249
1282
1520, ,
Kela drug reimbursment
+∞
21.9
21
*
3047, ,
Kela drug reimbursment
+∞
21.9
21
*
C01DA14
ATC
isosorbide mononitrate; oral
1.4
21.8
1150
8590
PD5BD
NOMESCO Finland
Extensive CT of aorta
2.4
21.8
149
627
196
Kela drug reimbursment
Paricalcitol and cinacalcet
4.3
21.7
56
132
TQW11
NOMESCO Finland
Vacuum treatment of wound
2.2
21.7
173
778
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
1.8
21.7
317
1771
M05BX04
ATC
denosumab; parenteral
1.6
21.6
457
2830
207
Kela drug reimbursment
Chronic arrhythmias
1.4
21.6
1170
8778
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
21.6
2149
17599
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.3
21.5
2011
16334
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
1.9
21.5
265
1403
E87.6
ICD-10 Finland
Hypokalaemia
1.9
21.4
270
1440
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.4
21.4
918
6617
E000001, ,
ATC
1.3
21.3
1525
11936
Z49.0
ICD-10 Finland
Preparatory care for dialysis
3.0
21.3
94
317
SPAT1255
SPAT
Intravenous administration of medicine
1.6
21.3
518
3320
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
6.6
21.2
34
52
R02
ICPC
Shortness of breath/dyspnoea
1.4
21.2
1066
7898
L03.9
ICD-10 Finland
Cellulitis, unspecified
2.2
21.1
181
839
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
1.7
21.1
385
2293
A02BC03
ATC
lansoprazole; oral
1.3
21.1
2110
17279
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
2.4
21.0
138
571
C09AA02
ATC
enalapril; systemic
1.3
20.9
1394
10802
K08.3
ICD-10 Finland
Retained dental root
1.5
20.8
599
3988
R72
ICD-10 Finland
Abnormality of white blood cells, not elsewhere classified
4.4
20.8
52
120
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
2.1
20.6
199
966
I27.0
ICD-10 Finland
Primary pulmonary hypertension
6.2
20.6
35
57
C07AB02
ATC
metoprolol; systemic
1.3
20.6
1456
11373
V03AE03
ATC
lanthanum carbonate; oral
4.8
20.5
46
97
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
5.9
20.4
36
61
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
7.2
20.3
30
42
E87.5
ICD-10 Finland
Hyperkalaemia
2.3
20.2
156
693
B01AF01
ATC
rivaroxaban; oral
1.4
20.1
920
6704
I83.2
ICD-10 Finland
Varicose veins of lower extremities with both ulcer and inflammation
3.5
20.1
69
200
SPAT1229
SPAT
Assessment of need for aid
1.5
20.0
557
3680
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.4
20.0
1213
9256
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
3.8
20.0
59
154
XCK10
NOMESCO Finland
Photography of fundus of eye
1.5
20.0
690
4771
K65.0
ICD-10 Finland
Acute peritonitis
2.8
19.9
99
357
B03BA03
ATC
hydroxocobalamin; parenteral
1.6
19.9
429
2671
ZXD35
NOMESCO Finland
Usual procedure
1.9
19.9
250
1333
Z94.1
ICD-10 Finland
Heart transplant status
6.1
19.8
34
56
28711
ICD-8 Finland
Purpura and other haemorrhagic conditions, Thrombocytopenia symptomatica
+∞
19.8
19
*
D67
ICD-10 Finland
Hereditary factor IX deficiency
+∞
19.8
19
*
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
3.4
19.7
70
207
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.3
19.7
1800
14555
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
2.7
19.7
102
376
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.0
19.7
225
1162
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
2.4
19.6
128
528
MA2DE
NOMESCO Finland
Detailed ultrasound examination of fetus including color doppler method
1.5
19.6
540
3561
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
2.4
19.6
139
596
K72.1
ICD-10 Finland
Chronic hepatic failure
7.7
19.5
27
35
N17.8
ICD-10 Finland
Other acute renal failure
2.6
19.5
111
429
M30.0
ICD-10 Finland
Polyarteritis nodosa
7.4
19.5
28
38
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
1.9
19.5
243
1292
ZST00
NOMESCO Finland
Procedure related to previous procedure classified in chapter T
7.1
19.5
29
41
DKW00
NOMESCO Finland
Cauterisation of mucosa of nose
2.8
19.4
94
334
RS220, ,
NOMESCO Finland
2.5
19.4
117
465
ZX114
NOMESCO Finland
Intramuscular
2.5
19.4
118
471
I48.2
ICD-10 Finland
Chronic atrial fibrillation
1.7
19.4
351
2087
N05CD07
ATC
temazepam; oral
1.4
19.4
807
5782
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
2.1
19.3
179
856
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.0
19.3
222
1148
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.3
19.2
1342
10454
R52.9
ICD-10 Finland
Pain, unspecified
1.4
19.2
801
5739
D07AB02
ATC
hydrocortisone butyrate; topical
1.3
19.2
2305
19261
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
3.5
19.1
65
187
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
1.7
19.1
379
2308
AN1
HP
Coronary angiography
1.4
19.1
769
5474
G40.9
ICD-10 Finland
Epilepsy, unspecified
1.9
19.1
258
1407
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
3.5
19.1
66
192
E000006, ,
ATC
1.6
19.0
491
3190
45100
ICD-8 Finland
Phlebitis and thrombophlebitis, Of lower extremities
3.3
19.0
71
217
R03DC03
ATC
montelukast; oral
1.3
19.0
1249
9643
A91
ICPC
Abnormal result investigation NOS
1.6
19.0
412
2567
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
2.3
19.0
138
598
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
1.8
18.9
308
1777
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
2.9
18.9
87
301
K72.0
ICD-10 Finland
Acute and subacute hepatic failure
4.4
18.9
46
104
SPAT1260
SPAT
Consultation of another employee
1.3
18.8
1319
10280
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
3.2
18.8
74
234
28698
ICD-8 Finland
Coagulation defects, Other
+∞
18.8
18
*
2872B
ICD-9 Finland
Purpura and other haemorrhagic conditions, Other nonthrombocytopenic purpuras
+∞
18.8
18
*
H04.10
ICD-10 Finland
Dry eye syndrome
1.4
18.7
892
6542
K70.9
ICD-10 Finland
Alcoholic liver disease, unspecified
5.0
18.7
40
81
C08CA02
ATC
felodipine; oral
1.5
18.7
671
4675
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
2.4
18.7
121
498
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
6.8
18.7
29
43
L52
ICD-10 Finland
Erythema nodosum
3.3
18.6
70
215
Z49.2
ICD-10 Finland
Other dialysis
3.2
18.6
71
220
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.4
18.6
947
7024
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
5.2
18.6
38
74
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
2.1
18.6
180
876
S06.0
ICD-10 Finland
Concussion
1.4
18.6
837
6082
2BD06, ,
NOMESCO Finland
190.3
18.5
19
*
ZY010
NOMESCO Finland
Hospital outpatient
1.6
18.5
399
2484
J01DA06
ATC
[U] cefuroxime
1.4
18.5
1025
7710
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
4.8
18.4
41
86
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
5.2
18.4
37
71
J96.0
ICD-10 Finland
Acute respiratory failure
2.6
18.3
105
408
B72
ICPC
Hodgkin Lymphoma
7.8
18.3
25
32
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.5
18.3
651
4529
XF402
NOMESCO Finland
ECG with work load test
1.4
18.2
734
5225
N03AX12
ATC
[U] gabapentin; oral
1.3
18.2
1171
9008
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
1.6
18.2
387
2400
D61.0
ICD-10 Finland
Constitutional aplastic anaemia
44.1
18.2
22
5
H05AA02
ATC
teriparatide; parenteral
4.0
18.2
50
124
PA6AE
NOMESCO Finland
Ulrasound examination of neck vasculature
3.0
18.2
81
275
A29
ICPC
General symptom/complaint other
1.4
18.2
1048
7928
Z01.9
ICD-10 Finland
Special examination, unspecified
1.6
18.2
457
2952
E66.8
ICD-10 Finland
Other obesity
1.6
18.1
421
2669
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
1.7
18.0
303
1765
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.4
18.0
961
7183
D75.2
ICD-10 Finland
Essential thrombocytosis
3.3
18.0
65
195
RD210, ,
NOMESCO Finland
2.2
17.9
153
709
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
3.5
17.9
61
176
W84
ICPC
Pregnancy high risk
1.8
17.9
246
1350
K84
ICPC
Heart disease other
1.9
17.9
222
1179
I71.4
ICD-10 Finland
Abdominal aortic aneurysm, without mention of rupture
2.1
17.8
167
803
PG9AC
NOMESCO Finland
Arteriography with X-ray not elsewhere classified
4.2
17.8
46
109
K70.4
ICD-10 Finland
Alcoholic hepatic failure
4.2
17.8
46
109
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
1.8
17.7
246
1354
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
3.2
17.7
68
212
GD2SN
NOMESCO Finland
Lung ventilation SPECT
3.3
17.7
66
202
SPAT1262
SPAT
Handing over of treatment supplies
1.3
17.6
1266
9894
D45
ICD-10 Finland
Polycythaemia vera
2.9
17.6
82
286
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
1.8
17.6
258
1445
WPA13
NOMESCO Finland
Palliative consultation
3.9
17.5
51
132
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.5
17.5
484
3193
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
1.9
17.4
220
1175
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.4
17.4
826
6055
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.3
17.4
1117
8591
UJF92
NOMESCO Finland
Capsular endoscopy
2.0
17.3
178
886
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
1.8
17.3
264
1497
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
1.7
17.3
284
1645
J01CE02
ATC
phenoxymethylpenicillin; oral
1.2
17.2
5630
51908
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.3
17.2
1329
10488
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
2.2
17.2
136
611
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
2.6
17.2
101
397
A01
ICPC
Pain general/multiple sites
1.4
17.1
774
5625
A04
ICPC
Weakness/tiredness general
1.3
17.1
1286
10112
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
3.0
17.0
74
248
I35.2
ICD-10 Finland
Aortic (valve) stenosis with insufficiency
1.9
17.0
197
1022
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
1.8
17.0
255
1437
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.5
16.9
625
4378
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
2.6
16.9
99
389
QX4YT
NOMESCO Finland
Puncture of superficial collection under ultrasound guidance
4.2
16.9
44
105
XQ800
NOMESCO Finland
Prick test
1.5
16.9
538
3660
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
4.3
16.8
43
101
I27.9
ICD-10 Finland
Pulmonary heart disease, unspecified
4.0
16.8
46
114
R07.3
ICD-10 Finland
Other chest pain
1.4
16.8
774
5645
318
Kela drug reimbursment
Teriparatide
3.7
16.8
52
141
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.5
16.7
492
3290
R56.8
ICD-10 Finland
Other and unspecified convulsions
1.6
16.7
371
2326
N06AB04
ATC
citalopram; systemic
1.3
16.7
1525
12300
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.4
16.7
929
6989
C01CA24
ATC
epinephrine; parenteral
1.5
16.6
455
2999
FMD00
NOMESCO Finland
Replacement of aortic valve using mechanical prosthesis
3.1
16.5
69
226
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.4
16.5
668
4757
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.5
16.5
567
3914
L88
ICPC
Rheumatoid/seropositive arthritis
1.7
16.5
302
1802
JAH01
NOMESCO Finland
Laparoscopy
1.6
16.4
337
2072
M81.4
ICD-10 Finland
Drug-induced osteoporosis
3.7
16.4
50
134
201
Kela drug reimbursment
Chronic cardiac insufficiency
1.6
16.4
402
2583
ZX100
NOMESCO Finland
Oral
2.4
16.3
113
480
X58
ICD-10 Finland
Exposure to other specified factors
1.3
16.3
1125
8736
SPAT1211
SPAT
Application of soft bandage
1.4
16.3
648
4601
XF620
NOMESCO Finland
Examination of circulation with color method
3.9
16.3
47
121
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.5
16.3
529
3612
L01BB02
ATC
mercaptopurine; oral
2.5
16.3
101
408
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.4
16.3
779
5717
N30.9
ICD-10 Finland
Cystitis, unspecified
1.5
16.2
501
3385
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
1.6
16.2
359
2250
81
HP
Angiography of the heart and coronary arteries
1.6
16.2
416
2700
Z71.9
ICD-10 Finland
Counselling, unspecified
1.4
16.2
619
4364
K29.7
ICD-10 Finland
Gastritis, unspecified
1.7
16.2
265
1534
2BD01, ,
NOMESCO Finland
5.8
16.1
29
50
D07AC13
ATC
mometasone; topical
1.2
16.1
2170
18309
H05BX01
ATC
cinacalcet; oral
3.3
16.1
58
174
NHQ40
NOMESCO Finland
Amputation of toe
2.3
16.0
122
540
B00.2
ICD-10 Finland
Herpesviral gingivostomatitis and pharyngotonsillitis
3.8
16.0
48
127
FKD00
NOMESCO Finland
Replacement of mitral valve using mechanical prosthesis
6.0
16.0
28
47
A02BA02
ATC
ranitidine; systemic
1.3
16.0
1347
10747
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
11.6
16.0
29
25
R5110, ,
SPAT
1.4
16.0
626
4433
Z2445
NOMESCO Finland
Psychologist
1.7
16.0
294
1758
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
3.0
15.9
69
231
N92.0
ICD-10 Finland
Excessive and frequent menstruation with regular cycle
1.4
15.9
642
4571
B82
ICPC
Anaemia other/unspecified
1.8
15.9
228
1269
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
1.7
15.9
310
1883
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
2.7
15.8
86
326
H11.3
ICD-10 Finland
Conjunctival haemorrhage
1.7
15.8
309
1878
L89
ICD-10 Finland
Decubitus ulcer and pressure area
2.1
15.7
149
720
D07AD01
ATC
clobetasol; topical
1.3
15.7
1221
9639
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
5.8
15.7
28
48
M81.9
ICD-10 Finland
Osteoporosis, unspecified
1.7
15.7
309
1881
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
2.7
15.7
84
316
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
7.2
15.7
23
32
M36.2
ICD-10 Finland
Haemophilic arthropathy
+∞
15.6
15
*
D68.1
ICD-10 Finland
Hereditary factor XI deficiency
+∞
15.6
15
*
B02.9
ICD-10 Finland
Zoster without complication
1.5
15.6
495
3364
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
1.5
15.6
463
3103
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.4
15.6
611
4327
R03BA02
ATC
budesonide; inhalant
1.3
15.6
1320
10538
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.3
15.6
951
7254
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
3.1
15.5
62
198
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.5
15.5
533
3681
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
2.0
15.5
162
812
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.3
15.5
1025
7910
R20.2
ICD-10 Finland
Paraesthesia of skin
1.5
15.5
532
3674
SPAT1088
SPAT
Blood transfusion
3.5
15.5
52
149
TPH00
NOMESCO Finland
Phlebotomy
3.5
15.5
52
149
-60
ICPC
Result test/procedure
1.6
15.5
413
2705
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
2.0
15.4
154
759
J01CF05
ATC
flucloxacillin; systemic
1.5
15.4
534
3694
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
2.2
15.4
130
601
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
1.6
15.4
357
2264
321
Kela drug reimbursment
Paricalcitol and cinacalcet
3.2
15.4
59
184
N03.3
ICD-10 Finland
Chronic nephritic syndrome, diffuse mesangial proliferative glomerulonephritis
6.4
15.3
25
39
K76.7
ICD-10 Finland
Hepatorenal syndrome
6.4
15.3
25
39
A10
ICPC
Bleeding/haemorrhage NOS
2.6
15.3
86
331
L93.0
ICD-10 Finland
Discoid lupus erythematosus
3.6
15.3
49
136
B05DA
ATC
Isotonic solutions
3.0
15.3
66
221
SPAT1301
SPAT
No procedures
1.2
15.3
2397
20537
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
2.5
15.2
94
379
XX9XE
NOMESCO Finland
Other ultrasound examination
2.8
15.2
77
281
L04AA13
ATC
[U] leflunomide
1.9
15.2
177
921
M25.5
ICD-10 Finland
Pain in joint
1.2
15.2
2552
22013
WPB10
NOMESCO Finland
Making a convalescent care decision
3.8
15.2
46
123
NF1AA
NOMESCO Finland
Hip X-ray examination
1.4
15.1
649
4671
JAH00
NOMESCO Finland
Laparotomy
1.9
15.1
197
1064
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
2.8
15.1
75
271
C91.4
ICD-10 Finland
Hairy-cell leukaemia
17.7
15.1
23
13
9680/3-C42.1
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of bone marrow
17.7
15.1
23
13
R03BB04
ATC
tiotropium bromide; inhalant
1.4
15.1
703
5133
R80
ICD-10 Finland
Isolated proteinuria
2.8
15.1
74
266
M05BA07
ATC
risedronic acid; oral
1.9
15.1
199
1080
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.2
15.0
2012
16947
C07AA05
ATC
propranolol; systemic
1.3
15.0
1470
11946
G43.9
ICD-10 Finland
Migraine, unspecified
1.5
15.0
457
3079
GD1LA
NOMESCO Finland
GD
2.3
14.9
112
493
S76
ICPC
Skin infection other
1.5
14.9
406
2670
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
2.3
14.9
111
487
390
Kela drug reimbursment
Ibrutinib
6.5
14.9
24
37
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
1.5
14.9
506
3487
I71.2
ICD-10 Finland
Thoracic aortic aneurysm, without mention of rupture
1.8
14.9
214
1193
H03AA01
ATC
levothyroxine sodium; systemic
1.3
14.9
1682
13905
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
1.9
14.8
191
1028
A06AC01
ATC
ispaghula (psylla seeds); oral
1.2
14.8
1959
16473
N03AF02
ATC
oxcarbazepine; oral
1.8
14.8
237
1363
O36.4
ICD-10 Finland
Maternal care for intrauterine death
3.7
14.8
46
125
C08DB01
ATC
diltiazem; oral
1.6
14.8
349
2222
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.3
14.8
1446
11748
9983/3-C42.1
ICD-O-3
Myelodysplastic syndrome with excess blasts of bone marrow
31.7
14.8
19
6
PA2AD
NOMESCO Finland
CT angiography of brain
2.7
14.7
80
303
A12AA12
ATC
[U] calcium acetate
5.5
14.7
28
51
L01AX03
ATC
temozolomide; systemic
3.0
14.7
64
215
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
1.7
14.7
255
1500
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.9
14.7
69
242
SAA04
NOMESCO Finland
Special examination of mouth
1.6
14.7
380
2472
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
1.6
14.7
382
2488
K76.9
ICD-10 Finland
Liver disease, unspecified
2.3
14.7
109
478
J01EA01
ATC
trimethoprim; systemic
1.2
14.7
1913
16062
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
1.9
14.7
172
898
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
13.2
14.6
25
19
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.3
14.6
960
7397
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.6
14.6
364
2347
TDM10
NOMESCO Finland
Puncture of maxillary antrum
1.7
14.6
265
1579
2879X
ICD-9 Finland
Purpura and other haemorrhagic conditions, Unspecified haemorrhagic conditions
+∞
14.6
14
*
N08.2*D65
ICD-10 Finland
Glomerular disorders in disseminated intravascular coagulation [defibrination syndrome]
+∞
14.6
14
*
2873X
ICD-9 Finland
Purpura and other haemorrhagic conditions, Primary thrombocytopenia[THROMBOCYTOPENIA PRIMARIA NUD]
+∞
14.6
14
*
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
1.5
14.6
409
2709
H26.3
ICD-10 Finland
Drug-induced cataract
3.2
14.6
55
170
PG1PT
NOMESCO Finland
Extensive endovascular embolisation for bleeding with radiological guidance not elsewhere classified
3.5
14.5
48
136
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.4
14.5
782
5847
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
1.9
14.5
175
923
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
2.4
14.5
98
413
R05
ICD-10 Finland
Cough
1.3
14.4
1657
13716
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
1.5
14.3
461
3142
I27.2
ICD-10 Finland
Other secondary pulmonary hypertension
3.4
14.3
50
147
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.4
14.3
761
5678
XX9XW, ,
NOMESCO Finland
3.0
14.3
62
208
C82.1
ICD-10 Finland
Follicular lymphoma grade II
3.2
14.3
56
177
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
3.3
14.3
53
162
WX722
NOMESCO Finland
PEEP
1.6
14.3
315
1975
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
1.9
14.2
169
886
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.4
14.2
637
4621
N06AA09
ATC
amitriptyline; systemic
1.4
14.2
631
4573
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
2.5
14.1
85
339
I10
ICD-10 Finland
Essential (primary) hypertension
1.2
14.1
4712
43156
N03AX09
ATC
lamotrigine; oral
1.6
14.1
348
2239
NGQ20
NOMESCO Finland
Amputation of lower leg
3.4
14.1
49
144
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
1.5
14.0
389
2570
ZXH04
NOMESCO Finland
Procedure performed in other inpatient unit
3.2
14.0
53
164
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
4.0
14.0
39
98
EB1WA, ,
NOMESCO Finland
3.0
14.0
59
195
ZYC01
NOMESCO Finland
Remote contact by phone
1.5
14.0
454
3101
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
1.8
14.0
210
1187
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
2.2
14.0
117
540
WF004
NOMESCO Finland
Palliative radiotherapy
2.0
14.0
153
781
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
2.0
13.9
142
706
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
1.7
13.9
266
1607
M54.5
ICD-10 Finland
Low back pain
1.2
13.9
2873
25225
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
10.0
13.9
27
27
KBV00
NOMESCO Finland
Insertion of stent into ureter
3.0
13.9
60
201
WX610
NOMESCO Finland
Patient controlled analgesia
2.9
13.9
63
217
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
4.1
13.9
37
90
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.4
13.9
685
5051
E27.4
ICD-10 Finland
Other and unspecified adrenocortical insufficiency
4.2
13.8
36
86
J01FA09
ATC
clarithromycin; systemic
1.2
13.8
2304
19823
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
1.5
13.8
399
2660
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
2.4
13.8
92
385
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
1.5
13.8
367
2403
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
4.3
13.8
35
82
ZXE60
NOMESCO Finland
More than 12 and less than 15 hours
2.9
13.8
63
218
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.3
13.7
853
6518
I36.1
ICD-10 Finland
Nonrheumatic tricuspid (valve) insufficiency
2.3
13.7
106
473
3A064, ,
NOMESCO Finland
3.9
13.6
39
100
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
2.7
13.6
70
258
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.6
13.6
342
2210
N02BF02
ATC
pregabalin; oral
1.5
13.6
494
3448
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
3.6
13.6
44
123
K07
ICPC
Swollen ankles/oedema
1.6
13.6
340
2195
103
Kela drug reimbursment
Diabetes, insulin-treated
1.2
13.6
1944
16468
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.8
13.6
212
1212
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.3
13.6
957
7448
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
1.6
13.5
353
2301
28798
ICD-8 Finland
Purpura and other haemorrhagic conditions, Purpura et status haemorrhagicus alius
+∞
13.5
13
*
L60.0
ICD-10 Finland
Ingrowing nail
1.6
13.5
352
2294
RS221, ,
NOMESCO Finland
2.2
13.5
110
502
G47.3
ICD-10 Finland
Sleep apnoea
1.2
13.5
1648
13727
WNF00
NOMESCO Finland
Infection source and contact determination
3.7
13.5
41
110
R05FB02
ATC
cough suppressants and expectorants; systemic
1.2
13.5
2686
23496
A07DA03
ATC
loperamide; oral
1.7
13.4
225
1312
C10AC01
ATC
colestyramine; oral
1.8
13.4
198
1113
M31.8
ICD-10 Finland
Other specified necrotizing vasculopathies
10.0
13.4
26
26
D83.0
ICD-10 Finland
Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
16.2
13.4
21
13
SPAT1254
SPAT
Administration of medicine
1.3
13.4
1100
8736
I82.80
ICD-10 Finland
Emboli and thrombosis in the subclavian vein
5.2
13.4
27
52
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
3.4
13.4
47
139
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
2.2
13.4
104
466
AA1BD
NOMESCO Finland
Extensive CT of head and brain
1.9
13.4
171
920
9940/3-C42.1
ICD-O-3
Hairy cell leukemia, NOS, of bone marrow
18.2
13.3
20
11
K02.9
ICD-10 Finland
Dental caries, unspecified
2.1
13.3
126
610
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
2.5
13.3
84
343
R00.0
ICD-10 Finland
Tachycardia, unspecified
1.6
13.3
300
1891
9680/3-C77.8
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions
4.8
13.3
29
60
C02AC05
ATC
moxonidine; oral
1.6
13.3
309
1963
T80.8
ICD-10 Finland
Other complications following infusion, transfusion and therapeutic injection
6.3
13.3
22
35
WVA30
NOMESCO Finland
Intramuscular and subcutaneous injection
3.1
13.3
54
175
WX890
NOMESCO Finland
Intesive care monitoring
2.9
13.2
60
207
288
Kela drug reimbursment
Febuxostat
3.7
13.2
40
107
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
2.0
13.2
146
748
R5140
NOMESCO Finland
Monitoring the use of the aid
1.3
13.2
767
5803
R4180
NOMESCO Finland
Podiatric therapy
2.3
13.2
95
412
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
2.1
13.1
122
587
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
3.5
13.0
43
122
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
2.1
13.0
114
536
W22
ICD-10 Finland
Striking against or struck by other object(s)
1.5
13.0
462
3214
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
3.6
13.0
41
113
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
2.7
13.0
70
265
R2110
NOMESCO Finland
Giving the first information
1.5
12.9
469
3274
ZXE90
NOMESCO Finland
More than 22 hours
2.9
12.9
58
199
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
1.4
12.9
593
4320
K76.6
ICD-10 Finland
Portal hypertension
13.0
12.9
22
17
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
4.2
12.9
33
78
D73.0
ICD-10 Finland
Hyposplenism
22.5
12.9
18
8
S01GX01
ATC
cromoglicic acid; ophthalmic
1.2
12.9
1455
12009
Z35.2
ICD-10 Finland
Supervision of pregnancy with other poor reproductive or obstetric history
2.0
12.9
127
625
E66.01
ICD-10 Finland
Obesity due to excess calories
1.4
12.8
684
5107
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
2.8
12.8
64
233
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
1.4
12.7
512
3645
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
1.8
12.7
189
1066
GD1UN
NOMESCO Finland
Lung circulation SPECT
3.2
12.7
50
159
E66.00
ICD-10 Finland
Metabolic syndrome
1.5
12.7
375
2514
TK820
NOMESCO Finland
Peritoneal dialysis
3.3
12.7
47
144
C83.00
ICD-10 Finland
Lymphocytic lymphoma
4.2
12.7
33
79
S20.2
ICD-10 Finland
Contusion of thorax
1.5
12.7
377
2531
SXB00
NOMESCO Finland
Removal of sutures from oral mucosa
1.5
12.6
460
3214
B81
ICPC
Anaemia vit B12/folate deficiency
1.6
12.6
272
1696
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
2.4
12.6
81
334
D07AA02
ATC
hydrocortisone; topical
1.3
12.6
1028
8157
C01BD01
ATC
amiodarone; systemic
1.8
12.6
191
1084
I82
ICD-10 Finland
Other venous embolism and thrombosis
4.5
12.6
30
67
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
2.7
12.5
66
247
XG410
NOMESCO Finland
Flow-volume spirometry
1.6
12.5
271
1692
A01AB09
ATC
miconazole; local oral
1.4
12.5
572
4164
194
Kela drug reimbursment
Blood coagulation factor VIII and von Willebrand factor for the treatment of von Willebrand disease
+∞
12.5
12
*
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
2.0
12.5
140
721
I34.2
ICD-10 Finland
Nonrheumatic mitral (valve) stenosis
3.9
12.5
36
93
D02AX
ATC
Other emollients and protectives
1.7
12.5
224
1333
SPAT1249
SPAT
Treatment-related counselling outside office
1.2
12.4
3025
26884
SXC03
NOMESCO Finland
Other oral or dental procedure
2.4
12.4
82
342
AB2
HP
AVR bio, stent
3.1
12.4
50
161
K90
ICPC
Stroke/cerebrovascular accident
1.7
12.4
206
1199
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
2.1
12.4
112
533
R05FA02
ATC
opium derivatives and expectorants; systemic
1.2
12.4
2918
25861
B73
ICPC
Leukaemia
5.0
12.4
26
52
J01CA08
ATC
pivmecillinam; oral
1.2
12.4
3024
26883
R06AX27
ATC
desloratadine; oral
1.2
12.4
2194
18955
EB1BA
NOMESCO Finland
Extensive intraoral X-ray examination
3.5
12.3
41
117
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.4
12.3
532
3835
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
1.5
12.3
384
2603
H53.1
ICD-10 Finland
Subjective visual disturbances
1.4
12.3
510
3650
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
1.6
12.3
247
1514
R04.2
ICD-10 Finland
Haemoptysis
1.6
12.3
246
1507
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
1.6
12.3
281
1779
N04BC05
ATC
pramipexole; oral
1.4
12.2
503
3596
C03AA03
ATC
hydrochlorothiazide; oral
1.4
12.2
588
4320
R05
ICPC
Cough
1.2
12.2
1929
16486
Y89.9
ICD-10 Finland
Sequelae of unspecified external cause
2.4
12.2
84
358
J45
ICD-10 Finland
Asthma
1.3
12.2
749
5716
N05BA06
ATC
lorazepam; systemic, sublingual
1.5
12.1
342
2269
J01MA06
ATC
norfloxacin; oral
1.3
12.1
881
6880
D06AX01
ATC
fusidic acid; topical
1.4
12.1
643
4795
B18.2
ICD-10 Finland
Chronic viral hepatitis C
2.4
12.1
81
340
WX213
NOMESCO Finland
Lower leg blockade
2.5
12.1
73
292
N25.0
ICD-10 Finland
Renal osteodystrophy
4.4
12.1
30
69
N03AG01
ATC
valproic acid; systemic, rectal
1.5
12.1
404
2776
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
6.0
12.1
21
35
K59.1
ICD-10 Finland
Functional diarrhoea
1.5
12.1
403
2769
349
Kela drug reimbursment
Febuxostat
3.9
12.0
35
91
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
2.4
12.0
79
329
315
Kela drug reimbursment
Clopidogrel
2.4
12.0
77
317
N03AX18
ATC
lacosamide; systemic
2.6
12.0
67
258
A07EC01
ATC
sulfasalazine; oral, rectal
1.4
12.0
536
3886
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.2
12.0
1668
14066
T81.9
ICD-10 Finland
Unspecified complication of procedure
1.9
12.0
137
711
K29.6
ICD-10 Finland
Other gastritis
2.3
12.0
89
392
Z51.3
ICD-10 Finland
Blood transfusion (without reported diagnosis)
9.2
11.9
24
26
4273A
ICD-9 Finland
Cardiac dysrhythmias, Atrial fibrillation and flutter
2.1
11.9
113
549
D51.9
ICD-10 Finland
Vitamin B12deficiency anaemia, unspecified
2.2
11.9
92
412
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
2.2
11.9
97
444
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
3.1
11.9
47
150
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.2
11.9
1723
14593
TGD00
NOMESCO Finland
Needle biopsy of lung
3.3
11.9
43
130
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
1.8
11.8
182
1037
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
2.0
11.8
133
686
R01AD09
ATC
mometasone; nasal
1.2
11.8
3520
31773
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
2.7
11.8
61
226
Z83.2
ICD-10 Finland
Family history of diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
11.7
11.8
21
18
Q79.6
ICD-10 Finland
Ehlers-Danlos syndrome
3.9
11.8
34
88
DKW30
NOMESCO Finland
Cauterisation of artery of internal nose
2.9
11.8
52
177
D83.9
ICD-10 Finland
Common variable immunodeficiency, unspecified
14.6
11.8
19
13
E86
ICD-10 Finland
Volume depletion
1.8
11.8
172
966
RS230, ,
NOMESCO Finland
3.1
11.8
47
151
N05CF02
ATC
zolpidem; oral
1.3
11.8
1200
9783
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
2.1
11.7
106
505
SPAT1325
SPAT
Vaccination
1.2
11.7
2503
21973
A02BA03
ATC
famotidine; systemic
1.6
11.7
241
1486
A07EC02
ATC
mesalazine; oral, rectal
1.5
11.7
361
2441
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.4
11.7
524
3800
AAA10
NOMESCO Finland
Biopsy through craniotomy
10.5
11.7
22
21
A01AB04
ATC
amphotericin B; local oral
1.6
11.6
287
1849
D50.8
ICD-10 Finland
Other iron deficiency anaemias
2.0
11.6
125
635
E83.51
ICD-10 Finland
Hypocalcemia
2.8
11.6
56
200
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
3.1
11.6
46
147
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
2.2
11.6
96
442
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
2.6
11.6
66
257
TLC00
NOMESCO Finland
Insertion of intrauterine device
1.5
11.6
415
2891
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.4
11.6
651
4901
A99
ICPC
Disease/condition unspecnature/site
1.3
11.5
756
5820
A40.0
ICD-10 Finland
Sepsis due to streptococcus, group A
3.7
11.5
35
94
I34.00
ICD-10 Finland
Mitral (valve) incompetence NOS or of specified cause, except rheumatic
1.9
11.5
132
686
L01BB01, ,
ATC
5.2
11.5
23
44
Y69
ICD-10 Finland
Unspecified misadventure during surgical and medical care
2.2
11.5
97
450
R03AC03
ATC
terbutaline; inhalant
1.3
11.5
966
7691
WPA15
NOMESCO Finland
Palliative care consultation with the patient and loved ones
3.1
11.5
46
148
L84
ICD-10 Finland
Corns and callosities
1.6
11.5
239
1479
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
1.9
11.5
136
715
D46.2
ICD-10 Finland
Refractory anaemia with excess of blasts [RAEB]
9.2
11.5
23
25
PD4CM
NOMESCO Finland
Extensive MRI examination of abdominal aorta and vasculature of lower extremities with 3 Tesla magnet
4.3
11.4
29
68
T78.4
ICD-10 Finland
Allergy, unspecified
1.5
11.4
323
2145
NHQ30
NOMESCO Finland
Amputation of foot, transmetatarsal
3.0
11.4
49
164
E000003, ,
ATC
1.6
11.4
293
1905
M03BC01
ATC
orphenadrine (citrate); systemic
1.2
11.4
1575
13266
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.5
11.4
298
1946
I95.9
ICD-10 Finland
Hypotension, unspecified
2.0
11.4
117
585
K74.3
ICD-10 Finland
Primary biliary cirrhosis
2.9
11.4
51
175
R52.0
ICD-10 Finland
Acute pain
1.6
11.4
242
1505
PA6AM
NOMESCO Finland
Simple MRI examination of neck vasculature with 3 Tesla magnet
4.7
11.4
26
56
E83.50
ICD-10 Finland
Hypercalcemia
2.2
11.4
97
452
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
2.1
11.4
104
498
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.2
11.4
1733
14742
A07EA06
ATC
budesonide; oral, local oral
1.6
11.3
257
1624
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
1.9
11.3
137
725
M10.3
ICD-10 Finland
Gout due to impairment of renal function
3.3
11.3
41
124
SPAT1104
SPAT
Monitoring of emergency patient
1.4
11.3
442
3131
KH1AD
NOMESCO Finland
CT of urinary organs
1.6
11.3
249
1563
M00.9
ICD-10 Finland
Pyogenic arthritis, unspecified
2.3
11.3
83
364
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
2.6
11.3
64
249
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
2.2
11.2
94
435
N18.4
ICD-10 Finland
Chronic kidney disease, stage 4
2.3
11.2
83
365
5BA08, ,
NOMESCO Finland
3.1
11.2
45
145
NH1AE
NOMESCO Finland
Ankle joint ultrasound examination
2.6
11.2
63
244
I61.6
ICD-10 Finland
Intracerebral haemorrhage, multiple localized
4.3
11.2
28
65
Z93
ICD-10 Finland
Artificial opening status
4.0
11.2
31
78
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
3.6
11.1
36
101
D89.9
ICD-10 Finland
Disorder involving the immune mechanism, unspecified
25.0
11.1
15
6
QDA99
NOMESCO Finland
Other local destruction of skin of lower limb
4.1
11.1
30
74
QDB99
NOMESCO Finland
Other procedure for wound of skin of lower limb
3.1
11.1
45
146
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
1.7
11.1
211
1277
TQW99
NOMESCO Finland
Other minor procedure on skin
1.5
11.0
347
2358
NK4AT
NOMESCO Finland
Puncture of joint with ultrasound guidance not elsewher classified
2.4
11.0
72
300
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
1.6
11.0
237
1480
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
1.4
11.0
570
4237
1512
Kela drug reimbursment
Ibrutinib
5.7
11.0
20
35
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
2.0
11.0
120
614
L50.9
ICD-10 Finland
Urticaria, unspecified
1.6
11.0
271
1748
J02AC04
ATC
posaconazole; systemic
9.2
11.0
22
24
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
1.9
11.0
130
684
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
1.5
11.0
296
1948
C09CA06
ATC
candesartan; oral
1.2
10.9
1730
14763
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
2.1
10.9
96
453
I11.0
ICD-10 Finland
Hypertensive heart disease with (congestive) heart failure
1.7
10.9
197
1175
K83.0
ICD-10 Finland
Cholangitis
2.0
10.9
108
533
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
1.5
10.9
338
2289
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
1.9
10.9
133
706
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.3
10.9
1138
9297
N03AE01
ATC
clonazepam; systemic
1.5
10.9
377
2610
R06AX13
ATC
loratadine; oral
1.3
10.9
1035
8363
N06AX16
ATC
venlafaxine; oral
1.3
10.9
995
8002
D86.0
ICD-10 Finland
Sarcoidosis of lung
2.3
10.9
83
370
L29
ICPC
Musculoskeletal sympt/complt other
1.3
10.9
643
4877
I62.0
ICD-10 Finland
Nontraumatic subdural haemorrhage
2.7
10.9
58
219
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.3
10.9
680
5201
UJH02
NOMESCO Finland
Anoscopy
1.6
10.9
262
1681
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.5
10.8
378
2622
LCA06
NOMESCO Finland
Biopsy of endometrium
1.3
10.8
727
5617
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.4
10.8
450
3224
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
11.9
10.8
19
16
E000002, ,
ATC
1.3
10.8
760
5909
PD4CG
NOMESCO Finland
Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
2.2
10.8
92
429
M05BB03
ATC
alendronic acid and colecalciferol; oral
1.9
10.8
137
737
WPA45
NOMESCO Finland
Continuous drug infusion in palliative care
4.2
10.8
28
67
N17.0
ICD-10 Finland
Acute renal failure with tubular necrosis
3.2
10.8
42
133
PB1DE
NOMESCO Finland
Upper extremity arteries ultrasound examination with Doppler method
3.3
10.8
39
118
S21
ICPC
Skin texture symptom/complaint
1.3
10.8
1118
9129
J01DA09
ATC
[U] cefadroxil
1.2
10.7
1901
16395
V03AE04
ATC
calcium acetate and magnesium carbonate; systemic
9.6
10.7
21
22
5AB14, ,
NOMESCO Finland
4.9
10.7
23
47
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.2
10.7
1206
9937
N96
ICD-10 Finland
Habitual aborter
2.9
10.7
50
176
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
2.9
10.7
47
160
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.3
10.7
75
323
SPAT1310
SPAT
Counselling related to known health issue
1.2
10.6
2345
20622
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
2.1
10.6
94
446
D73.5
ICD-10 Finland
Infarction of spleen
5.3
10.6
21
40
Z92.1
ICD-10 Finland
Personal history of long-term (current) use of anticoagulants
5.3
10.6
21
40
1CX01, ,
NOMESCO Finland
5.3
10.6
21
40
J80
ICD-10 Finland
Adult respiratory distress syndrome
3.7
10.5
32
86
M01AG02
ATC
tolfenamic acid; oral, rectal
1.3
10.5
985
7944
N08.5*M32.1
ICD-10 Finland
Glomerular disorders in systemic lupus erythematosus
11.2
10.5
19
17
PD1BD
NOMESCO Finland
Extensive CT of abdominal aorta and branches
2.5
10.5
64
258
WW402
NOMESCO Finland
Leucoferesis
8.5
10.5
22
26
I20.90
ICD-10 Finland
Angina pectoris, unspecified
1.6
10.5
212
1303
153
Kela drug reimbursment
Lenalidomid
2.9
10.5
48
167
B37.7
ICD-10 Finland
Candidal sepsis
4.5
10.5
25
56
R1260
NOMESCO Finland
Evaluation of communicative skills
2.0
10.4
109
549
J12.8
ICD-10 Finland
Other viral pneumonia
2.4
10.4
69
289
XFE00
NOMESCO Finland
Epicardial ultrasonography
1.8
10.4
149
832
A10BH05
ATC
linagliptin; oral
1.5
10.4
339
2320
2869X
ICD-9 Finland
Coagulation defects, Other and unspecified coagulation defects
+∞
10.4
10
*
M36.4
ICD-10 Finland
Arthropathy in hypersensitivity reactions classified elsewhere
+∞
10.4
10
*
B02BD06
ATC
von Willebrand factor and coagulation factor VIII in combination; parenteral, topical, urethral
+∞
10.4
10
*
M04AA03
ATC
febuxostat; oral
3.5
10.4
35
101
D09AB01
ATC
zinc bandage without supplements; topical
1.9
10.4
133
718
D75.8
ICD-10 Finland
Other specified diseases of blood and blood-forming organs
5.4
10.4
20
37
RS311, ,
NOMESCO Finland
3.7
10.4
32
87
Y88
ICD-10 Finland
Sequelae with surgical and medical care as external cause
2.5
10.4
65
266
R33
ICD-10 Finland
Retention of urine
1.4
10.3
551
4114
AP2
HP
Catheterization of the right side of the heart
3.6
10.3
33
92
B05DB
ATC
Hypertonic solutions
2.7
10.3
54
202
R10.0
ICD-10 Finland
Acute abdomen
1.6
10.3
227
1426
J01XX08
ATC
linezolid; systemic
2.7
10.3
52
191
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
2.7
10.3
52
191
C81.0
ICD-10 Finland
Nodular lymphocyte predominant Hodgkin lymphoma
5.1
10.3
21
41
N29
ICPC
Neurological sympt/complt other
1.8
10.3
137
749
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.5
10.3
365
2541
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
1.9
10.3
123
650
XF602
NOMESCO Finland
Bloodpressure monitoring
2.1
10.3
88
412
M31.3
ICD-10 Finland
Wegener granulomatosis
3.4
10.3
35
102
NG4AA
NOMESCO Finland
Lower leg X-ray examination
1.6
10.2
223
1397
I72.4
ICD-10 Finland
Aneurysm and dissection of artery of lower extremity
3.4
10.2
36
107
A10AE05
ATC
insulin detemir; parenteral
1.5
10.2
357
2477
A97
ICPC
No disease
1.2
10.2
1523
12914
SPAT1231
SPAT
Assessment of adjustments needed in living environment
1.9
10.2
124
658
R4150
NOMESCO Finland
Neuropsychological rehabilitation
2.5
10.2
60
238
TJA10
NOMESCO Finland
Laparocentesis
4.0
10.2
28
70
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
1.6
10.2
250
1611
R03AK08
ATC
formoterol and beclometasone; inhalant
1.5
10.2
299
2004
I25.2
ICD-10 Finland
Old myocardial infarction
1.4
10.2
426
3057
K50.1
ICD-10 Finland
Crohn disease of large intestine
2.1
10.2
87
407
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
2.7
10.1
51
187
D01
ICPC
Abdominal pain/cramps general
1.3
10.1
919
7383
UJD02
NOMESCO Finland
Gastroscopy
1.5
10.1
312
2113
B37.08
ICD-10 Finland
Other candidal stomatitis
2.4
10.1
68
288
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.3
10.0
738
5772
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
2.0
10.0
110
564
NH3EA
NOMESCO Finland
Feet X-ray examination with load
1.9
10.0
131
712
9945/3-C42.1
ICD-O-3
Chronic myelomonocytic leukemia, NOS, of bone marrow
11.3
10.0
18
16
C08DA01
ATC
verapamil; systemic
1.5
10.0
260
1697
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
4.0
10.0
28
71
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
2.1
10.0
91
436
ZXC40
NOMESCO Finland
Use of ultrasound
2.7
10.0
52
194
N92.2
ICD-10 Finland
Excessive menstruation at puberty
4.5
10.0
24
54
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
1.8
10.0
144
807
K50
ICPC
Cardiovascular, Medication/prescr/renewal
3.3
10.0
36
109
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.3
9.9
729
5701
S80.1
ICD-10 Finland
Contusion of other and unspecified parts of lower leg
1.6
9.9
238
1527
S00.0
ICD-10 Finland
Superficial injury of scalp
1.7
9.9
170
1002
R52.2
ICD-10 Finland
Other chronic pain
1.5
9.9
257
1678
Z02.7
ICD-10 Finland
Issue of medical certificate
1.4
9.9
533
3988
PG1XE
NOMESCO Finland
Other ultrasound examination of blood vessel not elsewhere classified
2.6
9.9
54
207
L12
ICPC
Hand/finger symptom/complaint
1.2
9.9
1280
10704
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.4
9.8
465
3406
Z51.88
ICD-10 Finland
Other specified medical care
1.8
9.8
144
811
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.4
9.8
411
2949
PA6AD
NOMESCO Finland
CT of neck arteries
1.6
9.8
252
1641
PWE00
NOMESCO Finland
Reoperation for deep haemorrhage in surgery of peripheral vessels and lymphatic system
3.3
9.8
36
110
R74.0
ICD-10 Finland
Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
1.8
9.8
148
841
R5599
NOMESCO Finland
Other rehabilitation service
1.7
9.8
189
1149
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.3
9.8
864
6918
R01BA52
ATC
pseudoephedrine, combinations; oral
1.2
9.8
2043
17858
WZA10
NOMESCO Finland
Extensive medical or dental certificate
2.1
9.8
94
460
WF002
NOMESCO Finland
Radical radiotherapy
1.4
9.8
368
2592
742, ,
NOMESCO Finland
4.0
9.7
27
68
K70.0
ICD-10 Finland
Alcoholic fatty liver
2.6
9.7
56
220
K60
ICPC
Cardiovascular, Result test/procedure
2.6
9.7
56
220
OAA80, ,
SPAT
0.7
9.7
370
5160
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
1.4
9.7
459
3364
C07AA07
ATC
sotalol; systemic
1.6
9.6
232
1489
R1240
NOMESCO Finland
Social assessment of need and possibilities of rehabilitation
2.3
9.6
69
300
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
1.6
9.6
208
1302
FPE00
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with ventricular electrode
1.8
9.6
138
773
RS121, ,
NOMESCO Finland
2.7
9.6
50
187
PH2DE
NOMESCO Finland
Ultrasound examination of bloodflow in veins of lower extremity with Doppler method
1.7
9.6
180
1087
K65.8
ICD-10 Finland
Other peritonitis
3.7
9.6
29
78
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
2.4
9.6
63
264
C10AA01
ATC
simvastatin; oral
1.2
9.6
2897
26075
T90
ICPC
Diabetes non-insulin dependent
1.2
9.5
1695
14604
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
2.0
9.5
102
519
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
2.1
9.5
86
411
M03BX02
ATC
tizanidine; oral
1.1
9.5
4814
44917
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
2.2
9.5
73
327
M79.0
ICD-10 Finland
Rheumatism, unspecified
1.6
9.5
203
1267
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.3
9.5
562
4265
S70.0
ICD-10 Finland
Contusion of hip
1.5
9.5
269
1791
PEH57
NOMESCO Finland
Bypass from femoral artery to popliteal artery below knee
2.5
9.5
56
223
XLA10, ,
NOMESCO Finland
1.5
9.5
277
1856
K22
ICPC
Risk factor cardiovascular disease
1.4
9.5
383
2733
AA1
HP
Conventional CABG
1.9
9.5
121
654
A04AD12
ATC
aprepitant; systemic
1.8
9.4
126
690
F01
ICPC
Eye pain
1.6
9.4
206
1293
K02.1
ICD-10 Finland
Caries of dentine
1.1
9.4
4765
44450
F43.29
ICD-10 Finland
Adaptation disorder UNS
1.7
9.4
162
956
E83.4
ICD-10 Finland
Disorders of magnesium metabolism
4.1
9.4
25
61
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
1.6
9.4
203
1270
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
1.5
9.4
308
2112
R03AK07
ATC
formoterol and budesonide; inhalant
1.2
9.4
1532
13095
K77
ICPC
Heart failure
1.7
9.4
148
852
2874X
ICD-9 Finland
Purpura and other haemorrhagic conditions, Secondary thrombocytopenia[THROMBOCYTOPENIA SECUNDARIA NUD]
+∞
9.4
9
*
K29.1
ICD-10 Finland
Other acute gastritis
2.1
9.4
86
414
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
1.4
9.4
450
3307
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
1.7
9.3
147
846
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
1.7
9.3
147
846
M30.8
ICD-10 Finland
Other conditions related to polyarteritis nodosa
12.3
9.3
16
13
Z35
ICD-10 Finland
Supervision of high-risk pregnancy
2.4
9.3
63
267
A79
ICPC
Malignancy NOS
1.9
9.3
110
579
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
2.3
9.3
70
311
Z94.2
ICD-10 Finland
Lung transplant status
4.3
9.3
23
53
C10AA05
ATC
atorvastatin; oral
1.2
9.3
3029
27396
-50
ICPC
Medication/prescr/renewal
1.5
9.3
268
1791
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.1
9.3
3576
32728
Z99.2
ICD-10 Finland
Dependence on renal dialysis
6.9
9.3
22
32
XX2RW, ,
NOMESCO Finland
2.0
9.3
97
490
XQ848
NOMESCO Finland
Dermatological photography
1.6
9.3
195
1213
R01AD12
ATC
fluticasone furoate; nasal
1.2
9.3
2336
20723
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
1.5
9.2
276
1858
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
2.5
9.2
54
214
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
1.7
9.2
160
946
Y96.9
ICD-10 Finland
Unspecified type of accident
1.8
9.2
130
724
R01AD08
ATC
fluticasone; nasal
1.2
9.2
2061
18104
NGM10
NOMESCO Finland
Fasciotomy of of knee or lower leg
2.5
9.2
56
226
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
1.6
9.2
233
1513
XF612
NOMESCO Finland
Measurement of central venous pressure
4.0
9.2
25
62
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
2.0
9.2
93
464
G04CA02
ATC
tamsulosin; oral
1.2
9.2
1639
14121
UJK12
NOMESCO Finland
Peroral cholangioscopy
3.8
9.2
27
71
9950/3-C42.1
ICD-O-3
Polycythemia vera of bone marrow
3.5
9.2
30
85
N03AF01
ATC
carbamazepine; oral, rectal
1.5
9.2
307
2115
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
2.4
9.2
61
257
AS4
HP
Physiological pacemaker insertion DDD (R)
2.1
9.2
88
431
C93.1
ICD-10 Finland
Chronic myelomonocytic leukaemia
13.7
9.2
15
11
Z35.1
ICD-10 Finland
Supervision of pregnancy with history of abortive outcome
2.9
9.2
40
136
RK110, ,
NOMESCO Finland
2.4
9.1
58
239
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
3.3
9.1
33
100
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
3.2
9.1
34
105
S80.0
ICD-10 Finland
Contusion of knee
1.3
9.1
530
4011
RS222, ,
NOMESCO Finland
2.1
9.1
82
392
R76.8
ICD-10 Finland
Other specified abnormal immunological findings in serum
7.7
9.1
20
26
M79.7
ICD-10 Finland
Fibromyalgia
1.6
9.1
227
1470
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
1.9
9.1
105
549
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
1.5
9.1
266
1784
S22.3
ICD-10 Finland
Fracture of rib
1.4
9.1
484
3616
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.2
9.1
1016
8361
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
1.4
9.1
348
2460
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
1.3
9.1
691
5432
L01XX52
ATC
venetoclax; oral
4.6
9.0
21
46
Z13.0
ICD-10 Finland
Special screening examination for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
8.3
9.0
19
23
NF3AA
NOMESCO Finland
Femur X-ray examination
1.7
9.0
145
840
A10AD05
ATC
insulin aspart; parenteral
1.9
9.0
112
600
D89.1
ICD-10 Finland
Cryoglobulinaemia
36.7
9.0
11
*
I42.9
ICD-10 Finland
Cardiomyopathy, unspecified
1.9
9.0
102
530
K50.9
ICD-10 Finland
Crohn disease, unspecified
1.9
9.0
104
544
D80.0
ICD-10 Finland
Hereditary hypogammaglobulinaemia
9.0
9.0
18
20
S92.3
ICD-10 Finland
Fracture of metatarsal bone
1.5
9.0
231
1506
SPAT1151
SPAT
Treatment of major wounds
2.1
9.0
82
394
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
2.0
9.0
87
428
HA1AA
NOMESCO Finland
X-ray mammography
1.4
8.9
489
3668
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
3.8
8.9
26
68
RK320, ,
NOMESCO Finland
2.4
8.9
60
254
ZX080
NOMESCO Finland
Image guided radiotherapy
1.8
8.9
130
732
PDQ05
NOMESCO Finland
Insertion of endovascular graft into infrarenal abdominal aorta
2.5
8.9
52
206
D59.3
ICD-10 Finland
Haemolytic-uraemic syndrome
18.6
8.9
13
7
B01AC04
ATC
clopidogrel; oral
1.2
8.9
1096
9109
WW200, ,
SPAT
0.8
8.9
1672
19205
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.3
8.9
699
5515
N08.2*D59.3
ICD-10 Finland
Glomerular disorders in haemolytic-uraemic syndrome
24.0
8.9
12
5
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
1.8
8.9
127
711
Z00.0
ICD-10 Finland
General medical examination
1.2
8.9
1404
11963
R13
ICD-10 Finland
Dysphagia
1.4
8.9
476
3560
J94.8
ICD-10 Finland
Other specified pleural conditions
1.9
8.9
107
568
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.2
8.9
923
7534
I34.1
ICD-10 Finland
Mitral (valve) prolapse
1.7
8.9
169
1026
-69
ICPC
Other reason for encounter NEC
1.5
8.9
249
1656
I20.09
ICD-10 Finland
Unstable angina
1.4
8.8
357
2547
XPX08
NOMESCO Finland
Intraoperative flow measurement
2.3
8.8
64
280
I67.6
ICD-10 Finland
Nonpyogenic thrombosis of intracranial venous system
3.9
8.8
25
64
B01AE07
ATC
dabigatran etexilate; oral
1.5
8.8
242
1601
PG5AC
NOMESCO Finland
Contrast examination of injection gate to artery or vein
4.9
8.8
19
39
WZC15, ,
NOMESCO Finland
2.3
8.8
62
268
PA6AG
NOMESCO Finland
Limited MRI examination of neck vasculature with high intensity magnet
2.6
8.8
49
190
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
1.9
8.8
105
556
N05AH04
ATC
quetiapine; oral
1.2
8.8
1269
10721
R03BA01
ATC
beclometasone; inhalant
1.2
8.8
944
7735
M79.1
ICD-10 Finland
Myalgia
1.2
8.8
1061
8804
AP3
HP
Catheterization of the right and left side of the heart
3.8
8.8
26
69
S40.0
ICD-10 Finland
Contusion of shoulder and upper arm
1.5
8.7
307
2135
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
1.6
8.7
209
1341
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.2
8.7
2032
17899
M01AH01
ATC
celecoxib; oral
1.2
8.7
1171
9819
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.3
8.7
606
4707
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
1.7
8.7
150
887
M54.6
ICD-10 Finland
Pain in thoracic spine
1.3
8.7
504
3815
R60.1
ICD-10 Finland
Generalized oedema
2.4
8.7
55
227
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
2.5
8.7
54
221
FMD10
NOMESCO Finland
Replacement of aortic valve using biological prosthesis
2.0
8.7
92
468
A06AH03
ATC
naloxegol; oral
2.0
8.6
94
482
B07.9
ICD-10 Finland
Verruca simplex
1.5
8.6
249
1665
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.2
8.6
952
7820
I71.9
ICD-10 Finland
Aortic aneurysm of unspecified site, without mention of rupture
2.0
8.6
88
441
R69
ICD-10 Finland
Unknown and unspecified causes of morbidity
1.8
8.6
128
725
M01AE03
ATC
ketoprofen; systemic, rectal
1.2
8.6
2616
23510
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
1.6
8.6
216
1401
9962/3-C42.1
ICD-O-3
Essential thrombocythemia of bone marrow
3.5
8.6
29
84
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.1
8.6
3044
27656
M01AH02
ATC
rofecoxib; oral
1.3
8.6
800
6446
N04.9
ICD-10 Finland
Nephrotic syndrome, unspecified
3.2
8.6
32
99
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
1.9
8.6
96
497
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.3
8.6
598
4645
PBU84
NOMESCO Finland
Plastic repair of arteriovenous fistula from artery of upper extremity
4.6
8.6
20
44
R41.0
ICD-10 Finland
Disorientation, unspecified
1.6
8.6
196
1245
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.2
8.6
2002
17639
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
3.0
8.5
36
120
R81
ICPC
Pneumonia
1.5
8.5
255
1718
J05AX18
ATC
letermovir; oral
16.3
8.5
13
8
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
2.2
8.5
70
323
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
2.4
8.5
56
235
9680/3-C71.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of brain, NOS
9.0
8.5
17
19
I31.9
ICD-10 Finland
Disease of pericardium, unspecified
2.5
8.5
53
217
J01FA15
ATC
telithromycin; oral
1.3
8.5
626
4899
N06AX21
ATC
duloxetine; oral
1.3
8.5
809
6537
D59.5
ICD-10 Finland
Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]
27.5
8.5
11
*
8461/3-C56.9
ICD-O-3
High grade serous carcinoma of ovary
3.1
8.5
33
105
M10
ICD-10 Finland
Gout
1.5
8.5
290
2008
62
HP
Catheterization and pressure measurement of the right side of the heart
3.2
8.5
32
100
Z85.7
ICD-10 Finland
Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
4.2
8.4
22
53
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
2.4
8.4
54
224
I33.0
ICD-10 Finland
Acute and subacute infective endocarditis
2.5
8.4
51
206
B04
ICPC
Blood symptom/complaint
2.6
8.4
45
171
G05.8*M32.1
ICD-10 Finland
Encephalitis in systemic lupus erythematosus
90.1
8.4
9
*
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
1.5
8.4
294
2044
G44.2
ICD-10 Finland
Tension-type headache
1.2
8.4
959
7907
H25.1
ICD-10 Finland
Senile nuclear cataract
1.2
8.4
1852
16239
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
4.3
8.4
21
49
KCW02
NOMESCO Finland
Lavation of bladder for coagulated blood
2.1
8.4
71
332
128
Kela drug reimbursment
Cancers of female genital organs
1.9
8.4
106
572
FNA01
NOMESCO Finland
Anastomosis to coronary artery from internal mammary artery, one distal anastamosis
1.5
8.4
285
1971
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
2.1
8.4
76
365
C01BC04
ATC
flecainide; systemic
1.6
8.4
208
1347
K50.8
ICD-10 Finland
Other Crohn disease
1.9
8.4
102
544
V03AC03
ATC
deferasirox; oral
12.7
8.4
14
11
9811/3-C42.1
ICD-O-3
B lymphoblastic leukemia/lymphoma, NOS, of bone marrow
12.7
8.4
14
11
R74
ICPC
Upper respiratory infection acute
1.2
8.3
2534
22765
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.3
8.3
621
4867
C07AB03
ATC
atenolol; systemic
1.4
8.3
358
2583
M30.1
ICD-10 Finland
Polyarteritis with lung involvement [Churg-Strauss]
7.8
8.3
18
23
MAC96
NOMESCO Finland
Other induction or advancement of labour
1.7
8.3
133
770
28610
ICD-8 Finland
Coagulation defects, Christmas disease
+∞
8.3
8
*
2BDXX, ,
NOMESCO Finland
+∞
8.3
8
*
J01CE08
ATC
benzathine benzylpenicillin; parenteral
2.1
8.3
76
366
C09CA01
ATC
losartan; oral
1.2
8.3
1770
15475
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.3
8.3
742
5951
M03BX01
ATC
baclofen; systemic
1.8
8.3
125
712
FWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels
2.5
8.3
48
190
H53.2
ICD-10 Finland
Diplopia
1.5
8.3
212
1383
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
1.6
8.3
190
1209
PAW37
NOMESCO Finland
Biopsy of temporal artery
2.5
8.3
51
208
I70.9
ICD-10 Finland
Generalized and unspecified atherosclerosis
1.8
8.3
112
618
J01MA01
ATC
ofloxacin; systemic
1.3
8.2
523
4011
9101
FHL
Bone biopsy
4.1
8.2
22
54
O36.5
ICD-10 Finland
Maternal care for poor fetal growth
1.7
8.2
152
916
I20.80
ICD-10 Finland
Other angina pectoris no detected stenosis of coronary artery
1.9
8.2
91
470
N39.1
ICD-10 Finland
Persistent proteinuria, unspecified
2.7
8.2
42
156
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
1.6
8.2
178
1117
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
1.5
8.2
252
1709
R03BA05
ATC
fluticasone; inhalant
1.2
8.2
1279
10881
QXA20
NOMESCO Finland
Skin abrasion, unspecified location
3.2
8.2
31
97
A40.9
ICD-10 Finland
Streptococcal sepsis, unspecified
3.3
8.2
29
87
A60
ICPC
General and Unspecified, Result test/procedure
1.5
8.2
283
1964
399
Kela drug reimbursment
Venetoclax
4.2
8.2
21
50
K01.16
ICD-10 Finland
Retained molar with obstruction in the upper jaw
2.0
8.2
89
457
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
1.3
8.2
460
3467
L08.0
ICD-10 Finland
Pyoderma
2.1
8.2
70
329
J01DC02
ATC
cefuroxime; systemic
1.4
8.2
343
2466
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
1.6
8.2
181
1142
WX203
NOMESCO Finland
Infraclavicular plexus blockade
1.7
8.2
153
926
I47.1
ICD-10 Finland
Supraventricular tachycardia
1.5
8.2
269
1850
N28
ICPC
Limited function/disability (N)
1.8
8.1
117
657
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
7.5
8.1
18
24
ZPB22
NOMESCO Finland
Autograft of vein
2.8
8.1
39
140
E66.9
ICD-10 Finland
Obesity, unspecified
1.5
8.1
240
1614
C10AA03
ATC
pravastatin; oral
1.3
8.1
442
3314
K91
ICPC
Cerebrovascular disease
1.9
8.1
93
486
3025
Kela drug reimbursment
Calcium carbonate
2.5
8.1
47
186
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
2.0
8.1
79
390
M54
ICD-10 Finland
Dorsalgia
1.2
8.1
877
7189
L01XX35
ATC
anagrelide; oral
4.7
8.1
18
38
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
1.7
8.1
132
770
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.2
8.1
860
7039
QC6S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in hand
4.0
8.0
22
55
A10BA02
ATC
metformin; oral
1.2
8.0
1987
17571
T36
ICD-10 Finland
Poisoning by systemic antibiotics
1.5
8.0
266
1831
N02BF01
ATC
gabapentin; oral
1.3
8.0
702
5615
O20.9
ICD-10 Finland
Haemorrhage in early pregnancy, unspecified
1.6
8.0
156
953
S06.6
ICD-10 Finland
Traumatic subarachnoid haemorrhage
2.2
8.0
65
299
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
1.6
8.0
174
1093
PD5AD
NOMESCO Finland
CT of aorta
1.6
8.0
156
954
XG466
NOMESCO Finland
Sleep oxymetry
1.6
8.0
183
1164
X57
ICD-10 Finland
Unspecified privation
1.7
8.0
154
939
GE1BE
NOMESCO Finland
Mediastinal ultrasound examinaiton through oesophagus
4.1
8.0
21
51
SPAT1281
SPAT
Other administrative function
1.3
8.0
519
3995
N02AC04
ATC
dextropropoxyphene; oral
1.5
8.0
219
1451
N02AA01
ATC
morphine; systemic, rectal
1.8
8.0
121
691
S01
ICPC
Pain/tenderness of skin
1.4
8.0
314
2233
130
Kela drug reimbursment
Malignant tumour
1.3
8.0
568
4428
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
2.0
7.9
79
393
WPA44
NOMESCO Finland
Nursing home for palliative care
3.5
7.9
26
74
TJJ00
NOMESCO Finland
Percutaneous needle biopsy of liver
3.5
7.9
26
74
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
1.5
7.9
217
1436
R06AE09
ATC
levocetirizine; oral
1.2
7.9
970
8055
N08.5*M31.3
ICD-10 Finland
Glomerular disorders in Wegener's granulomatosis
4.3
7.9
20
47
D01AE15
ATC
terbinafine; topical
1.3
7.9
454
3432
SBB10
NOMESCO Finland
Dental impressions
1.3
7.9
470
3572
S22.0
ICD-10 Finland
Fracture of thoracic vertebra
1.7
7.9
132
775
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
1.7
7.9
137
813
ZX095
NOMESCO Finland
Combined chemoradiotherapy
2.5
7.9
45
177
3A149, ,
NOMESCO Finland
13.0
7.9
13
10
T14.5
ICD-10 Finland
Injury of blood vessel(s) of unspecified body region
2.5
7.9
47
189
C95.9
ICD-10 Finland
Leukaemia, unspecified
7.7
7.9
17
22
D46.0
ICD-10 Finland
Refractory anaemia without ring sideroblasts, so stated
7.7
7.9
17
22
XCK00
NOMESCO Finland
Perimetry
1.4
7.8
392
2902
L02
ICPC
Back symptom/complaint
1.3
7.8
723
5821
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
2.0
7.8
82
416
N01BB20
ATC
amides - combinations; parenteral
2.4
7.8
53
226
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
2.1
7.8
71
342
Z22.3
ICD-10 Finland
Carrier of other specified bacterial diseases
3.5
7.8
26
75
PD1CD
NOMESCO Finland
Very extensive CT of abdominal aorta and branches
3.2
7.8
30
95
Z95.8
ICD-10 Finland
Presence of other cardiac and vascular implants and grafts
2.8
7.8
38
138
JN1AD
NOMESCO Finland
CT examination of upper part of abdomen
2.7
7.8
41
155
I72.8
ICD-10 Finland
Aneurysm and dissection of other specified arteries
3.0
7.7
33
111
I49.5
ICD-10 Finland
Sick sinus syndrome
1.5
7.7
237
1607
L04AX04
ATC
lenalidomide; oral
2.6
7.7
43
167
XMA22
NOMESCO Finland
General examination of pregnant woman
1.4
7.7
315
2254
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
1.5
7.7
213
1413
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
1.7
7.7
132
780
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
1.8
7.7
116
661
L30.3
ICD-10 Finland
Infective dermatitis
1.5
7.7
230
1551
9705/3-C77.9
ICD-O-3
Angioimmunoblastic T-cell lymphoma of lymph node, NOS
45.0
7.7
9
*
K59.09
ICD-10 Finland
Constipation, unspecified
1.3
7.7
470
3586
K28
ICPC
Limited function/disability (K)
1.7
7.7
143
864
I42.0
ICD-10 Finland
Dilated cardiomyopathy
1.6
7.7
160
995
4538X
ICD-9 Finland
Other venous embolism and thrombosis, Of other specified veins
3.9
7.7
22
57
WX204
NOMESCO Finland
Axillary plexus blockaced
1.5
7.7
207
1367
QDB10, ,
SPAT
1.6
7.7
164
1027
C01BA03
ATC
disopyramide; systemic
2.6
7.7
42
162
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.2
7.7
2182
19494
J03.9
ICD-10 Finland
Acute tonsillitis, unspecified
1.4
7.6
343
2495
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
1.7
7.6
123
715
M03BC51
ATC
orphenadrine, combinations; systemic
1.2
7.6
1855
16376
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
1.5
7.6
215
1433
AA1AA
NOMESCO Finland
Head X-ray examination
2.2
7.6
58
260
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
1.5
7.6
230
1555
R4130
NOMESCO Finland
Speech therapy
1.6
7.6
172
1091
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.1
7.6
4302
40194
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
1.5
7.6
191
1242
GD1CQ
NOMESCO Finland
Lung circulation SPECT with low dose CT
4.0
7.6
21
53
C92.4
ICD-10 Finland
Acute promyelocytic leukaemia [PML]
18.3
7.6
11
6
R03BB01
ATC
ipratropium bromide; inhalant
1.5
7.6
225
1516
M80.8
ICD-10 Finland
Other osteoporosis with pathological fracture
2.7
7.6
38
140
R35
ICD-10 Finland
Polyuria
1.3
7.6
463
3534
4019X
ICD-9 Finland
Essential hypertension, Unspecified
1.6
7.6
161
1007
AB18W, ,
NOMESCO Finland
11.8
7.6
13
11
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
1.8
7.6
98
534
N92.6
ICD-10 Finland
Irregular menstruation, unspecified
1.4
7.6
403
3014
Z71
ICD-10 Finland
Persons encountering health services for other counselling and medical advice, not elsewhere classified
1.5
7.6
242
1656
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
1.3
7.5
451
3431
SPAT1216
SPAT
Assessment of functional ability
1.2
7.5
1036
8705
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.4
7.5
394
2938
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
1.6
7.5
147
900
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
4.1
7.5
20
49
1518, ,
Kela drug reimbursment
4.1
7.5
20
49
L04AA05
ATC
[U] tacrolimus
6.1
7.5
19
31
C84.49
ICD-10 Finland
Peripheral T-cell lymphoma, unspecified cell type
10.0
7.5
14
14
121
Kela drug reimbursment
Severe hypofunction of sexual glands
1.8
7.5
115
659
L88
ICD-10 Finland
Pyoderma gangrenosum
3.8
7.5
22
58
WYA20
NOMESCO Finland
Home visit
1.7
7.5
121
704
L01AA02
ATC
chlorambucil; oral
3.3
7.5
27
82
L04AB01
ATC
etanercept; parenteral
1.8
7.5
104
579
A08.3
ICD-10 Finland
Other viral enteritis
3.0
7.5
32
108
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
2.1
7.5
65
308
D02AE01
ATC
carbamide; topical
1.3
7.5
405
3038
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
1.5
7.4
218
1465
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.4
7.4
371
2746
G03DB01
ATC
dydrogesterone; oral
1.2
7.4
756
6156
M05BA01
ATC
etidronic acid; systemic
2.7
7.4
37
136
N03.8
ICD-10 Finland
Chronic nephritic syndrome, other
4.4
7.4
18
41
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
2.8
7.4
35
125
K51.5
ICD-10 Finland
Left sided colitis
1.6
7.4
172
1100
AP1
HP
Catheterization of the left side of the heart
1.8
7.4
95
517
M25.0
ICD-10 Finland
Haemarthrosis
2.0
7.4
75
377
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
1.6
7.4
152
944
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
1.8
7.4
112
641
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
1.6
7.4
157
983
H53.4
ICD-10 Finland
Visual field defects
1.7
7.4
134
806
K07.63
ICD-10 Finland
Pain in the jaw joint UNS
1.7
7.3
130
776
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
1.7
7.3
116
671
NH1AD
NOMESCO Finland
Ankle and foot CT
1.6
7.3
147
906
J01.8
ICD-10 Finland
Other acute sinusitis
2.3
7.3
50
214
F43.20
ICD-10 Finland
Adaptation disorder with short-term depression
1.9
7.3
87
461
L01XE27
ATC
[U] ibrutinib
8.3
7.3
15
18
D59.2
ICD-10 Finland
Drug-induced nonautoimmune haemolytic anaemia
+∞
7.3
7
*
B02BD04
ATC
coagulation factor IX; parenteral
+∞
7.3
7
*
2867X
ICD-9 Finland
Coagulation defects, Acquired coagulation factor deficiency[DEFECTIO COAGULATIONIS, E DEFICIENTIA NON DEFINITA]
+∞
7.3
7
*
Z89.7
ICD-10 Finland
Acquired absence of both lower limbs [any level, except toes alone]
+∞
7.3
7
*
2870X
ICD-9 Finland
Purpura and other haemorrhagic conditions, Allergic purpura[PURPURA ALLERGICA NUD]
+∞
7.3
7
*
2878X
ICD-9 Finland
Purpura and other haemorrhagic conditions, Other specified haemorrhagic conditions
+∞
7.3
7
*
O991, D688,
ICD-10 Finland
+∞
7.3
7
*
S11
ICPC
Skin infection post-traumatic
1.9
7.3
86
455
F43.21
ICD-10 Finland
Adaptation disorder with prolonged depression
2.1
7.3
63
298
R03BA08
ATC
ciclesonide; inhalant
1.3
7.3
561
4419
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
1.6
7.3
180
1167
D638, N189,
ICD-10 Finland
6.8
7.3
17
25
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
2.2
7.3
59
272
D70
ICD-10 Finland
Agranulocytosis
9.3
7.3
14
15
R57.9
ICD-10 Finland
Shock, unspecified
9.3
7.3
14
15
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.2
7.3
760
6208
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
1.3
7.3
447
3416
PG1CG
NOMESCO Finland
Extensive MRI examination of vasculature with high intensity magnet not elsewhere classified
4.1
7.3
19
46
A04AA55
ATC
palonosetron, combinations; systemic
1.5
7.2
219
1483
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
2.0
7.2
69
339
J01CF02
ATC
cloxacillin; systemic
1.7
7.2
132
795
W84
ICD-10 Finland
Unspecified threat to breathing
3.3
7.2
26
79
PC1CC
NOMESCO Finland
Very extensive angiography of aorta and abdominal arteries
3.3
7.2
26
79
C83.71
ICD-10 Finland
Burkitt's tumour
15.7
7.2
11
7
MA2HE
NOMESCO Finland
Detailed morfological ultrasound examination of fetus
1.2
7.2
827
6822
SAA01
NOMESCO Finland
Simple examination of mouth
1.1
7.2
5919
56472
B35.3
ICD-10 Finland
Tinea pedis
1.4
7.2
311
2249
K83
ICPC
Heart valve disease NOS
2.0
7.2
71
353
N92.1
ICD-10 Finland
Excessive and frequent menstruation with irregular cycle
1.4
7.2
356
2633
S91.1
ICD-10 Finland
Open wound of toe(s) without damage to nail
1.8
7.2
98
543
M54.4
ICD-10 Finland
Lumbago with sciatica
1.2
7.2
1259
10817
L02BG06
ATC
exemestane; oral
1.8
7.2
101
565
AB1
HP
AVR mechanical
3.0
7.2
30
100
SXA20
NOMESCO Finland
Local application of medicine to mouth
1.4
7.2
379
2832
PEE25
NOMESCO Finland
Thrombectomy or embolectomy of superficial femoral artery
4.5
7.2
17
38
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
1.5
7.2
204
1364
W10
ICD-10 Finland
Fall on and from stairs and steps
1.4
7.2
340
2498
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.2
7.2
1583
13867
PH2AE, ,
SPAT
1.6
7.2
141
866
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.2
7.1
1751
15460
N07BC02
ATC
methadone; systemic
2.9
7.1
32
111
QD9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in lower extremities, unspecified
2.4
7.1
45
186
R03AC13
ATC
formoterol; inhalant
1.4
7.1
308
2228
K74.0
ICD-10 Finland
Hepatic fibrosis
3.5
7.1
23
65
Z01.2
ICD-10 Finland
Dental examination
1.1
7.1
3648
33840
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
1.7
7.1
126
753
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
1.7
7.1
124
738
D46.1
ICD-10 Finland
Refractory anaemia with ring sideroblasts
7.9
7.1
15
19
8474
FHL
Coagulation, excision, or biopsy of local change (eg, condyloma, tumor) in operating room or anesthesia
3.3
7.1
25
75
WX302
NOMESCO Finland
Thoracal epidural anesthesy
1.4
7.1
331
2426
NG1DA
NOMESCO Finland
X-ray of knees
1.7
7.1
110
634
TPJ00
NOMESCO Finland
Biopsy of superficial lymph node
3.8
7.1
21
56
H65.3
ICD-10 Finland
Chronic mucoid otitis media
1.6
7.1
145
900
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
2.7
7.1
36
134
C08CA13
ATC
lercanidipine; oral
1.2
7.1
938
7855
C09BA02
ATC
enalapril and diuretics; systemic
1.3
7.1
484
3755
PD4ST
NOMESCO Finland
Endovascular thrombolysis of pelvic and lower extremity arteries
6.0
7.1
18
30
C02KX04
ATC
macitentan; oral
6.0
7.1
18
30
R21
ICPC
Throat symptom/complaint
1.2
7.1
1594
13986
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.2
7.0
901
7516
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.4
7.0
365
2719
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.3
7.0
693
5622
ECB00
NOMESCO Finland
Suture of gingiva
1.5
7.0
236
1631
TKA00
NOMESCO Finland
Needle biopsy of kidney or pelvis of kidney
10.0
7.0
13
13
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
2.0
7.0
68
336
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.3
7.0
605
4833
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
2.2
7.0
54
244
K51.8
ICD-10 Finland
Other ulcerative colitis
1.8
7.0
95
526
D07XC01
ATC
betamethasone; topical
1.2
7.0
784
6452
L05
ICPC
Flank/axilla symptom/complaint
1.3
7.0
429
3278
D63.8
ICD-10 Finland
Anaemia in other chronic diseases classified elsewhere
2.9
7.0
31
107
X50
ICD-10 Finland
Overexertion and strenuous or repetitive movements
1.7
7.0
128
772
Y88.1
ICD-10 Finland
Sequelae of misadventures to patients during surgical and medical procedures
1.9
7.0
86
462
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
1.5
7.0
235
1626
PHM76
NOMESCO Finland
Endovenous obliteration of v.saphena magna
1.5
7.0
235
1626
PD5CG
NOMESCO Finland
Extensive MRI examination of thoracal and abdominal aortta with high intensity magnet
3.1
7.0
27
86
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
1.4
7.0
255
1792
DKW99
NOMESCO Finland
Other procedures for control of epistaxis
3.2
7.0
26
81
E78.9
ICD-10 Finland
Disorder of lipoprotein metabolism, unspecified
1.5
6.9
209
1414
A23
ICPC
Risk factor NOS
1.3
6.9
676
5478
ZXD40
NOMESCO Finland
Procedure on patient requiring isolation
2.9
6.9
30
102
I72.3
ICD-10 Finland
Aneurysm and dissection of iliac artery
2.9
6.9
30
102
A87
ICPC
Complication of medical treatment
2.2
6.9
56
258
WYA10
NOMESCO Finland
Emergency care or similar visit
1.3
6.9
481
3738
I84.9
ICD-10 Finland
Unspecified hemorrhoids without complication
1.4
6.9
276
1969
FM1DE, ,
SPAT
2.8
6.9
32
113
C84.59
ICD-10 Finland
Other and unspecified T-cell lymphomas
6.3
6.9
17
27
D10
ICPC
Vomiting
1.3
6.9
411
3127
R06.2
ICD-10 Finland
Wheezing
1.4
6.9
291
2097
C56
ICD-10 Finland
Malignant neoplasm of ovary
2.5
6.9
40
159
NH3FA
NOMESCO Finland
Weight-bearing X-ray of foot
1.7
6.9
120
714
K25.0
ICD-10 Finland
Gastric ulcer, Acute with haemorrhage
2.0
6.9
71
359
TFP30
NOMESCO Finland
Cathetric examination for cardiac arrythmia
2.1
6.9
60
285
ZXE80
NOMESCO Finland
More than 18 and less than 21 hours
4.0
6.9
19
48
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.3
6.9
452
3488
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
1.4
6.9
263
1864
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
1.7
6.8
130
792
H01
ICPC
Ear pain/earache
1.2
6.8
848
7054
RK290, ,
NOMESCO Finland
3.4
6.8
23
67
JN5KR
NOMESCO Finland
Very extensive PET-CT of upper body metabolism (eyebrows to thighs)
3.2
6.8
26
82
I20.00
ICD-10 Finland
Unstable angina
1.5
6.8
173
1129
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
1.5
6.8
226
1559
E87.2
ICD-10 Finland
Acidosis
2.5
6.8
40
160
R19.8
ICD-10 Finland
Other specified symptoms and signs involving the digestive system and abdomen
1.8
6.8
92
509
I80.2
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
3.8
6.8
20
53
D60.9
ICD-10 Finland
Acquired pure red cell aplasia, unspecified
9.3
6.8
13
14
D86.2
ICD-10 Finland
Sarcoidosis of lung with sarcoidosis of lymph nodes
2.1
6.8
58
274
JCA42
NOMESCO Finland
Other endoscopic procedure for hemostasis
6.1
6.8
17
28
SPAT1312
SPAT
General health counselling
1.1
6.7
2337
21136
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
2.1
6.7
61
294
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
1.3
6.7
367
2756
JJ6LT
NOMESCO Finland
Coagulation of focal hepatic lesion under ultrasound guidance
4.3
6.7
17
40
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
2.5
6.7
39
155
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.2
6.7
1747
15485
WVA40
NOMESCO Finland
Initiation and monitoring of intravenous hydration
1.8
6.7
88
482
O99.0
ICD-10 Finland
Anaemia complicating pregnancy, childbirth and the puerperium
2.0
6.7
66
328
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
2.0
6.7
66
328
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
1.9
6.7
76
397
M02AA07
ATC
piroxicam; topical
1.1
6.7
2468
22406
RJ420, ,
NOMESCO Finland
2.8
6.7
32
115
A01AB10
ATC
natamycin; local oral
1.5
6.7
182
1206
WX400
NOMESCO Finland
Inhalation anesthesy
1.4
6.7
264
1881
Z32.1
ICD-10 Finland
Pregnancy confirmed
1.3
6.7
553
4396
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
2.3
6.7
45
192
J45.8
ICD-10 Finland
Mixed asthma
1.5
6.7
194
1304
D05BB02
ATC
acitretin; oral
1.6
6.7
134
828
D76.1
ICD-10 Finland
Haemophagocytic lymphohistiocytosis
22.5
6.7
9
*
PH1ST
NOMESCO Finland
Endovascular thrombolysis of upper extremity veins with radiological guidance
22.5
6.7
9
*
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
1.7
6.7
105
608
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
1.4
6.7
284
2051
AAD05
NOMESCO Finland
Evacuation of acute subdural haematoma
2.8
6.7
31
110
MA2AE
NOMESCO Finland
Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus
1.2
6.7
868
7256
T14.0
ICD-10 Finland
Superficial injury of unspecified body region
1.8
6.6
98
557
A11
ICPC
Chest pain NOS
1.3
6.6
571
4561
C02CA01
ATC
prazosin; oral
1.8
6.6
95
535
F05.9
ICD-10 Finland
Delirium, unspecified
1.6
6.6
135
837
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
1.6
6.6
142
892
SPAT1234
SPAT
Support of social functional capacity
1.4
6.6
330
2446
TLC02
NOMESCO Finland
Simple extraction of IUD
1.4
6.6
244
1719
Z86.7
ICD-10 Finland
Personal history of diseases of the circulatory system
5.9
6.6
17
29
Z00.8
ICD-10 Finland
Other general examinations
1.3
6.6
536
4253
A10BH01
ATC
sitagliptin; oral
1.3
6.6
595
4781
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
2.6
6.6
37
145
I63.8
ICD-10 Finland
Other cerebral infarction
2.1
6.6
61
297
SPAT1279
SPAT
Preparation of immediate hospitalisation
2.1
6.6
61
297
198
Kela drug reimbursment
Sorafenib
3.6
6.6
21
59
0388X
ICD-9 Finland
Septicaemia, Other specified septicaemias
3.6
6.6
21
59
TPH05
NOMESCO Finland
Open cannulation of peripheral vein
2.2
6.6
54
251
N02CA01
ATC
dihydroergotamine; nasal, systemic
2.9
6.6
29
100
N05BB01
ATC
hydroxyzine; systemic
1.3
6.6
383
2907
6489X
ICD-9 Finland
Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Other current conditions classifiable elsewhere
3.4
6.5
22
64
I82.0
ICD-10 Finland
Budd-Chiari syndrome
8.7
6.5
13
15
ZXD20
NOMESCO Finland
Day surgery
1.2
6.5
824
6865
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
1.3
6.5
435
3363
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.2
6.5
994
8432
A98.5
ICD-10 Finland
Haemorrhagic fever with renal syndrome
1.7
6.5
118
710
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.3
6.5
394
3005
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
1.6
6.5
147
935
XF640, ,
NOMESCO Finland
1.6
6.5
160
1038
N63
ICD-10 Finland
Unspecified lump in breast
1.3
6.5
420
3235
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
2.7
6.5
33
123
T81.2
ICD-10 Finland
Accidental puncture and laceration during a procedure, not elsewhere classified
2.0
6.5
65
326
R83
ICPC
Respiratory infection other
1.1
6.5
1874
16738
K27
ICPC
Fear cardiovascular disease other
2.0
6.5
66
333
A03FA02
ATC
cisapride; oral, rectal
1.3
6.5
442
3430
11
HP
Coronary artery bypass surgery
1.6
6.5
124
758
S06.3
ICD-10 Finland
Focal brain injury
1.9
6.4
77
410
FM1DG
NOMESCO Finland
Very extensive MRI examination of heart with high intesity magnet
1.8
6.4
84
460
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
1.5
6.4
219
1519
S06
ICPC
Rash localized
1.3
6.4
359
2707
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
1.5
6.4
197
1339
K04.7
ICD-10 Finland
Periapical abscess without sinus
1.3
6.4
363
2742
2BD02, ,
NOMESCO Finland
69.9
6.4
7
*
4462A
ICD-9 Finland
Polyarteritis nodosa and allied conditions, Hypersensitivity angiitis
69.9
6.4
7
*
E66.0
ICD-10 Finland
Obesity due to excess calories
2.0
6.4
65
327
XX4BW, ,
NOMESCO Finland
3.5
6.4
21
60
KCH00
NOMESCO Finland
Suture of bladder
3.2
6.4
24
75
M33.2
ICD-10 Finland
Polymyositis
3.4
6.4
22
65
FQA10
NOMESCO Finland
Orthotopic transplantation of heart with bicaval anastomosis
7.4
6.4
14
19
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
1.9
6.4
72
376
N06AX12
ATC
bupropion; oral
1.3
6.4
467
3656
C83.2
ICD-10 Finland
Mixed small and large cell (diffuse) non-Hodgkin's lymphoma
14.3
6.4
10
7
9689/3-C42.2
ICD-O-3
Splenic marginal zone B-cell lymphoma of spleen
14.3
6.4
10
7
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
1.5
6.4
208
1431
C02EA02, ,
ATC
1.4
6.4
244
1730
D06BB03
ATC
aciclovir; topical
1.4
6.4
273
1974
E21.3
ICD-10 Finland
Hyperparathyroidism, unspecified
2.0
6.4
66
335
I45.9
ICD-10 Finland
Conduction disorder, unspecified
2.0
6.4
61
301
Z31.6
ICD-10 Finland
General counselling and advice on procreation
2.0
6.4
67
342
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
1.6
6.4
133
831
L01CB
ATC
Podophyllotoxin derivatives
3.7
6.3
19
51
N30
ICD-10 Finland
Cystitis
1.3
6.3
557
4461
WX870
NOMESCO Finland
Other postsurgical intensive care
2.6
6.3
35
136
W0X00, ,
SPAT
4.1
6.3
17
42
SHA02
NOMESCO Finland
Stomatognathic treatment, basic
1.3
6.3
461
3607
L57.0
ICD-10 Finland
Actinic keratosis
1.2
6.3
675
5526
N17
ICPC
Vertigo/dizziness
1.2
6.3
883
7429
183
Kela drug reimbursment
Lamotrigin and topiramate
2.1
6.3
59
288
B37.00
ICD-10 Finland
Acute pseudomembraneuous candidal stomatitis
3.0
6.3
26
86
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.2
6.3
710
5846
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
1.4
6.3
222
1551
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
2.8
6.3
30
108
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.2
6.3
892
7518
D64.3
ICD-10 Finland
Other sideroblastic anaemias
5.5
6.3
17
31
F29
ICPC
Eye symptom/complaint other
1.2
6.3
726
5996
R03AC12
ATC
salmeterol; inhalant
1.4
6.3
265
1912
F34.1
ICD-10 Finland
Dysthymia
1.4
6.3
223
1561
WF099
NOMESCO Finland
Other radiotherapy
2.4
6.3
41
173
I85
ICD-10 Finland
Oesophageal varices
18.0
6.3
9
5
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
2.4
6.3
40
167
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.4
6.2
289
2117
O991, D680,
ICD-10 Finland
+∞
6.2
6
*
2873C
ICD-9 Finland
Purpura and other haemorrhagic conditions, Primary thrombocytopenia[THROMBOCYTOPENIA PRIMARIA ALIA DEFINITA]
+∞
6.2
6
*
28730
ICD-8 Finland
Purpura and other haemorrhagic conditions, Thrombocytopathy
+∞
6.2
6
*
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
2.5
6.2
36
143
IGY02
NOMESCO Finland
Psychiatric monitoring contact
1.5
6.2
209
1446
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.3
6.2
390
2990
U02
ICPC
Urinary frequency/urgency
1.2
6.2
1019
8700
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
1.8
6.2
90
509
1BC01, ,
NOMESCO Finland
26.7
6.2
8
*
D60.0
ICD-10 Finland
Chronic acquired pure red cell aplasia
26.7
6.2
8
*
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
1.7
6.2
112
674
QBA10
NOMESCO Finland
Incision of skin of trunk
1.9
6.2
71
373
GD6BD
NOMESCO Finland
Extensive CT of chest and neck
3.7
6.2
19
52
J01DA08
ATC
[U] cefaclor
1.2
6.2
728
6024
H26.9
ICD-10 Finland
Cataract, unspecified
1.7
6.2
99
577
E66.1
ICD-10 Finland
Drug-induced obesity
3.1
6.2
25
82
JKA20
NOMESCO Finland
Cholecystectomy
1.5
6.2
159
1043
F10.09
ICD-10 Finland
Alcohol intoxication UNS
1.6
6.2
119
729
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
1.3
6.2
492
3896
H43.1
ICD-10 Finland
Vitreous haemorrhage
1.6
6.2
145
932
J96.1
ICD-10 Finland
Chronic respiratory failure
1.6
6.2
127
791
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
2.7
6.2
31
115
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
1.4
6.2
286
2097
EB1AA, ,
SPAT
1.3
6.1
407
3146
NA3CM
NOMESCO Finland
Lumbar spine extensive MRI examination with 3 Tesla magnet
2.9
6.1
27
93
WX210
NOMESCO Finland
Plexus blockade of nervus ichiadicus
2.8
6.1
29
104
PHD76
NOMESCO Finland
Resection of long saphenous vein
1.4
6.1
258
1861
I27.8
ICD-10 Finland
Other specified pulmonary heart diseases
3.2
6.1
23
72
K63.5
ICD-10 Finland
Polyp of colon
1.6
6.1
138
878
I77.6
ICD-10 Finland
Arteritis, unspecified
3.3
6.1
22
67
G57.3
ICD-10 Finland
Lesion of lateral popliteal nerve
1.7
6.1
93
534
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.2
6.1
653
5348
Z50.1
ICD-10 Finland
Other physical therapy
1.3
6.1
320
2391
D638, N188,
ICD-10 Finland
7.7
6.1
13
17
WX306
NOMESCO Finland
Lumbar epidural anesthesy
1.3
6.1
428
3334
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
2.0
6.1
61
306
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.2
6.1
610
4961
Z51.4
ICD-10 Finland
Preparatory care for subsequent treatment, not elsewhere classified
2.0
6.1
62
313
D97
ICPC
Liver disease NOS
2.5
6.1
37
151
L30.8
ICD-10 Finland
Other specified dermatitis
1.5
6.1
179
1208
N05.9
ICD-10 Finland
Unspecified nephritic syndrome, unspecified
4.1
6.1
16
39
V03AG01
ATC
sodium cellulose phosphate; systemic
4.1
6.1
16
39
5604
FHL
Vascular preparation or cannulation in the operating room
3.8
6.1
18
48
S70.1
ICD-10 Finland
Contusion of thigh
1.7
6.1
110
663
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
1.6
6.1
132
833
B37.0
ICD-10 Finland
Candidal stomatitis
1.9
6.1
70
369
9981A
ICD-9 Finland
Other complications of procedures, not elsewhere classified, Haemorrhage or haematoma complicating a procedure
2.2
6.1
48
220
160
Kela drug reimbursment
exenatide
1.7
6.0
110
664
R06.4
ICD-10 Finland
Hyperventilation
1.7
6.0
97
566
R00.2
ICD-10 Finland
Palpitations
1.3
6.0
522
4175
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
1.5
6.0
168
1121
Z72.8
ICD-10 Finland
Other problems related to lifestyle
2.4
6.0
40
170
KAS40
NOMESCO Finland
Excision of transplanted kidney
10.0
6.0
11
11
FM1CG
NOMESCO Finland
Extensive examination of hear with high intensity magnet
2.6
6.0
33
128
A10BB12
ATC
glimepiride; oral
1.3
6.0
394
3041
L04AB04
ATC
adalimumab; parenteral
1.6
6.0
140
898
PA6BG
NOMESCO Finland
MRI examination of neck vasculature with high intensity magnet
2.2
6.0
46
208
N18
ICPC
Paralysis/weakness
1.6
6.0
123
765
M80.5
ICD-10 Finland
Idiopathic osteoporosis with pathological fracture
2.5
6.0
34
134
WVA20, ,
SPAT
1.4
6.0
229
1624
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Hematology
82 [38004501]
82 [38004501]
1.6e+00
2.2e+00
2.8e+00
7.5e+00
4.3e+00
3.6e+00
2.8e+00
cases:4.35%
controls:0.96%
cases:5.59%
controls:0.66%
cases:3.66%
controls:0.24%
cases:18.27%
controls:0.01%
cases:13.01%
controls:0.21%
cases:19.72%
controls:0.68%
cases:15.83%
controls:1.12%
382
836
8397
86661
491
579
8299
87005
322
206
8468
87378
1606
11
7184
87573
1086
185
7264
87215
1527
580
6217
84265
1005
797
5342
70582
Morphology [Interpretation] in Bone marrow Narrative
51628-6 [3042111]
51628-6 [3042111]
1.8e+00
2.9e+00
5.4e+00
1.0e+50
5.8e+00
3.6e+00
2.1e+00
cases:1.31%
controls:0.22%
cases:1.89%
controls:0.10%
cases:1.22%
controls:0.01%
cases:1.35%
controls:0.00%
cases:2.84%
controls:0.01%
cases:2.74%
controls:0.08%
cases:2.17%
controls:0.27%
115
190
8664
87307
166
90
8624
87494
107
5
8683
87579
119
0
8671
87584
237
8
8113
87392
212
65
7532
84780
138
195
6209
71184
Thrombocytopenia, unspecified
D69.6 [45581327]
D69.6 [45581327]
3.1e+00
5.2e+00
1.0e+50
1.0e+50
—
7.3e+00
5.8e+00
cases:0.48%
controls:0.02%
cases:1.25%
controls:0.01%
cases:1.39%
controls:0.00%
cases:29.72%
controls:0.00%
—
—
cases:12.27%
controls:0.01%
cases:6.43%
controls:0.02%
42
19
8737
87478
110
6
8680
87578
122
0
8668
87584
2612
0
6178
87584
—
950
8
6794
84837
408
15
5939
71364
Bone marrow Pathology biopsy report
33721-2 [3045142]
33721-2 [3045142]
1.8e+00
3.0e+00
4.8e+00
1.0e+50
5.7e+00
3.5e+00
2.2e+00
cases:0.84%
controls:0.14%
cases:1.57%
controls:0.08%
cases:0.72%
controls:0.01%
cases:0.36%
controls:0.00%
cases:1.66%
controls:0.01%
cases:1.85%
controls:0.06%
cases:1.23%
controls:0.13%
74
120
8705
87377
138
71
8652
87513
63
5
8727
87579
32
0
8758
87584
139
5
8211
87395
143
47
7601
84798
78
96
6269
71283
Drug-induced neutropenia
D70.82 [2000501376]
D70.82 [2000501376]
1.9e+00
3.1e+00
4.3e+00
1.0e+50
5.3e+00
4.3e+00
2.1e+00
cases:0.54%
controls:0.08%
cases:0.89%
controls:0.04%
cases:0.51%
controls:0.01%
cases:2.84%
controls:0.00%
cases:1.10%
controls:0.01%
cases:1.78%
controls:0.02%
cases:0.61%
controls:0.08%
47
67
8732
87430
78
37
8712
87547
45
6
8745
87578
250
0
8540
87584
92
5
8258
87395
138
21
7606
84824
39
55
6308
71324
Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
3181-5 [3009041]
3181-5 [3009041]
1.9e+00
3.3e+00
5.4e+00
1.0e+50
5.0e+00
3.2e+00
2.1e+00
cases:1.40%
controls:0.20%
cases:2.40%
controls:0.09%
cases:1.26%
controls:0.01%
cases:0.22%
controls:0.00%
cases:0.81%
controls:0.01%
cases:1.39%
controls:0.06%
cases:1.59%
controls:0.20%
123
178
8656
87319
211
77
8579
87507
111
5
8679
87579
19
0
8771
87584
68
5
8282
87395
108
51
7636
84794
101
145
6246
71234
Mantle cell lymphoma
C83.1 [45542646]
C83.1 [45542646]
2.2e+00
3.3e+00
4.3e+00
1.0e+50
4.1e+00
3.5e+00
3.3e+00
cases:0.19%
controls:0.02%
cases:0.74%
controls:0.03%
cases:0.73%
controls:0.01%
cases:0.63%
controls:0.00%
cases:0.77%
controls:0.01%
cases:0.89%
controls:0.03%
cases:0.88%
controls:0.03%
17
18
8762
87479
65
23
8725
87561
64
9
8726
87575
55
0
8735
87584
64
11
8286
87389
69
23
7675
84822
56
23
6291
71356
Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
44448-9 [3044355]
44448-9 [3044355]
1.9e+00
3.4e+00
5.3e+00
1.0e+50
4.8e+00
3.2e+00
2.2e+00
cases:1.34%
controls:0.20%
cases:2.48%
controls:0.08%
cases:1.34%
controls:0.01%
cases:0.25%
controls:0.00%
cases:0.93%
controls:0.01%
cases:1.47%
controls:0.06%
cases:1.81%
controls:0.21%
118
179
8661
87318
218
74
8572
87510
118
6
8672
87578
22
0
8768
87584
78
7
8272
87393
114
50
7630
84795
115
153
6232
71226
Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
3209-4 [3019250]
3209-4 [3019250]
1.8e+00
2.9e+00
5.2e+00
1.0e+50
5.1e+00
3.1e+00
2.3e+00
cases:2.37%
controls:0.41%
cases:3.54%
controls:0.20%
cases:3.09%
controls:0.02%
cases:0.64%
controls:0.00%
cases:2.29%
controls:0.01%
cases:3.27%
controls:0.16%
cases:4.00%
controls:0.40%
208
360
8571
87137
311
173
8479
87411
272
15
8518
87569
56
0
8734
87584
191
12
8159
87388
253
132
7491
84713
254
288
6093
71091
Bone marrow biopsy
XW000 [2001310618]
XW000 [2001310618]
1.6e+00
3.0e+00
4.4e+00
1.0e+50
5.2e+00
3.6e+00
2.3e+00
cases:1.62%
controls:0.34%
cases:2.55%
controls:0.13%
cases:1.25%
controls:0.02%
cases:3.13%
controls:0.00%
cases:2.25%
controls:0.01%
cases:3.36%
controls:0.09%
cases:2.60%
controls:0.27%
142
295
8637
87202
224
111
8566
87473
110
14
8680
87570
275
0
8515
87584
188
11
8162
87389
260
78
7484
84767
165
190
6182
71189
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
3255-7 [3016407]
3255-7 [3016407]
1.6e+00
2.6e+00
5.1e+00
1.0e+50
5.5e+00
3.0e+00
2.2e+00
cases:1.99%
controls:0.43%
cases:2.62%
controls:0.20%
cases:3.09%
controls:0.02%
cases:0.90%
controls:0.00%
cases:2.87%
controls:0.01%
cases:3.40%
controls:0.17%
cases:4.29%
controls:0.47%
175
376
8604
87121
230
177
8560
87407
272
17
8518
87567
79
0
8711
87584
240
11
8110
87389
263
142
7481
84703
272
339
6075
71040
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
14804-9 [3022250]
1.1e+00
1.8e+00
3.4e+00
6.1e+00
3.6e+00
2.2e+00
1.5e+00
cases:5.33%
controls:1.91%
cases:6.64%
controls:1.12%
cases:5.48%
controls:0.19%
cases:2.42%
controls:0.01%
cases:6.55%
controls:0.19%
cases:8.78%
controls:1.07%
cases:10.56%
controls:2.49%
468
1675
8311
85822
584
978
8206
86606
482
168
8308
87416
213
5
8577
87579
547
162
7803
87238
680
904
7064
83941
670
1780
5677
69599
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
4679-7 [3027945]
9.0e-01
1.8e+00
3.4e+00
6.0e+00
4.0e+00
2.1e+00
1.2e+00
cases:5.03%
controls:2.11%
cases:5.55%
controls:0.94%
cases:4.73%
controls:0.17%
cases:2.80%
controls:0.01%
cases:6.35%
controls:0.13%
cases:7.46%
controls:0.98%
cases:8.73%
controls:2.80%
442
1844
8337
85653
488
826
8302
86758
416
146
8374
87438
246
6
8544
87578
530
110
7820
87290
578
834
7166
84011
554
2001
5793
69378
Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
27811-9 [3000515]
27811-9 [3000515]
1.7e+00
2.8e+00
4.9e+00
1.0e+50
4.8e+00
2.9e+00
2.1e+00
cases:2.43%
controls:0.46%
cases:3.42%
controls:0.22%
cases:2.61%
controls:0.02%
cases:0.63%
controls:0.00%
cases:2.10%
controls:0.02%
cases:3.02%
controls:0.18%
cases:3.72%
controls:0.46%
213
400
8566
87097
301
191
8489
87393
229
18
8561
87566
55
0
8735
87584
175
15
8175
87385
234
152
7510
84693
236
325
6111
71054
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
14979-9 [3018677]
7.9e-01
1.8e+00
3.8e+00
5.5e+00
3.9e+00
2.0e+00
1.2e+00
cases:5.71%
controls:2.67%
cases:6.11%
controls:1.04%
cases:5.14%
controls:0.13%
cases:2.43%
controls:0.01%
cases:5.05%
controls:0.11%
cases:6.70%
controls:0.92%
cases:9.53%
controls:3.03%
501
2334
8278
85163
537
909
8253
86675
452
111
8338
87473
214
9
8576
87575
422
93
7928
87307
519
783
7225
84062
605
2160
5742
69219
Anaemia, unspecified
D64.9 [45600610]
D64.9 [45600610]
9.1e-01
1.8e+00
2.9e+00
6.6e+00
3.4e+00
2.1e+00
9.4e-01
cases:2.75%
controls:1.13%
cases:2.89%
controls:0.51%
cases:1.77%
controls:0.10%
cases:4.93%
controls:0.01%
cases:3.14%
controls:0.10%
cases:4.31%
controls:0.53%
cases:3.72%
controls:1.48%
241
987
8538
86510
254
449
8536
87135
156
85
8634
87499
433
6
8357
87578
262
91
8088
87309
334
452
7410
84393
236
1056
6111
70323
Thrombin time
3243-3 [3036489]
3243-3 [3036489]
1.6e+00
2.8e+00
4.7e+00
1.0e+50
5.0e+00
2.7e+00
2.0e+00
cases:2.76%
controls:0.57%
cases:3.77%
controls:0.24%
cases:2.88%
controls:0.03%
cases:0.66%
controls:0.00%
cases:2.08%
controls:0.01%
cases:3.00%
controls:0.21%
cases:3.94%
controls:0.57%
242
496
8537
87001
331
211
8459
87373
253
23
8537
87561
58
0
8732
87584
174
13
8176
87387
232
182
7512
84663
250
410
6097
70969
lipegfilgrastim; parenteral
L03AA14 [43534819]
L03AA14 [43534819]
1.4e+00
2.9e+00
4.4e+00
—
4.4e+00
3.9e+00
1.6e+00
cases:0.51%
controls:0.12%
cases:1.30%
controls:0.07%
cases:1.25%
controls:0.01%
—
—
cases:1.02%
controls:0.01%
cases:1.16%
controls:0.02%
cases:0.33%
controls:0.07%
45
106
8734
87391
114
62
8676
87522
110
13
8680
87571
—
85
11
8265
87389
90
21
7654
84824
21
49
6326
71330
Blood transfusion
WW500 [2001310603]
WW500 [2001310603]
1.5e+00
2.6e+00
4.2e+00
1.0e+50
4.7e+00
3.5e+00
1.8e+00
cases:1.08%
controls:0.24%
cases:1.79%
controls:0.14%
cases:1.38%
controls:0.02%
cases:3.80%
controls:0.00%
cases:2.13%
controls:0.02%
cases:3.72%
controls:0.11%
cases:1.75%
controls:0.29%
95
214
8684
87283
157
121
8633
87463
121
18
8669
87566
334
0
8456
87584
178
18
8172
87382
288
96
7456
84749
111
206
6236
71173
Diffuse lymphoma with large B cells
C83.31 [2000501224]
C83.31 [2000501224]
1.9e+00
2.9e+00
3.9e+00
—
3.8e+00
3.1e+00
2.5e+00
cases:0.68%
controls:0.10%
cases:1.64%
controls:0.09%
cases:1.74%
controls:0.04%
—
—
cases:1.95%
controls:0.04%
cases:2.07%
controls:0.09%
cases:1.72%
controls:0.15%
60
91
8719
87406
144
83
8646
87501
153
32
8637
87552
—
163
38
8187
87362
160
80
7584
84765
109
107
6238
71272
Bacterial infection, unspecified
A49.9 [45590816]
A49.9 [45590816]
9.5e-01
1.8e+00
3.0e+00
5.7e+00
3.2e+00
2.1e+00
9.3e-01
cases:2.45%
controls:0.97%
cases:2.43%
controls:0.42%
cases:1.24%
controls:0.06%
cases:2.37%
controls:0.01%
cases:1.69%
controls:0.07%
cases:3.38%
controls:0.41%
cases:3.58%
controls:1.44%
215
845
8564
86652
214
371
8576
87213
109
53
8681
87531
208
7
8582
87577
141
59
8209
87341
262
345
7482
84500
227
1029
6120
70350
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
2601-3 [3012095]
8.3e-01
1.7e+00
3.2e+00
4.8e+00
3.5e+00
2.0e+00
1.2e+00
cases:5.90%
controls:2.65%
cases:6.30%
controls:1.20%
cases:4.80%
controls:0.20%
cases:1.11%
controls:0.01%
cases:5.51%
controls:0.17%
cases:7.54%
controls:1.11%
cases:9.55%
controls:3.23%
518
2321
8261
85176
554
1049
8236
86535
422
172
8368
87412
98
8
8692
87576
460
152
7890
87248
584
944
7160
83901
606
2303
5741
69076
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
117 [2001600117]
117 [2001600117]
1.6e+00
3.0e+00
3.9e+00
—
4.8e+00
2.5e+00
1.4e+00
cases:1.70%
controls:0.36%
cases:2.57%
controls:0.13%
cases:0.41%
controls:0.01%
—
—
cases:0.97%
controls:0.01%
cases:1.02%
controls:0.09%
cases:1.09%
controls:0.27%
149
315
8630
87182
226
117
8564
87467
36
7
8754
87577
—
81
7
8269
87393
79
74
7665
84771
69
196
6278
71183
Complement+Immunoglobulin [Units/volume] in Red Blood Cells
4533-6 [3024403]
4533-6 [3024403]
1.3e+00
2.4e+00
4.3e+00
—
5.0e+00
2.5e+00
1.6e+00
cases:1.21%
controls:0.35%
cases:1.43%
controls:0.13%
cases:1.19%
controls:0.02%
—
—
cases:2.02%
controls:0.01%
cases:1.56%
controls:0.13%
cases:2.16%
controls:0.44%
106
302
8673
87195
126
112
8664
87472
105
14
8685
87570
—
169
12
8181
87388
121
112
7623
84733
137
311
6210
71068
Simple antiboidy therapy of methastized malignancy
WD405 [2001310688]
WD405 [2001310688]
1.6e+00
2.9e+00
3.6e+00
—
3.8e+00
3.1e+00
2.2e+00
cases:0.68%
controls:0.14%
cases:1.70%
controls:0.10%
cases:1.42%
controls:0.04%
—
—
cases:1.31%
controls:0.03%
cases:2.07%
controls:0.10%
cases:1.31%
controls:0.15%
60
126
8719
87371
149
87
8641
87497
125
35
8665
87549
—
109
27
8241
87373
160
81
7584
84764
83
108
6264
71271
Protein C actual/normal in Platelet poor plasma by Coagulation assay
27819-2 [3020287]
27819-2 [3020287]
2.0e+00
3.5e+00
4.7e+00
1.0e+50
3.6e+00
2.0e+00
1.2e+00
cases:1.37%
controls:0.19%
cases:2.28%
controls:0.07%
cases:0.64%
controls:0.01%
cases:0.14%
controls:0.00%
cases:0.20%
controls:0.01%
cases:0.43%
controls:0.06%
cases:0.63%
controls:0.18%
120
163
8659
87334
200
64
8590
87520
56
5
8734
87579
12
0
8778
87584
17
5
8333
87395
33
49
7711
84796
40
130
6307
71249
Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
80721-4 [21493690]
80721-4 [21493690]
1.4e+00
2.1e+00
3.6e+00
—
3.7e+00
3.3e+00
2.5e+00
cases:0.56%
controls:0.14%
cases:0.60%
controls:0.08%
cases:0.22%
controls:0.01%
—
—
cases:0.26%
controls:0.01%
cases:1.45%
controls:0.05%
cases:1.70%
controls:0.14%
49
119
8730
87378
53
66
8737
87518
19
5
8771
87579
—
22
6
8328
87394
112
44
7632
84801
108
99
6239
71280
Thrombophilia screening test
314089003 [4195642]
314089003 [4195642]
2.0e+00
3.5e+00
4.6e+00
1.0e+50
3.4e+00
2.2e+00
1.1e+00
cases:1.42%
controls:0.20%
cases:2.18%
controls:0.07%
cases:0.55%
controls:0.01%
cases:0.10%
controls:0.00%
cases:0.17%
controls:0.01%
cases:0.48%
controls:0.05%
cases:0.52%
controls:0.18%
125
177
8654
87320
192
62
8598
87522
48
5
8742
87579
9
0
8781
87584
14
5
8336
87395
37
45
7707
84800
33
126
6314
71253
Demanding antibody therapy of methastized malignancy
WD415 [2001310689]
WD415 [2001310689]
1.9e+00
2.9e+00
3.7e+00
—
3.3e+00
3.0e+00
1.7e+00
cases:0.55%
controls:0.08%
cases:0.94%
controls:0.05%
cases:0.57%
controls:0.01%
—
—
cases:0.53%
controls:0.02%
cases:0.96%
controls:0.05%
cases:0.41%
controls:0.07%
48
69
8731
87428
83
46
8707
87538
50
12
8740
87572
—
44
17
8306
87383
74
39
7670
84806
26
53
6321
71326
dalteparin; parenteral
B01AB04 [21600975]
B01AB04 [21600975]
1.6e+00
2.8e+00
3.5e+00
1.0e+50
3.7e+00
3.1e+00
2.0e+00
cases:1.58%
controls:0.32%
cases:1.59%
controls:0.10%
cases:1.02%
controls:0.03%
cases:0.24%
controls:0.00%
cases:1.34%
controls:0.03%
cases:2.18%
controls:0.10%
cases:2.62%
controls:0.37%
139
276
8640
87221
140
87
8650
87497
90
28
8700
87556
21
0
8769
87584
112
30
8238
87370
169
89
7575
84756
166
262
6181
71117
Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
71668-8 [43055361]
71668-8 [43055361]
1.4e+00
3.1e+00
3.5e+00
1.0e+50
4.2e+00
2.9e+00
1.4e+00
cases:0.23%
controls:0.06%
cases:0.58%
controls:0.03%
cases:0.31%
controls:0.01%
cases:0.15%
controls:0.00%
cases:0.61%
controls:0.01%
cases:0.71%
controls:0.04%
cases:0.39%
controls:0.10%
20
51
8759
87446
51
23
8739
87561
27
8
8763
87576
13
0
8777
87584
51
8
8299
87392
55
32
7689
84813
25
70
6322
71309
Lupus anticoagulant assay
63300003 [4268621]
63300003 [4268621]
2.2e+00
3.5e+00
5.3e+00
1.0e+50
—
3.4e+00
2.0e+00
cases:0.97%
controls:0.11%
cases:1.93%
controls:0.06%
cases:1.14%
controls:0.01%
cases:0.19%
controls:0.00%
—
—
cases:1.10%
controls:0.04%
cases:1.28%
controls:0.17%
85
97
8694
87400
170
52
8620
87532
100
5
8690
87579
17
0
8773
87584
—
85
32
7659
84813
81
122
6266
71257
Embolism and thrombosis of other specified veins
I82.88 [2000502550]
I82.88 [2000502550]
1.8e+00
3.0e+00
3.5e+00
1.0e+50
3.2e+00
3.2e+00
1.7e+00
cases:0.68%
controls:0.11%
cases:0.65%
controls:0.03%
cases:0.22%
controls:0.01%
cases:0.33%
controls:0.00%
cases:0.25%
controls:0.01%
cases:0.63%
controls:0.03%
cases:0.66%
controls:0.12%
60
96
8719
87401
57
29
8733
87555
19
6
8771
87578
29
0
8761
87584
21
9
8329
87391
49
23
7695
84822
42
85
6305
71294
CD3-CD16+CD56+ (Natural killer) cells/cells in Blood
8112-5 [3027831]
8112-5 [3027831]
1.3e+00
2.0e+00
3.6e+00
—
3.7e+00
3.2e+00
2.5e+00
cases:0.51%
controls:0.14%
cases:0.60%
controls:0.08%
cases:0.20%
controls:0.01%
—
—
cases:0.26%
controls:0.01%
cases:1.39%
controls:0.06%
cases:1.70%
controls:0.15%
45
120
8734
87377
53
70
8737
87514
18
5
8772
87579
—
22
6
8328
87394
108
50
7636
84795
108
104
6239
71275
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
O99.1 [45563195]
O99.1 [45563195]
3.4e+00
3.8e+00
—
1.0e+50
—
5.0e+00
4.0e+00
cases:0.39%
controls:0.01%
cases:0.35%
controls:0.01%
—
—
cases:0.84%
controls:0.00%
—
—
cases:1.21%
controls:0.01%
cases:1.54%
controls:0.03%
34
11
8745
87486
31
7
8759
87577
—
74
0
8716
87584
—
94
7
7650
84838
98
21
6249
71358
filgrastim; parenteral
L03AA02 [21603851]
L03AA02 [21603851]
1.6e+00
2.8e+00
3.5e+00
—
3.3e+00
3.2e+00
1.8e+00
cases:0.88%
controls:0.18%
cases:1.40%
controls:0.09%
cases:1.01%
controls:0.03%
—
—
cases:0.69%
controls:0.03%
cases:1.92%
controls:0.08%
cases:0.98%
controls:0.16%
77
159
8702
87338
123
76
8667
87508
89
27
8701
87557
—
58
23
8292
87377
149
69
7595
84776
62
116
6285
71263
Other transplanted organ and tissue status
Z94.8 [45600381]
Z94.8 [45600381]
2.1e+00
2.3e+00
2.3e+00
1.0e+50
2.7e+00
3.2e+00
3.4e+00
cases:0.17%
controls:0.02%
cases:0.22%
controls:0.02%
cases:0.11%
controls:0.01%
cases:0.14%
controls:0.00%
cases:0.17%
controls:0.01%
cases:0.62%
controls:0.02%
cases:0.72%
controls:0.03%
15
18
8764
87479
19
19
8771
87565
10
10
8780
87574
12
0
8778
87584
14
10
8336
87390
48
21
7696
84824
46
18
6301
71361
CD3 cells/Lymphocytes in Blood
90304-7 [1175426]
90304-7 [1175426]
1.3e+00
2.0e+00
3.6e+00
—
3.5e+00
3.1e+00
2.4e+00
cases:0.51%
controls:0.14%
cases:0.60%
controls:0.08%
cases:0.20%
controls:0.01%
—
—
cases:0.26%
controls:0.01%
cases:1.41%
controls:0.06%
cases:1.76%
controls:0.16%
45
122
8734
87375
53
71
8737
87513
18
5
8772
87579
—
22
7
8328
87393
109
53
7635
84792
112
112
6235
71267
enoxaparin; parenteral
B01AB05 [21600976]
B01AB05 [21600976]
9.4e-01
1.7e+00
2.8e+00
3.9e+00
3.2e+00
2.1e+00
1.3e+00
cases:11.36%
controls:4.78%
cases:7.95%
controls:1.53%
cases:3.50%
controls:0.22%
cases:0.67%
controls:0.01%
cases:5.70%
controls:0.23%
cases:9.81%
controls:1.36%
cases:13.93%
controls:4.31%
997
4185
7782
83312
699
1342
8091
86242
308
194
8482
87390
59
12
8731
87572
476
205
7874
87195
760
1154
6984
83691
884
3076
5463
68303
Demanding cystostatic therapy of methastized malignancy
WD125 [2001310680]
WD125 [2001310680]
1.7e+00
2.8e+00
3.8e+00
—
3.6e+00
2.9e+00
1.1e+00
cases:1.32%
controls:0.25%
cases:2.99%
controls:0.19%
cases:2.48%
controls:0.06%
—
—
cases:2.08%
controls:0.06%
cases:2.63%
controls:0.15%
cases:0.74%
controls:0.26%
116
223
8663
87274
263
165
8527
87419
218
49
8572
87535
—
174
50
8176
87350
204
126
7540
84719
47
184
6300
71195
Immunoglobulin A (IgA) nephropathy
N08.2*D89.80 [2000503126]
N08.2*D89.80 [2000503126]
1.8e+00
2.3e+00
2.6e+00
1.0e+50
3.2e+00
3.0e+00
2.9e+00
cases:0.38%
controls:0.06%
cases:0.42%
controls:0.04%
cases:0.20%
controls:0.01%
cases:0.17%
controls:0.00%
cases:0.30%
controls:0.01%
cases:0.84%
controls:0.04%
cases:1.06%
controls:0.06%
33
52
8746
87445
37
39
8753
87545
18
13
8772
87571
15
0
8775
87584
25
11
8325
87389
65
34
7679
84811
67
44
6280
71335
Thorax X-ray examination
GD1AA [2001303617]
GD1AA [2001303617]
6.1e-01
1.3e+00
2.3e+00
7.0e+00
2.3e+00
1.5e+00
9.5e-01
cases:14.35%
controls:8.34%
cases:10.64%
controls:3.27%
cases:3.57%
controls:0.39%
cases:5.63%
controls:0.01%
cases:3.60%
controls:0.39%
cases:11.67%
controls:2.97%
cases:19.69%
controls:8.69%
1260
7301
7519
80196
935
2864
7855
84720
314
339
8476
87245
495
5
8295
87579
301
339
8049
87061
904
2524
6840
82321
1250
6201
5097
65178
Hemodialysis
TK800 [2001305768]
TK800 [2001305768]
1.6e+00
2.3e+00
2.2e+00
3.1e+00
2.5e+00
2.3e+00
1.8e+00
cases:0.81%
controls:0.17%
cases:0.85%
controls:0.08%
cases:0.55%
controls:0.06%
cases:0.51%
controls:0.02%
cases:0.68%
controls:0.05%
cases:0.92%
controls:0.10%
cases:1.13%
controls:0.20%
71
151
8708
87346
75
74
8715
87510
48
51
8742
87533
45
21
8745
87563
57
48
8293
87352
71
81
7673
84764
72
141
6275
71238
Hemoglobin [Entitic mass] in Reticulocytes
42810-2 [3029080]
42810-2 [3029080]
1.1e+00
2.4e+00
4.2e+00
1.0e+50
3.9e+00
2.4e+00
1.6e+00
cases:0.62%
controls:0.21%
cases:1.04%
controls:0.09%
cases:0.88%
controls:0.01%
cases:0.55%
controls:0.00%
cases:0.95%
controls:0.02%
cases:1.23%
controls:0.11%
cases:1.29%
controls:0.25%
54
180
8725
87317
91
82
8699
87502
77
12
8713
87572
48
0
8742
87584
79
17
8271
87383
95
91
7649
84754
82
182
6265
71197
Band form neutrophils/Leukocytes in Blood
26508-2 [3004809]
26508-2 [3004809]
1.3e+00
2.2e+00
3.7e+00
—
4.3e+00
2.6e+00
1.5e+00
cases:0.84%
controls:0.23%
cases:1.05%
controls:0.12%
cases:0.80%
controls:0.02%
—
—
cases:1.54%
controls:0.02%
cases:1.69%
controls:0.13%
cases:1.34%
controls:0.30%
74
200
8705
87297
92
101
8698
87483
70
18
8720
87566
—
129
18
8221
87382
131
109
7613
84736
85
212
6262
71167
Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
43730-1 [3043849]
43730-1 [3043849]
1.4e+00
2.1e+00
3.3e+00
—
4.4e+00
2.7e+00
1.7e+00
cases:0.88%
controls:0.22%
cases:1.09%
controls:0.14%
cases:0.64%
controls:0.02%
—
—
cases:1.78%
controls:0.02%
cases:1.78%
controls:0.12%
cases:1.75%
controls:0.33%
77
192
8702
87305
96
121
8694
87463
56
20
8734
87564
—
149
19
8201
87381
138
101
7606
84744
111
239
6236
71140
Extracorporeal dialysis
Z49.1 [45537649]
Z49.1 [45537649]
1.6e+00
2.2e+00
2.2e+00
3.0e+00
2.5e+00
2.3e+00
1.8e+00
cases:0.50%
controls:0.10%
cases:0.55%
controls:0.06%
cases:0.35%
controls:0.04%
cases:0.23%
controls:0.01%
cases:0.46%
controls:0.04%
cases:0.61%
controls:0.06%
cases:0.82%
controls:0.13%
44
91
8735
87406
48
55
8742
87529
31
35
8759
87549
20
10
8770
87574
38
33
8312
87367
47
52
7697
84793
52
94
6295
71285
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
5894-1 [3033658]
7.0e-01
1.4e+00
3.0e+00
4.9e+00
2.8e+00
1.6e+00
1.0e+00
cases:9.74%
controls:5.09%
cases:9.68%
controls:2.49%
cases:6.55%
controls:0.34%
cases:3.24%
controls:0.02%
cases:5.76%
controls:0.35%
cases:9.63%
controls:2.19%
cases:14.34%
controls:5.67%
855
4451
7924
83046
851
2181
7939
85403
576
294
8214
87290
285
21
8505
87563
481
310
7869
87090
746
1861
6998
82984
910
4046
5437
67333
Systemic lupus erythematosus, unspecified
M32.9 [45553167]
M32.9 [45553167]
1.9e+00
2.3e+00
2.6e+00
—
3.3e+00
2.8e+00
2.6e+00
cases:0.54%
controls:0.08%
cases:0.48%
controls:0.05%
cases:0.19%
controls:0.01%
—
—
cases:0.31%
controls:0.01%
cases:0.77%
controls:0.05%
cases:1.04%
controls:0.08%
47
69
8732
87428
42
44
8748
87540
17
13
8773
87571
—
26
10
8324
87390
60
39
7684
84806
66
56
6281
71323
Internal Medicine
11 [38004456]
11 [38004456]
6.4e-01
1.1e+00
2.1e+00
6.5e+00
2.6e+00
1.6e+00
9.4e-01
cases:33.69%
controls:21.06%
cases:22.56%
controls:8.61%
cases:10.28%
controls:1.45%
cases:29.32%
controls:0.06%
cases:15.95%
controls:1.45%
cases:29.96%
controls:8.29%
cases:38.51%
controls:19.67%
2958
18426
5821
69071
1983
7539
6807
80045
904
1273
7886
86311
2577
55
6213
87529
1332
1264
7018
86136
2320
7033
5424
77812
2444
14039
3903
57340
Other myelodysplastic syndromes
D46.7 [45595762]
D46.7 [45595762]
1.7e+00
2.3e+00
2.3e+00
1.0e+50
3.5e+00
3.8e+00
3.5e+00
cases:0.08%
controls:0.01%
cases:0.13%
controls:0.01%
cases:0.08%
controls:0.01%
cases:0.13%
controls:0.00%
cases:0.26%
controls:0.01%
cases:0.62%
controls:0.01%
cases:0.63%
controls:0.02%
7
13
8772
87484
11
11
8779
87573
7
7
8783
87577
11
0
8779
87584
22
7
8328
87393
48
12
7696
84833
40
14
6307
71365
pegfilgrastim; parenteral
L03AA13 [21603856]
L03AA13 [21603856]
1.4e+00
2.7e+00
3.8e+00
—
3.6e+00
2.9e+00
1.1e+00
cases:1.15%
controls:0.30%
cases:1.96%
controls:0.14%
cases:1.66%
controls:0.04%
—
—
cases:1.20%
controls:0.03%
cases:1.67%
controls:0.10%
cases:0.74%
controls:0.26%
101
262
8678
87235
172
119
8618
87465
146
34
8644
87550
—
100
30
8250
87370
129
82
7615
84763
47
183
6300
71196
Follicular lymphoma grade III, unspecified
C82.2 [45542638]
C82.2 [45542638]
1.6e+00
2.4e+00
3.0e+00
1.0e+50
3.1e+00
2.4e+00
2.8e+00
cases:0.11%
controls:0.02%
cases:0.18%
controls:0.02%
cases:0.11%
controls:0.01%
cases:0.10%
controls:0.00%
cases:0.13%
controls:0.01%
cases:0.18%
controls:0.02%
cases:0.22%
controls:0.01%
10
21
8769
87476
16
15
8774
87569
10
5
8780
87579
9
0
8781
87584
11
5
8339
87395
14
14
7730
84831
14
10
6333
71369
Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
62424-7 [40765161]
62424-7 [40765161]
1.1e+00
2.0e+00
3.2e+00
1.0e+50
4.3e+00
2.8e+00
1.8e+00
cases:0.83%
controls:0.29%
cases:0.85%
controls:0.11%
cases:0.38%
controls:0.02%
cases:0.18%
controls:0.00%
cases:0.95%
controls:0.01%
cases:1.56%
controls:0.10%
cases:1.61%
controls:0.26%
73
252
8706
87245
75
100
8715
87484
33
14
8757
87570
16
0
8774
87584
79
11
8271
87389
121
86
7623
84759
102
188
6245
71191
Reticulocyte production index
31111-8 [3000012]
31111-8 [3000012]
1.1e+00
2.3e+00
3.7e+00
1.0e+50
3.9e+00
2.5e+00
1.6e+00
cases:0.72%
controls:0.23%
cases:1.17%
controls:0.12%
cases:0.75%
controls:0.02%
cases:0.47%
controls:0.00%
cases:0.99%
controls:0.02%
cases:1.42%
controls:0.11%
cases:1.40%
controls:0.30%
63
202
8716
87295
103
104
8687
87480
66
16
8724
87568
41
0
8749
87584
83
18
8267
87382
110
97
7634
84748
89
213
6258
71166
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 [43055120]
72493-0 [43055120]
1.3e+00
1.9e+00
3.2e+00
—
4.2e+00
2.7e+00
1.8e+00
cases:1.16%
controls:0.31%
cases:1.31%
controls:0.19%
cases:0.84%
controls:0.03%
—
—
cases:2.20%
controls:0.04%
cases:2.52%
controls:0.18%
cases:2.43%
controls:0.41%
102
270
8677
87227
115
169
8675
87415
74
29
8716
87555
—
184
31
8166
87369
195
150
7549
84695
154
294
6193
71085
Simple therapy of methastized malignancy with biomodifiers
WD305 [2001310685]
WD305 [2001310685]
1.5e+00
2.4e+00
3.1e+00
1.0e+50
3.3e+00
3.0e+00
1.8e+00
cases:0.36%
controls:0.08%
cases:0.46%
controls:0.04%
cases:0.23%
controls:0.01%
cases:0.42%
controls:0.00%
cases:0.18%
controls:0.01%
cases:0.96%
controls:0.05%
cases:0.50%
controls:0.08%
32
68
8747
87429
40
37
8750
87547
20
9
8770
87575
37
0
8753
87584
15
6
8335
87394
74
42
7670
84803
32
57
6315
71322
Bacteria identified in Blood by Culture
600-7 [3023368]
600-7 [3023368]
6.5e-01
1.3e+00
2.7e+00
5.5e+00
2.9e+00
1.4e+00
7.0e-01
cases:8.50%
controls:4.64%
cases:7.37%
controls:2.20%
cases:4.52%
controls:0.31%
cases:4.35%
controls:0.02%
cases:5.68%
controls:0.34%
cases:8.32%
controls:2.24%
cases:12.07%
controls:6.38%
746
4064
8033
83433
648
1924
8142
85660
397
275
8393
87309
382
16
8408
87568
474
294
7876
87106
644
1901
7100
82944
766
4551
5581
66828
Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
21363-7 [3020565]
21363-7 [3020565]
9.1e-01
2.1e+00
3.8e+00
1.0e+50
4.3e+00
2.5e+00
1.5e+00
cases:0.46%
controls:0.18%
cases:0.61%
controls:0.08%
cases:0.40%
controls:0.01%
cases:0.11%
controls:0.00%
cases:0.61%
controls:0.01%
cases:0.93%
controls:0.08%
cases:1.34%
controls:0.31%
40
161
8739
87336
54
66
8736
87518
35
8
8755
87576
10
0
8780
87584
51
7
8299
87393
72
68
7672
84777
85
224
6262
71155
Nodular sclerosis classical Hodgkin lymphoma
C81.1 [45547530]
C81.1 [45547530]
1.9e+00
2.4e+00
3.1e+00
1.0e+50
3.1e+00
2.5e+00
2.2e+00
cases:0.13%
controls:0.02%
cases:0.20%
controls:0.02%
cases:0.19%
controls:0.01%
cases:0.15%
controls:0.00%
cases:0.18%
controls:0.01%
cases:0.25%
controls:0.02%
cases:0.27%
controls:0.03%
11
17
8768
87480
18
17
8772
87567
17
8
8773
87576
13
0
8777
87584
15
7
8335
87393
19
18
7725
84827
17
21
6330
71358
Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
3216-9 [3020427]
3216-9 [3020427]
1.4e+00
2.1e+00
3.6e+00
—
4.1e+00
2.2e+00
1.6e+00
cases:1.94%
controls:0.48%
cases:1.63%
controls:0.21%
cases:0.77%
controls:0.02%
—
—
cases:1.38%
controls:0.02%
cases:1.50%
controls:0.16%
cases:2.55%
controls:0.51%
170
422
8609
87075
143
183
8647
87401
68
18
8722
87566
—
115
21
8235
87379
116
137
7628
84708
162
366
6185
71013
Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
50548-7 [3030692]
50548-7 [3030692]
1.0e+00
2.1e+00
3.3e+00
1.0e+50
3.9e+00
2.6e+00
1.9e+00
cases:0.67%
controls:0.24%
cases:0.67%
controls:0.08%
cases:0.28%
controls:0.01%
cases:0.15%
controls:0.00%
cases:0.56%
controls:0.01%
cases:1.07%
controls:0.08%
cases:1.23%
controls:0.18%
59
208
8720
87289
59
69
8731
87515
25
9
8765
87575
13
0
8777
87584
47
10
8303
87390
83
65
7661
84780
78
131
6269
71248
B-cell lymphoma in marginal zone
C83.80 [2000501237]
C83.80 [2000501237]
2.1e+00
2.1e+00
2.9e+00
1.0e+50
2.8e+00
2.5e+00
2.5e+00
cases:0.19%
controls:0.02%
cases:0.17%
controls:0.02%
cases:0.13%
controls:0.01%
cases:0.09%
controls:0.00%
cases:0.13%
controls:0.01%
cases:0.28%
controls:0.02%
cases:0.35%
controls:0.03%
17
20
8762
87477
15
19
8775
87565
11
6
8779
87578
8
0
8782
87584
11
7
8339
87393
22
19
7722
84826
22
20
6325
71359
Lymph node Pathology biopsy report
66112-4 [40768795]
66112-4 [40768795]
1.5e+00
3.0e+00
3.6e+00
—
2.5e+00
2.7e+00
1.8e+00
cases:0.66%
controls:0.15%
cases:0.99%
controls:0.05%
cases:0.24%
controls:0.01%
—
—
cases:0.12%
controls:0.01%
cases:0.39%
controls:0.03%
cases:0.61%
controls:0.10%
58
130
8721
87367
87
43
8703
87541
21
6
8769
87578
—
10
9
8340
87391
30
23
7714
84822
39
74
6308
71305
HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]
75622-1 [46235355]
4.8e-01
1.4e+00
3.0e+00
4.6e+00
3.3e+00
1.3e+00
8.1e-01
cases:5.51%
controls:3.48%
cases:5.52%
controls:1.42%
cases:2.87%
controls:0.15%
cases:0.69%
controls:0.01%
cases:3.64%
controls:0.14%
cases:4.36%
controls:1.22%
cases:9.03%
controls:4.24%
484
3046
8295
84451
485
1247
8305
86337
252
127
8538
87457
61
6
8729
87578
304
119
8046
87281
338
1031
7406
83814
573
3025
5774
68354
sulfamethoxazole and trimethoprim
J01EE01 [21602961]
J01EE01 [21602961]
1.3e+00
2.4e+00
3.3e+00
—
3.3e+00
2.9e+00
1.8e+00
cases:1.81%
controls:0.52%
cases:2.54%
controls:0.24%
cases:1.26%
controls:0.05%
—
—
cases:1.56%
controls:0.06%
cases:4.21%
controls:0.23%
cases:3.37%
controls:0.58%
159
456
8620
87041
223
207
8567
87377
111
43
8679
87541
—
130
51
8220
87349
326
199
7418
84646
214
416
6133
70963
CD19 cells [#/volume] in Blood
8116-6 [3010503]
8116-6 [3010503]
1.5e+00
2.2e+00
2.9e+00
—
2.8e+00
3.2e+00
2.4e+00
cases:0.46%
controls:0.10%
cases:0.44%
controls:0.05%
cases:0.16%
controls:0.01%
—
—
cases:0.14%
controls:0.01%
cases:1.20%
controls:0.05%
cases:1.24%
controls:0.11%
40
91
8739
87406
39
45
8751
87539
14
8
8776
87576
—
12
8
8338
87392
93
40
7651
84805
79
80
6268
71299
Complement C3 [Mass/volume] in Serum or Plasma
4485-9 [3000620]
4485-9 [3000620]
1.1e+00
1.8e+00
3.5e+00
1.0e+50
4.5e+00
2.3e+00
1.7e+00
cases:1.58%
controls:0.52%
cases:1.35%
controls:0.23%
cases:0.77%
controls:0.02%
cases:0.46%
controls:0.00%
cases:1.35%
controls:0.02%
cases:1.73%
controls:0.18%
cases:2.99%
controls:0.57%
139
455
8640
87042
119
198
8671
87386
68
20
8722
87564
40
0
8750
87584
113
14
8237
87386
134
155
7610
84690
190
408
6157
70971
Complement C4 [Mass/volume] in Serum or Plasma
4498-2 [3017766]
4498-2 [3017766]
1.2e+00
1.8e+00
3.5e+00
1.0e+50
4.4e+00
2.3e+00
1.7e+00
cases:1.58%
controls:0.50%
cases:1.35%
controls:0.22%
cases:0.77%
controls:0.02%
cases:0.46%
controls:0.00%
cases:1.35%
controls:0.02%
cases:1.72%
controls:0.18%
cases:2.96%
controls:0.56%
139
441
8640
87056
119
196
8671
87388
68
20
8722
87564
40
0
8750
87584
113
15
8237
87385
133
152
7611
84693
188
400
6159
70979
Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22246-3 [3017918]
22246-3 [3017918]
1.0e+00
2.2e+00
3.3e+00
1.0e+50
4.3e+00
2.5e+00
1.6e+00
cases:0.89%
controls:0.33%
cases:0.97%
controls:0.11%
cases:0.42%
controls:0.02%
cases:0.14%
controls:0.00%
cases:1.13%
controls:0.01%
cases:1.25%
controls:0.11%
cases:1.39%
controls:0.29%
78
286
8701
87211
85
99
8705
87485
37
14
8753
87570
12
0
8778
87584
94
13
8256
87387
97
90
7647
84755
88
209
6259
71170
CD3+CD4+ (T4 helper) cells [#/volume] in Blood
24467-3 [3028167]
24467-3 [3028167]
1.3e+00
2.1e+00
3.3e+00
—
3.4e+00
2.5e+00
2.2e+00
cases:0.50%
controls:0.14%
cases:0.57%
controls:0.07%
cases:0.16%
controls:0.01%
—
—
cases:0.30%
controls:0.01%
cases:0.75%
controls:0.06%
cases:0.99%
controls:0.11%
44
121
8735
87376
50
63
8740
87521
14
5
8776
87579
—
25
9
8325
87391
58
52
7686
84793
63
76
6284
71303
Toxoplasma gondii IgM Ab [Units/volume] in Serum
8040-8 [3027529]
8040-8 [3027529]
9.1e-01
2.3e+00
2.9e+00
—
4.2e+00
2.6e+00
1.8e+00
cases:0.42%
controls:0.17%
cases:0.43%
controls:0.04%
cases:0.15%
controls:0.01%
—
—
cases:0.47%
controls:0.01%
cases:0.66%
controls:0.05%
cases:0.90%
controls:0.15%
37
149
8742
87348
38
38
8752
87546
13
7
8777
87577
—
39
6
8311
87394
51
40
7693
84805
57
105
6290
71274
Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
41001-9 [3042596]
41001-9 [3042596]
9.4e-01
2.0e+00
3.2e+00
1.0e+50
4.0e+00
2.7e+00
1.9e+00
cases:0.52%
controls:0.21%
cases:0.59%
controls:0.08%
cases:0.26%
controls:0.01%
cases:0.11%
controls:0.00%
cases:0.59%
controls:0.01%
cases:1.12%
controls:0.07%
cases:1.29%
controls:0.20%
46
180
8733
87317
52
70
8738
87514
23
9
8767
87575
10
0
8780
87584
49
9
8301
87391
87
63
7657
84782
82
146
6265
71233
CD3 cells [#/volume] in Blood
8122-4 [3011412]
8122-4 [3011412]
1.3e+00
1.9e+00
3.0e+00
—
3.2e+00
3.0e+00
2.3e+00
cases:0.67%
controls:0.18%
cases:0.71%
controls:0.11%
cases:0.24%
controls:0.01%
—
—
cases:0.32%
controls:0.01%
cases:1.60%
controls:0.08%
cases:1.94%
controls:0.19%
59
161
8720
87336
62
92
8728
87492
21
10
8769
87574
—
27
11
8323
87389
124
71
7620
84774
123
136
6224
71243
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
40987-0 [3043924]
6.9e-01
1.3e+00
2.6e+00
5.3e+00
2.9e+00
1.4e+00
7.6e-01
cases:2.79%
controls:1.43%
cases:2.76%
controls:0.80%
cases:1.50%
controls:0.12%
cases:1.09%
controls:0.01%
cases:1.88%
controls:0.11%
cases:3.56%
controls:0.93%
cases:6.24%
controls:3.00%
245
1247
8534
86250
243
703
8547
86881
132
104
8658
87480
96
5
8694
87579
157
92
8193
87308
276
788
7468
84057
396
2144
5951
69235
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
7852-7 [3010130]
7852-7 [3010130]
9.3e-01
2.1e+00
3.2e+00
1.0e+50
4.4e+00
2.5e+00
1.6e+00
cases:0.79%
controls:0.31%
cases:0.85%
controls:0.10%
cases:0.38%
controls:0.01%
cases:0.11%
controls:0.00%
cases:1.07%
controls:0.01%
cases:1.12%
controls:0.09%
cases:1.31%
controls:0.27%
69
272
8710
87225
75
88
8715
87496
33
13
8757
87571
10
0
8780
87584
89
12
8261
87388
87
78
7657
84767
83
190
6264
71189
Demanding cystostatic therapy of methastized malignancy
WD135 [2001310681]
WD135 [2001310681]
1.8e+00
3.9e+00
3.8e+00
—
—
3.5e+00
1.6e+00
cases:0.24%
controls:0.04%
cases:0.61%
controls:0.01%
cases:0.31%
controls:0.01%
—
—
—
—
cases:0.53%
controls:0.02%
cases:0.19%
controls:0.04%
21
33
8758
87464
54
11
8736
87573
27
6
8763
87578
—
—
41
13
7703
84832
12
26
6335
71353
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
57782-5 [40760892]
5.8e-01
1.3e+00
2.6e+00
5.3e+00
2.7e+00
1.4e+00
8.0e-01
cases:6.89%
controls:3.99%
cases:7.65%
controls:2.27%
cases:5.20%
controls:0.41%
cases:2.56%
controls:0.01%
cases:5.54%
controls:0.39%
cases:8.70%
controls:2.26%
cases:11.94%
controls:5.72%
605
3490
8174
84007
672
1985
8118
85599
457
355
8333
87229
225
11
8565
87573
463
345
7887
87055
674
1920
7070
82925
758
4082
5589
67297
Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5159-9 [3007844]
5159-9 [3007844]
1.0e+00
2.0e+00
3.3e+00
1.0e+50
4.3e+00
2.5e+00
1.5e+00
cases:0.89%
controls:0.31%
cases:0.83%
controls:0.12%
cases:0.41%
controls:0.01%
cases:0.16%
controls:0.00%
cases:1.15%
controls:0.02%
cases:1.12%
controls:0.09%
cases:1.28%
controls:0.28%
78
275
8701
87222
73
101
8717
87483
36
13
8754
87571
14
0
8776
87584
96
14
8254
87386
87
77
7657
84768
81
197
6266
71182
Differential panel, method unspecified - Blood
69738-3 [42870588]
69738-3 [42870588]
7.0e-01
1.3e+00
2.5e+00
4.9e+00
2.7e+00
1.5e+00
1.0e+00
cases:13.05%
controls:6.93%
cases:13.19%
controls:4.16%
cases:9.28%
controls:0.81%
cases:5.10%
controls:0.04%
cases:11.17%
controls:0.80%
cases:15.65%
controls:4.03%
cases:20.03%
controls:8.28%
1146
6066
7633
81431
1159
3640
7631
83944
816
711
7974
86873
448
34
8342
87550
933
700
7417
86700
1212
3419
6532
81426
1271
5909
5076
65470
Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
31374-2 [3007080]
31374-2 [3007080]
1.1e+00
2.0e+00
3.4e+00
1.0e+50
4.2e+00
2.4e+00
1.5e+00
cases:0.88%
controls:0.29%
cases:0.78%
controls:0.11%
cases:0.40%
controls:0.01%
cases:0.14%
controls:0.00%
cases:1.03%
controls:0.01%
cases:0.96%
controls:0.08%
cases:1.21%
controls:0.27%
77
256
8702
87241
69
96
8721
87488
35
12
8755
87572
12
0
8778
87584
86
13
8264
87387
74
72
7670
84773
77
190
6270
71189
Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
1952-1 [3013201]
1952-1 [3013201]
1.1e+00
2.1e+00
3.5e+00
—
4.2e+00
2.0e+00
1.7e+00
cases:0.40%
controls:0.13%
cases:0.51%
controls:0.06%
cases:0.18%
controls:0.01%
—
—
cases:0.48%
controls:0.01%
cases:0.36%
controls:0.05%
cases:0.76%
controls:0.14%
35
113
8744
87384
45
54
8745
87530
16
5
8774
87579
—
40
6
8310
87394
28
43
7716
84802
48
100
6299
71279
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
34487-9 [3044938]
6.9e-01
1.2e+00
2.5e+00
5.2e+00
2.9e+00
1.3e+00
7.6e-01
cases:4.17%
controls:2.13%
cases:3.78%
controls:1.14%
cases:2.08%
controls:0.17%
cases:1.81%
controls:0.01%
cases:2.54%
controls:0.15%
cases:4.79%
controls:1.31%
cases:8.04%
controls:3.91%
366
1867
8413
85630
332
998
8458
86586
183
146
8607
87438
159
9
8631
87575
212
128
8138
87272
371
1113
7373
83732
510
2794
5837
68585
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]
47598-8 [3048816]
6.5e-01
1.4e+00
2.7e+00
4.6e+00
2.8e+00
1.5e+00
9.3e-01
cases:2.84%
controls:1.51%
cases:3.06%
controls:0.79%
cases:2.14%
controls:0.14%
cases:0.69%
controls:0.01%
cases:2.43%
controls:0.15%
cases:3.13%
controls:0.75%
cases:4.40%
controls:1.78%
249
1317
8530
86180
269
691
8521
86893
188
123
8602
87461
61
6
8729
87578
203
128
8147
87272
242
636
7502
84209
279
1272
6068
70107
Toxoplasma gondii IgG Ab [Units/volume] in Serum
8039-0 [3014959]
8039-0 [3014959]
8.8e-01
2.3e+00
2.8e+00
1.0e+50
4.2e+00
2.6e+00
1.8e+00
cases:0.43%
controls:0.18%
cases:0.48%
controls:0.05%
cases:0.15%
controls:0.01%
cases:0.06%
controls:0.00%
cases:0.48%
controls:0.01%
cases:0.67%
controls:0.05%
cases:0.90%
controls:0.16%
38
158
8741
87339
42
42
8748
87542
13
8
8777
87576
5
0
8785
87584
40
6
8310
87394
52
43
7692
84802
57
111
6290
71268
Leukocyte morphology finding [Identifier] in Blood
11156-7 [3008757]
11156-7 [3008757]
1.2e+00
1.9e+00
2.9e+00
—
4.3e+00
2.6e+00
1.6e+00
cases:0.60%
controls:0.17%
cases:0.59%
controls:0.09%
cases:0.31%
controls:0.02%
—
—
cases:0.86%
controls:0.01%
cases:1.02%
controls:0.08%
cases:0.85%
controls:0.17%
53
152
8726
87345
52
75
8738
87509
27
15
8763
87569
—
72
10
8278
87390
79
68
7665
84777
54
123
6293
71256
Secondary malignant neoplasm of other specified sites
C79.8 [45547524]
C79.8 [45547524]
1.2e+00
1.8e+00
2.2e+00
4.8e+00
2.3e+00
1.4e+00
8.0e-01
cases:0.54%
controls:0.16%
cases:1.01%
controls:0.17%
cases:0.83%
controls:0.09%
cases:0.69%
controls:0.01%
cases:0.80%
controls:0.08%
cases:0.76%
controls:0.19%
cases:0.54%
controls:0.24%
47
137
8732
87360
89
151
8701
87433
73
79
8717
87505
61
5
8729
87579
67
70
8283
87330
59
159
7685
84686
34
173
6313
71206
Metastasis
OMOP4998856 [36769180]
OMOP4998856 [36769180]
1.3e+00
1.8e+00
2.2e+00
4.8e+00
2.3e+00
1.4e+00
7.5e-01
cases:0.55%
controls:0.16%
cases:1.01%
controls:0.17%
cases:0.83%
controls:0.09%
cases:0.69%
controls:0.01%
cases:0.83%
controls:0.08%
cases:0.76%
controls:0.19%
cases:0.54%
controls:0.25%
48
137
8731
87360
89
152
8701
87432
73
79
8717
87505
61
5
8729
87579
69
70
8281
87330
59
161
7685
84684
34
182
6313
71197
Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7853-5 [3015635]
7853-5 [3015635]
9.7e-01
2.1e+00
3.2e+00
1.0e+50
4.3e+00
2.5e+00
1.5e+00
cases:0.85%
controls:0.32%
cases:0.90%
controls:0.12%
cases:0.38%
controls:0.02%
cases:0.16%
controls:0.00%
cases:1.20%
controls:0.02%
cases:1.20%
controls:0.10%
cases:1.35%
controls:0.29%
75
284
8704
87213
79
101
8711
87483
33
14
8757
87570
14
0
8776
87584
100
14
8250
87386
93
87
7651
84758
86
208
6261
71171
Myeloperoxidase IgG Ab [Units/volume] in Serum
48404-8 [3049804]
48404-8 [3049804]
9.9e-01
1.9e+00
3.6e+00
—
4.6e+00
2.1e+00
1.3e+00
cases:1.15%
controls:0.43%
cases:1.18%
controls:0.18%
cases:0.66%
controls:0.02%
—
—
cases:1.21%
controls:0.01%
cases:1.16%
controls:0.14%
cases:1.65%
controls:0.44%
101
377
8678
87120
104
157
8686
87427
58
16
8732
87568
—
101
11
8249
87389
90
123
7654
84722
105
313
6242
71066
Medical doctor
Z2221 [2001311556]
Z2221 [2001311556]
5.5e-01
1.3e+00
1.9e+00
5.4e+00
2.2e+00
1.7e+00
1.3e+00
cases:7.64%
controls:4.54%
cases:4.64%
controls:1.28%
cases:1.34%
controls:0.19%
cases:2.25%
controls:0.01%
cases:1.70%
controls:0.19%
cases:6.28%
controls:1.19%
cases:10.37%
controls:3.05%
671
3976
8108
83521
408
1117
8382
86467
118
170
8672
87414
198
9
8592
87575
142
163
8208
87237
486
1008
7258
83837
658
2177
5689
69202
Haptoglobin [Mass/volume] in Serum or Plasma
4542-7 [3012336]
4542-7 [3012336]
1.1e+00
1.8e+00
3.6e+00
—
4.5e+00
2.1e+00
1.3e+00
cases:2.13%
controls:0.69%
cases:1.93%
controls:0.32%
cases:1.40%
controls:0.04%
—
—
cases:2.73%
controls:0.03%
cases:2.31%
controls:0.29%
cases:3.66%
controls:1.01%
187
603
8592
86894
170
279
8620
87305
123
35
8667
87549
—
228
26
8122
87374
179
247
7565
84598
232
724
6115
70655
Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
23826-1 [3012477]
23826-1 [3012477]
8.4e-01
1.9e+00
3.6e+00
1.0e+50
4.4e+00
2.3e+00
1.4e+00
cases:0.47%
controls:0.20%
cases:0.65%
controls:0.10%
cases:0.41%
controls:0.01%
cases:0.13%
controls:0.00%
cases:0.66%
controls:0.01%
cases:1.02%
controls:0.10%
cases:1.54%
controls:0.39%
41
177
8738
87320
57
85
8733
87499
36
10
8754
87574
11
0
8779
87584
55
7
8295
87393
79
84
7665
84761
98
278
6249
71101
Chronic lymphocytic leukaemia of B-cell type
C91.1 [45600564]
C91.1 [45600564]
1.3e+00
1.6e+00
2.1e+00
4.1e+00
2.3e+00
1.8e+00
1.3e+00
cases:0.60%
controls:0.16%
cases:0.63%
controls:0.13%
cases:0.38%
controls:0.05%
cases:0.41%
controls:0.01%
cases:0.47%
controls:0.05%
cases:0.75%
controls:0.12%
cases:0.61%
controls:0.16%
53
144
8726
87353
55
110
8735
87474
33
41
8757
87543
36
6
8754
87578
39
43
8311
87357
58
106
7686
84739
39
117
6308
71262
Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
34645-2 [3031478]
34645-2 [3031478]
1.0e+00
1.8e+00
3.6e+00
1.0e+50
4.1e+00
2.4e+00
1.5e+00
cases:0.52%
controls:0.19%
cases:0.59%
controls:0.09%
cases:0.42%
controls:0.01%
cases:0.13%
controls:0.00%
cases:0.65%
controls:0.01%
cases:0.99%
controls:0.09%
cases:1.56%
controls:0.36%
46
165
8733
87332
52
83
8738
87501
37
10
8753
87574
11
0
8779
87584
54
9
8296
87391
77
80
7667
84765
99
256
6248
71123
von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
68324-3 [40770918]
68324-3 [40770918]
2.2e+00
4.3e+00
—
1.0e+50
1.0e+50
4.8e+00
3.1e+00
cases:0.50%
controls:0.05%
cases:0.94%
controls:0.01%
—
—
cases:0.09%
controls:0.00%
cases:0.62%
controls:0.00%
cases:0.99%
controls:0.01%
cases:1.29%
controls:0.06%
44
48
8735
87449
83
11
8707
87573
—
8
0
8782
87584
52
0
8298
87400
77
7
7667
84838
82
44
6265
71335
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
34531-4 [3044640]
4.4e-01
1.0e+00
2.4e+00
5.5e+00
2.9e+00
1.4e+00
7.0e-01
cases:9.36%
controls:6.21%
cases:7.01%
controls:2.65%
cases:3.57%
controls:0.33%
cases:3.48%
controls:0.01%
cases:5.44%
controls:0.31%
cases:8.41%
controls:2.20%
cases:12.16%
controls:6.45%
822
5437
7957
82060
616
2319
8174
85265
314
289
8476
87295
306
13
8484
87571
454
271
7896
87129
651
1865
7093
82980
772
4601
5575
66778
Infectious Disease
44 [38004484]
44 [38004484]
7.1e-01
1.2e+00
2.0e+00
5.0e+00
2.5e+00
1.7e+00
1.2e+00
cases:3.14%
controls:1.57%
cases:2.13%
controls:0.64%
cases:0.89%
controls:0.12%
cases:1.19%
controls:0.01%
cases:1.39%
controls:0.11%
cases:3.31%
controls:0.63%
cases:5.45%
controls:1.67%
276
1371
8503
86126
187
557
8603
87027
78
107
8712
87477
105
7
8685
87577
116
97
8234
87303
256
533
7488
84312
346
1194
6001
70185
Segmented neutrophils/Leukocytes in Blood
26505-8 [3017354]
26505-8 [3017354]
1.2e+00
1.8e+00
3.2e+00
—
4.4e+00
2.3e+00
1.3e+00
cases:0.49%
controls:0.14%
cases:0.43%
controls:0.07%
cases:0.32%
controls:0.01%
—
—
cases:0.81%
controls:0.01%
cases:0.89%
controls:0.09%
cases:0.74%
controls:0.19%
43
126
8736
87371
38
65
8752
87519
28
11
8762
87573
—
68
9
8282
87391
69
74
7675
84771
47
138
6300
71241
Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
38917-1 [3042194]
38917-1 [3042194]
9.3e-01
1.8e+00
3.2e+00
1.0e+50
4.2e+00
2.5e+00
1.6e+00
cases:0.96%
controls:0.38%
cases:0.99%
controls:0.16%
cases:0.51%
controls:0.02%
cases:0.18%
controls:0.00%
cases:1.09%
controls:0.02%
cases:1.76%
controls:0.14%
cases:2.19%
controls:0.46%
84
333
8695
87164
87
138
8703
87446
45
19
8745
87565
16
0
8774
87584
91
14
8259
87386
136
120
7608
84725
139
330
6208
71049
Nonfamilial hypogammaglobulinaemia
D80.1 [45533001]
D80.1 [45533001]
2.0e+00
1.9e+00
2.6e+00
1.0e+50
2.3e+00
2.4e+00
3.2e+00
cases:0.19%
controls:0.03%
cases:0.15%
controls:0.02%
cases:0.10%
controls:0.01%
cases:0.09%
controls:0.00%
cases:0.08%
controls:0.01%
cases:0.17%
controls:0.02%
cases:0.39%
controls:0.02%
17
24
8762
87473
13
20
8777
87564
9
7
8781
87577
8
0
8782
87584
7
7
8343
87393
13
13
7731
84832
25
12
6322
71367
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
2472-9 [3028026]
1.0e+00
1.9e+00
3.7e+00
—
3.8e+00
2.2e+00
1.5e+00
cases:2.68%
controls:0.95%
cases:2.87%
controls:0.45%
cases:1.89%
controls:0.05%
—
—
cases:2.35%
controls:0.05%
cases:3.49%
controls:0.38%
cases:4.60%
controls:1.04%
235
835
8544
86662
252
397
8538
87187
166
41
8624
87543
—
196
46
8154
87354
270
325
7474
84520
292
741
6055
70638
Monocytes/Leukocytes in Blood
26485-3 [3019069]
26485-3 [3019069]
5.9e-01
1.2e+00
2.5e+00
4.9e+00
2.7e+00
1.4e+00
9.1e-01
cases:16.80%
controls:10.09%
cases:17.12%
controls:6.01%
cases:12.25%
controls:1.13%
cases:6.22%
controls:0.05%
cases:14.10%
controls:1.08%
cases:20.40%
controls:5.79%
cases:26.19%
controls:12.53%
1475
8826
7304
78671
1505
5263
7285
82321
1077
987
7713
86597
547
43
8243
87541
1177
947
7173
86453
1580
4913
6164
79932
1662
8943
4685
62436
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
26450-7 [3006504]
5.9e-01
1.2e+00
2.5e+00
4.9e+00
2.7e+00
1.4e+00
9.0e-01
cases:16.74%
controls:10.05%
cases:17.14%
controls:6.01%
cases:12.21%
controls:1.13%
cases:6.09%
controls:0.05%
cases:13.93%
controls:1.08%
cases:20.36%
controls:5.78%
cases:26.11%
controls:12.53%
1470
8792
7309
78705
1507
5260
7283
82324
1073
987
7717
86597
535
42
8255
87542
1163
946
7187
86454
1577
4906
6167
79939
1657
8942
4690
62437
Pulmonary embolism without mention of acute cor pulmonale
I26.9 [45552785]
I26.9 [45552785]
1.6e+00
2.4e+00
3.1e+00
—
3.2e+00
2.5e+00
1.5e+00
cases:2.11%
controls:0.45%
cases:2.17%
controls:0.21%
cases:0.83%
controls:0.04%
—
—
cases:1.17%
controls:0.05%
cases:2.39%
controls:0.19%
cases:2.39%
controls:0.57%
185
391
8594
87106
191
183
8599
87401
73
34
8717
87550
—
98
43
8252
87357
185
162
7559
84683
152
404
6195
70975
Vasculitis limited to skin, unspecified
L95.9 [45591658]
L95.9 [45591658]
2.2e+00
4.0e+00
—
—
—
4.5e+00
3.4e+00
cases:0.21%
controls:0.02%
cases:0.46%
controls:0.01%
—
—
—
—
—
—
cases:0.90%
controls:0.01%
cases:0.65%
controls:0.02%
18
19
8761
87478
40
7
8750
87577
—
—
—
70
9
7674
84836
41
15
6306
71364
Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
40976-3 [3040853]
40976-3 [3040853]
9.2e-01
1.8e+00
3.2e+00
1.0e+50
4.2e+00
2.5e+00
1.5e+00
cases:0.90%
controls:0.36%
cases:1.00%
controls:0.16%
cases:0.52%
controls:0.02%
cases:0.20%
controls:0.00%
cases:1.15%
controls:0.02%
cases:1.74%
controls:0.15%
cases:2.21%
controls:0.49%
79
317
8700
87180
88
142
8702
87442
46
19
8744
87565
18
0
8772
87584
96
15
8254
87385
135
125
7609
84720
140
350
6207
71029
Neutrophil cytoplasmic Ab [Units/volume] in Serum
5128-4 [3001334]
5128-4 [3001334]
8.7e-01
1.8e+00
3.8e+00
1.0e+50
4.2e+00
2.1e+00
1.4e+00
cases:1.51%
controls:0.64%
cases:1.42%
controls:0.23%
cases:0.77%
controls:0.02%
cases:0.57%
controls:0.00%
cases:1.40%
controls:0.02%
cases:1.38%
controls:0.17%
cases:2.11%
controls:0.53%
133
560
8646
86937
125
205
8665
87379
68
16
8722
87568
50
0
8740
87584
117
19
8233
87381
107
142
7637
84703
134
380
6213
70999
Basophils/Leukocytes in Blood
30180-4 [3022096]
30180-4 [3022096]
5.8e-01
1.2e+00
2.5e+00
4.9e+00
2.7e+00
1.4e+00
9.0e-01
cases:16.64%
controls:10.01%
cases:17.06%
controls:6.01%
cases:12.12%
controls:1.13%
cases:6.04%
controls:0.05%
cases:13.83%
controls:1.09%
cases:20.33%
controls:5.81%
cases:26.04%
controls:12.53%
1461
8761
7318
78736
1500
5260
7290
82324
1065
987
7725
86597
531
43
8259
87541
1155
951
7195
86449
1574
4927
6170
79918
1653
8945
4694
62434
Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29257-3 [3002482]
29257-3 [3002482]
8.1e-01
1.8e+00
3.6e+00
1.0e+50
4.2e+00
2.3e+00
1.4e+00
cases:0.55%
controls:0.24%
cases:0.73%
controls:0.12%
cases:0.49%
controls:0.01%
cases:0.13%
controls:0.00%
cases:0.75%
controls:0.01%
cases:1.11%
controls:0.11%
cases:1.86%
controls:0.46%
48
213
8731
87284
64
104
8726
87480
43
12
8747
87572
11
0
8779
87584
63
10
8287
87390
86
96
7658
84749
118
327
6229
71052
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
1963-8 [3016293]
7.7e-01
1.4e+00
2.4e+00
4.3e+00
2.7e+00
1.5e+00
9.7e-01
cases:1.98%
controls:0.93%
cases:1.99%
controls:0.50%
cases:0.74%
controls:0.07%
cases:0.61%
controls:0.01%
cases:1.02%
controls:0.07%
cases:2.17%
controls:0.47%
cases:3.29%
controls:1.28%
174
810
8605
86687
175
436
8615
87148
65
60
8725
87524
54
7
8736
87577
85
63
8265
87337
168
399
7576
84446
209
914
6138
70465
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
26478-8 [3002030]
5.7e-01
1.2e+00
2.5e+00
4.9e+00
2.7e+00
1.4e+00
8.7e-01
cases:16.94%
controls:10.36%
cases:17.32%
controls:6.18%
cases:12.38%
controls:1.14%
cases:6.28%
controls:0.05%
cases:14.18%
controls:1.12%
cases:20.45%
controls:6.00%
cases:26.41%
controls:13.08%
1487
9066
7292
78431
1522
5412
7268
82172
1088
1000
7702
86584
552
44
8238
87540
1184
977
7166
86423
1584
5091
6160
79754
1676
9333
4671
62046
Emergency Room Visit
ER [9203]
ER [9203]
5.4e-01
1.2e+00
2.3e+00
6.0e+00
2.1e+00
1.2e+00
8.2e-01
cases:46.05%
controls:33.19%
cases:29.07%
controls:11.44%
cases:12.81%
controls:1.44%
cases:22.63%
controls:0.08%
cases:10.56%
controls:1.47%
cases:28.80%
controls:10.80%
cases:48.61%
controls:29.45%
4043
29041
4736
58456
2555
10023
6235
77561
1126
1261
7664
86323
1989
66
6801
87518
882
1288
7468
86112
2230
9164
5514
75681
3085
21024
3262
50355
Chemotherapy session for neoplasm
Z51.1 [45595526]
Z51.1 [45595526]
8.9e-01
2.6e+00
3.8e+00
—
2.8e+00
2.8e+00
1.1e+00
cases:0.22%
controls:0.09%
cases:0.63%
controls:0.05%
cases:0.55%
controls:0.01%
—
—
cases:0.31%
controls:0.02%
cases:0.46%
controls:0.03%
cases:0.22%
controls:0.07%
19
78
8760
87419
55
42
8735
87542
48
11
8742
87573
—
26
17
8324
87383
36
24
7708
84821
14
52
6333
71327
Morphology [Interpretation] in Blood Narrative
18314-5 [3000093]
18314-5 [3000093]
1.2e+00
2.9e+00
4.9e+00
—
—
3.1e+00
1.8e+00
cases:0.55%
controls:0.16%
cases:0.81%
controls:0.05%
cases:0.92%
controls:0.01%
—
—
—
—
cases:0.72%
controls:0.03%
cases:0.88%
controls:0.14%
48
138
8731
87359
71
41
8719
87543
81
6
8709
87578
—
—
56
29
7688
84816
56
100
6291
71279
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
14879-1 [3003458]
6.7e-01
1.2e+00
2.2e+00
4.7e+00
2.6e+00
1.6e+00
1.0e+00
cases:4.68%
controls:2.46%
cases:4.84%
controls:1.45%
cases:2.42%
controls:0.29%
cases:0.73%
controls:0.01%
cases:3.63%
controls:0.27%
cases:5.98%
controls:1.32%
cases:7.93%
controls:3.05%
411
2153
8368
85344
425
1273
8365
86311
213
250
8577
87334
64
6
8726
87578
303
240
8047
87160
463
1119
7281
83726
503
2179
5844
69200
Emergency Room and Inpatient Visit
ERIP [262]
ERIP [262]
5.5e-01
1.2e+00
2.3e+00
6.1e+00
2.3e+00
9.5e-01
4.5e-01
cases:8.47%
controls:5.05%
cases:8.65%
controls:2.88%
cases:4.20%
controls:0.43%
cases:7.34%
controls:0.02%
cases:4.57%
controls:0.46%
cases:8.21%
controls:3.35%
cases:13.99%
controls:9.40%
744
4422
8035
83075
760
2521
8030
85063
369
380
8421
87204
645
15
8145
87569
382
401
7968
86999
636
2839
7108
82006
888
6709
5459
64670
Inpatient Hospital
21 [8717]
21 [8717]
4.5e-01
9.7e-01
2.1e+00
5.9e+00
2.4e+00
1.3e+00
7.7e-01
cases:42.42%
controls:31.86%
cases:23.47%
controls:10.43%
cases:10.86%
controls:1.40%
cases:19.72%
controls:0.07%
cases:13.70%
controls:1.46%
cases:27.93%
controls:9.55%
cases:41.34%
controls:24.59%
3724
27878
5055
59619
2063
9139
6727
78445
955
1230
7835
86354
1733
61
7057
87523
1144
1273
7206
86127
2163
8099
5581
76746
2624
17550
3723
53829
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
77397-8 [46236098]
5.0e-01
9.9e-01
2.4e+00
5.2e+00
2.8e+00
1.3e+00
6.7e-01
cases:6.91%
controls:4.29%
cases:4.97%
controls:1.91%
cases:2.51%
controls:0.24%
cases:2.39%
controls:0.01%
cases:3.93%
controls:0.25%
cases:6.00%
controls:1.65%
cases:8.79%
controls:4.68%
607
3757
8172
83740
437
1672
8353
85912
221
207
8569
87377
210
12
8580
87572
328
219
8022
87181
465
1399
7279
83446
558
3341
5789
68038
Monocytes [#/volume] in Blood
26484-6 [3001604]
26484-6 [3001604]
5.6e-01
1.2e+00
2.5e+00
4.8e+00
2.6e+00
1.4e+00
8.9e-01
cases:17.13%
controls:10.54%
cases:17.95%
controls:6.39%
cases:12.50%
controls:1.16%
cases:5.69%
controls:0.05%
cases:13.27%
controls:1.14%
cases:21.31%
controls:6.22%
cases:27.86%
controls:13.74%
1504
9220
7275
78277
1578
5595
7212
81989
1099
1020
7691
86564
500
45
8290
87539
1108
996
7242
86404
1650
5279
6094
79566
1768
9805
4579
61574
Basophils [#/volume] in Blood
26444-0 [3006315]
26444-0 [3006315]
5.6e-01
1.2e+00
2.5e+00
4.8e+00
2.6e+00
1.4e+00
8.8e-01
cases:17.18%
controls:10.57%
cases:17.96%
controls:6.40%
cases:12.48%
controls:1.17%
cases:5.72%
controls:0.05%
cases:13.27%
controls:1.14%
cases:21.37%
controls:6.24%
cases:27.92%
controls:13.80%
1508
9251
7271
78246
1579
5609
7211
81975
1097
1021
7693
86563
503
45
8287
87539
1108
997
7242
86403
1655
5297
6089
79548
1772
9847
4575
61532
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
26474-7 [3019198]
5.5e-01
1.1e+00
2.5e+00
4.8e+00
2.6e+00
1.4e+00
8.6e-01
cases:17.63%
controls:10.97%
cases:18.19%
controls:6.61%
cases:12.78%
controls:1.19%
cases:5.90%
controls:0.05%
cases:13.64%
controls:1.18%
cases:21.57%
controls:6.44%
cases:28.17%
controls:14.20%
1548
9596
7231
77901
1599
5792
7191
81792
1123
1044
7667
86540
519
46
8271
87538
1139
1028
7211
86372
1670
5463
6074
79382
1788
10135
4559
61244
Eosinophils [#/volume] in Blood
26449-9 [3013115]
26449-9 [3013115]
5.5e-01
1.2e+00
2.5e+00
4.8e+00
2.6e+00
1.4e+00
8.7e-01
cases:17.74%
controls:11.03%
cases:18.36%
controls:6.61%
cases:12.83%
controls:1.23%
cases:6.11%
controls:0.05%
cases:13.84%
controls:1.19%
cases:21.80%
controls:6.45%
cases:28.41%
controls:14.31%
1557
9653
7222
77844
1614
5785
7176
81799
1128
1079
7662
86505
537
48
8253
87536
1156
1044
7194
86356
1688
5476
6056
79369
1803
10215
4544
61164
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
14196-0 [3023520]
9.7e-01
1.9e+00
3.5e+00
—
4.0e+00
2.2e+00
1.2e+00
cases:3.43%
controls:1.33%
cases:4.32%
controls:0.67%
cases:3.52%
controls:0.11%
—
—
cases:5.03%
controls:0.10%
cases:6.06%
controls:0.73%
cases:6.95%
controls:2.12%
301
1165
8478
86332
380
587
8410
86997
309
92
8481
87492
—
420
87
7930
87313
469
620
7275
84225
441
1515
5906
69864
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
26511-6 [3018010]
5.6e-01
1.1e+00
2.4e+00
4.9e+00
2.6e+00
1.4e+00
8.7e-01
cases:16.32%
controls:10.07%
cases:16.50%
controls:6.04%
cases:11.33%
controls:1.11%
cases:5.52%
controls:0.05%
cases:12.91%
controls:1.09%
cases:19.72%
controls:5.87%
cases:25.79%
controls:12.75%
1433
8809
7346
78688
1450
5289
7340
82295
996
974
7794
86610
485
40
8305
87544
1078
957
7272
86443
1527
4980
6217
79865
1637
9100
4710
62279
Inpatient Visit
IP [9201]
IP [9201]
4.3e-01
9.2e-01
2.3e+00
5.8e+00
2.5e+00
1.2e+00
5.0e-01
cases:10.14%
controls:6.86%
cases:7.27%
controls:3.03%
cases:3.56%
controls:0.37%
cases:4.52%
controls:0.01%
cases:4.56%
controls:0.37%
cases:9.14%
controls:2.88%
cases:12.78%
controls:8.16%
890
6002
7889
81495
639
2654
8151
84930
313
321
8477
87263
397
12
8393
87572
381
326
7969
87074
708
2440
7036
82405
811
5823
5536
65556
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
22664-7 [3020779]
8.8e-01
1.4e+00
2.2e+00
4.1e+00
2.5e+00
1.6e+00
1.1e+00
cases:3.68%
controls:1.57%
cases:3.74%
controls:0.96%
cases:1.66%
controls:0.19%
cases:0.56%
controls:0.01%
cases:2.48%
controls:0.21%
cases:4.46%
controls:0.94%
cases:5.86%
controls:2.01%
323
1371
8456
86126
329
841
8461
86743
146
169
8644
87415
49
8
8741
87576
207
181
8143
87219
345
797
7399
84048
372
1432
5975
69947
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
751-8 [3013650]
5.1e-01
1.1e+00
2.4e+00
4.9e+00
2.5e+00
1.4e+00
8.4e-01
cases:19.31%
controls:12.58%
cases:20.89%
controls:7.77%
cases:16.59%
controls:1.79%
cases:9.99%
controls:0.08%
cases:17.46%
controls:1.76%
cases:24.25%
controls:7.51%
cases:30.03%
controls:15.58%
1695
11011
7084
76486
1836
6803
6954
80781
1458
1572
7332
86012
878
70
7912
87514
1458
1537
6892
85863
1878
6375
5866
78470
1906
11123
4441
60256
Follicular lymphoma grade II
C82.1 [45532946]
C82.1 [45532946]
1.7e+00
2.0e+00
2.8e+00
1.0e+50
3.2e+00
2.1e+00
1.9e+00
cases:0.32%
controls:0.06%
cases:0.36%
controls:0.05%
cases:0.27%
controls:0.02%
cases:0.22%
controls:0.00%
cases:0.28%
controls:0.01%
cases:0.37%
controls:0.05%
cases:0.39%
controls:0.06%
28
52
8751
87445
32
42
8758
87542
24
15
8766
87569
19
0
8771
87584
23
10
8327
87390
29
40
7715
84805
25
42
6322
71337
Other and unspecified cirrhosis of liver
K74.6 [45538546]
K74.6 [45538546]
1.7e+00
1.9e+00
1.8e+00
1.0e+50
3.2e+00
2.5e+00
2.5e+00
cases:0.42%
controls:0.08%
cases:0.36%
controls:0.06%
cases:0.11%
controls:0.02%
cases:0.24%
controls:0.00%
cases:0.29%
controls:0.01%
cases:0.79%
controls:0.06%
cases:1.42%
controls:0.12%
37
68
8742
87429
32
49
8758
87535
10
16
8780
87568
21
0
8769
87584
24
10
8326
87390
61
55
7683
84790
90
83
6257
71296
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
14631-6 [3006140]
5.2e-01
1.2e+00
2.5e+00
4.7e+00
2.6e+00
1.3e+00
7.6e-01
cases:16.45%
controls:10.46%
cases:16.23%
controls:5.58%
cases:11.84%
controls:1.13%
cases:5.72%
controls:0.05%
cases:13.46%
controls:1.09%
cases:18.61%
controls:5.64%
cases:24.41%
controls:13.06%
1444
9156
7335
78341
1427
4886
7363
82698
1041
986
7749
86598
503
48
8287
87536
1124
954
7226
86446
1441
4785
6303
80060
1549
9325
4798
62054
Enterovirus RNA [Presence] in Specimen by NAA with probe detection
29591-5 [3016881]
29591-5 [3016881]
9.3e-01
1.7e+00
2.9e+00
1.0e+50
4.0e+00
2.5e+00
1.5e+00
cases:0.44%
controls:0.18%
cases:0.36%
controls:0.07%
cases:0.17%
controls:0.01%
cases:0.08%
controls:0.00%
cases:0.50%
controls:0.01%
cases:0.67%
controls:0.06%
cases:0.77%
controls:0.17%
39
154
8740
87343
32
60
8758
87524
15
8
8775
87576
7
0
8783
87584
42
8
8308
87392
52
47
7692
84798
49
120
6298
71259
Outpatient Hospital
22 [8756]
22 [8756]
4.6e-01
1.0e+00
2.1e+00
5.5e+00
2.3e+00
1.4e+00
8.2e-01
cases:33.65%
controls:24.31%
cases:17.05%
controls:6.86%
cases:6.69%
controls:0.87%
cases:9.29%
controls:0.04%
cases:8.23%
controls:0.89%
cases:20.65%
controls:6.06%
cases:32.94%
controls:17.81%
2954
21274
5825
66223
1499
6012
7291
81572
588
759
8202
86825
817
38
7973
87546
687
778
7663
86622
1599
5140
6145
79705
2091
12712
4256
58667
Office Visit
OMOP4822458 [581477]
OMOP4822458 [581477]
4.8e-01
1.0e+00
1.9e+00
5.5e+00
2.5e+00
1.3e+00
7.7e-01
cases:13.49%
controls:8.77%
cases:6.92%
controls:2.54%
cases:2.42%
controls:0.36%
cases:2.70%
controls:0.01%
cases:4.06%
controls:0.34%
cases:8.38%
controls:2.42%
cases:13.82%
controls:6.88%
1184
7671
7595
79826
608
2226
8182
85358
213
317
8577
87267
237
10
8553
87574
339
293
8011
87107
649
2055
7095
82790
877
4910
5470
66469
Hepatitis A virus IgM Ab [Presence] in Serum
22314-9 [3013327]
22314-9 [3013327]
5.9e-01
1.9e+00
3.2e+00
1.0e+50
4.6e+00
2.1e+00
1.2e+00
cases:0.48%
controls:0.27%
cases:0.51%
controls:0.08%
cases:0.20%
controls:0.01%
cases:0.15%
controls:0.00%
cases:0.89%
controls:0.01%
cases:0.53%
controls:0.07%
cases:0.77%
controls:0.24%
42
233
8737
87264
45
68
8745
87516
18
7
8772
87577
13
0
8777
87584
74
8
8276
87392
41
57
7703
84788
49
172
6298
71207
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
207NI0002X [38003841]
4.5e-01
7.7e-01
1.4e+00
6.1e+00
2.5e+00
1.4e+00
8.4e-01
cases:10.97%
controls:7.28%
cases:6.37%
controls:3.06%
cases:2.17%
controls:0.53%
cases:9.00%
controls:0.02%
cases:6.12%
controls:0.52%
cases:11.25%
controls:2.94%
cases:15.91%
controls:7.52%
963
6369
7816
81128
560
2682
8230
84902
191
464
8599
87120
791
20
7999
87564
511
458
7839
86942
871
2496
6873
82349
1010
5367
5337
66012
Granulocytes/Leukocytes in Blood
30395-8 [3035933]
30395-8 [3035933]
9.3e-01
1.8e+00
3.3e+00
—
3.3e+00
2.4e+00
1.8e+00
cases:1.21%
controls:0.48%
cases:0.84%
controls:0.14%
cases:0.58%
controls:0.02%
—
—
cases:0.63%
controls:0.02%
cases:1.07%
controls:0.10%
cases:1.75%
controls:0.30%
106
419
8673
87078
74
124
8716
87460
51
19
8739
87565
—
53
20
8297
87380
83
86
7661
84759
111
212
6236
71167
Gas panel - Venous blood
24339-4 [3000991]
24339-4 [3000991]
7.3e-01
1.3e+00
2.4e+00
4.6e+00
2.4e+00
1.4e+00
7.4e-01
cases:2.51%
controls:1.22%
cases:2.55%
controls:0.73%
cases:1.08%
controls:0.10%
cases:0.55%
controls:0.01%
cases:1.22%
controls:0.11%
cases:2.80%
controls:0.71%
cases:4.16%
controls:2.02%
220
1070
8559
86427
224
635
8566
86949
95
88
8695
87496
48
5
8742
87579
102
99
8248
87301
217
604
7527
84241
264
1442
6083
69937
Hepatitis B virus core Ab [Presence] in Serum
16933-4 [3021879]
16933-4 [3021879]
8.8e-01
2.0e+00
3.6e+00
—
4.0e+00
1.9e+00
1.1e+00
cases:2.78%
controls:1.17%
cases:3.15%
controls:0.44%
cases:1.50%
controls:0.04%
—
—
cases:2.10%
controls:0.04%
cases:2.58%
controls:0.39%
cases:3.77%
controls:1.27%
244
1024
8535
86473
277
388
8513
87196
132
36
8658
87548
—
175
36
8175
87364
200
332
7544
84513
239
910
6108
70469
Epstein Barr virus Ab [Presence] in Serum
49178-7 [3048929]
49178-7 [3048929]
8.7e-01
1.8e+00
3.2e+00
1.0e+50
4.2e+00
2.2e+00
1.1e+00
cases:1.14%
controls:0.48%
cases:1.02%
controls:0.17%
cases:0.47%
controls:0.02%
cases:0.19%
controls:0.00%
cases:1.17%
controls:0.02%
cases:1.28%
controls:0.14%
cases:1.58%
controls:0.51%
100
421
8679
87076
90
145
8700
87439
41
17
8749
87567
17
0
8773
87584
98
15
8252
87385
99
122
7645
84723
100
366
6247
71013
Nephrology
39 [38004479]
39 [38004479]
1.1e+00
1.4e+00
1.7e+00
3.7e+00
2.0e+00
1.9e+00
1.7e+00
cases:2.75%
controls:0.95%
cases:2.78%
controls:0.72%
cases:1.40%
controls:0.26%
cases:1.33%
controls:0.03%
cases:2.01%
controls:0.27%
cases:4.44%
controls:0.70%
cases:5.29%
controls:1.06%
241
827
8538
86670
244
632
8546
86952
123
229
8667
87355
117
30
8673
87554
168
233
8182
87167
344
598
7400
84247
336
757
6011
70622
Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7993-9 [3025023]
7993-9 [3025023]
8.6e-01
1.7e+00
2.9e+00
1.0e+50
4.0e+00
2.4e+00
1.5e+00
cases:0.39%
controls:0.16%
cases:0.33%
controls:0.06%
cases:0.17%
controls:0.01%
cases:0.08%
controls:0.00%
cases:0.49%
controls:0.01%
cases:0.61%
controls:0.05%
cases:0.71%
controls:0.16%
34
144
8745
87353
29
54
8761
87530
15
8
8775
87576
7
0
8783
87584
41
8
8309
87392
47
46
7697
84799
45
113
6302
71266
pH of Serum or Plasma
2753-2 [3018418]
2753-2 [3018418]
5.5e-01
1.2e+00
2.4e+00
4.5e+00
2.6e+00
1.2e+00
7.9e-01
cases:9.59%
controls:5.75%
cases:9.64%
controls:2.99%
cases:5.03%
controls:0.50%
cases:1.65%
controls:0.02%
cases:6.19%
controls:0.49%
cases:9.66%
controls:2.98%
cases:15.08%
controls:7.44%
842
5028
7937
82469
847
2622
7943
84962
442
436
8348
87148
145
16
8645
87568
517
424
7833
86976
748
2531
6996
82314
957
5314
5390
66065
Malignant neoplasm: Female genital organ, unspecified
C57.9 [45566609]
C57.9 [45566609]
2.0e+00
2.5e+00
2.7e+00
1.0e+50
3.0e+00
3.0e+00
—
cases:0.07%
controls:0.01%
cases:0.11%
controls:0.01%
cases:0.10%
controls:0.01%
cases:0.08%
controls:0.00%
cases:0.12%
controls:0.01%
cases:0.12%
controls:0.01%
—
—
6
8
8773
87489
10
8
8780
87576
9
6
8781
87578
7
0
8783
87584
10
5
8340
87395
9
5
7735
84840
—
Pulmonary embolism with mention of acute cor pulmonale
I26.0 [45567169]
I26.0 [45567169]
1.3e+00
2.2e+00
2.9e+00
1.0e+50
3.2e+00
2.2e+00
1.4e+00
cases:0.40%
controls:0.11%
cases:0.48%
controls:0.05%
cases:0.25%
controls:0.01%
cases:0.42%
controls:0.00%
cases:0.23%
controls:0.01%
cases:0.54%
controls:0.06%
cases:0.63%
controls:0.15%
35
96
8744
87401
42
47
8748
87537
22
12
8768
87572
37
0
8753
87584
19
8
8331
87392
42
53
7702
84792
40
107
6307
71272
ECG with 12 standard connections
XF400 [2001303368]
XF400 [2001303368]
8.8e-01
1.4e+00
2.6e+00
4.4e+00
1.7e+00
1.2e+00
1.0e+00
cases:4.20%
controls:1.79%
cases:2.14%
controls:0.56%
cases:0.68%
controls:0.05%
cases:0.58%
controls:0.01%
cases:0.40%
controls:0.07%
cases:1.52%
controls:0.47%
cases:3.73%
controls:1.38%
369
1564
8410
85933
188
487
8602
87097
60
46
8730
87538
51
6
8739
87578
33
62
8317
87338
118
395
7626
84450
237
985
6110
70394
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
890-4 [3001079]
3.8e-01
9.9e-01
2.4e+00
5.1e+00
2.6e+00
1.2e+00
5.1e-01
cases:12.62%
controls:9.01%
cases:9.75%
controls:3.84%
cases:4.94%
controls:0.49%
cases:3.88%
controls:0.02%
cases:6.30%
controls:0.49%
cases:10.37%
controls:3.34%
cases:15.68%
controls:10.05%
1108
7884
7671
79613
857
3366
7933
84218
434
429
8356
87155
341
21
8449
87563
526
425
7824
86975
803
2836
6941
82009
995
7176
5352
64203
Granulocytes [#/volume] in Blood
30394-1 [3035715]
30394-1 [3035715]
9.9e-01
1.8e+00
3.0e+00
—
3.1e+00
2.2e+00
2.0e+00
cases:1.07%
controls:0.40%
cases:0.72%
controls:0.11%
cases:0.35%
controls:0.02%
—
—
cases:0.42%
controls:0.02%
cases:0.81%
controls:0.09%
cases:1.56%
controls:0.22%
94
352
8685
87145
63
100
8727
87484
31
15
8759
87569
—
35
16
8315
87384
63
74
7681
84771
99
159
6248
71220
Osmolality of Urine
2695-5 [3026782]
2695-5 [3026782]
4.5e-01
9.5e-01
2.2e+00
5.5e+00
2.3e+00
1.1e+00
7.7e-01
cases:6.74%
controls:4.40%
cases:4.81%
controls:1.91%
cases:2.15%
controls:0.25%
cases:1.64%
controls:0.01%
cases:2.42%
controls:0.25%
cases:4.67%
controls:1.69%
cases:8.71%
controls:4.23%
592
3851
8187
83646
423
1676
8367
85908
189
218
8601
87366
144
6
8646
87578
202
218
8148
87182
362
1430
7382
83415
553
3022
5794
68357
CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
9728-7 [3025271]
9728-7 [3025271]
1.1e+00
1.6e+00
2.8e+00
—
3.3e+00
2.4e+00
2.0e+00
cases:0.41%
controls:0.14%
cases:0.41%
controls:0.08%
cases:0.13%
controls:0.01%
—
—
cases:0.25%
controls:0.01%
cases:0.74%
controls:0.07%
cases:1.12%
controls:0.15%
36
121
8743
87376
36
73
8754
87511
11
7
8779
87577
—
21
8
8329
87392
57
59
7687
84786
71
105
6276
71274
Polycystic kidney, autosomal dominant
Q61.2 [45558415]
Q61.2 [45558415]
1.3e+00
1.3e+00
2.1e+00
3.3e+00
2.2e+00
1.5e+00
1.4e+00
cases:0.23%
controls:0.06%
cases:0.19%
controls:0.05%
cases:0.17%
controls:0.02%
cases:0.15%
controls:0.01%
cases:0.17%
controls:0.02%
cases:0.22%
controls:0.05%
cases:0.25%
controls:0.06%
20
53
8759
87444
17
45
8773
87539
15
18
8775
87566
13
5
8777
87579
14
16
8336
87384
17
43
7727
84802
16
43
6331
71336
Insertion of central venous catheter through external or internal jugular vein
TPH15 [2001309600]
TPH15 [2001309600]
9.6e-01
1.8e+00
3.4e+00
1.0e+50
3.3e+00
2.4e+00
1.3e+00
cases:1.45%
controls:0.56%
cases:1.11%
controls:0.18%
cases:0.41%
controls:0.01%
cases:0.50%
controls:0.00%
cases:0.60%
controls:0.02%
cases:1.50%
controls:0.14%
cases:1.65%
controls:0.46%
127
488
8652
87009
98
159
8692
87425
36
12
8754
87572
44
0
8746
87584
50
20
8300
87380
116
117
7628
84728
105
331
6242
71048
Proteinase 3 Ab [Units/volume] in Serum
6968-2 [3009445]
6968-2 [3009445]
9.1e-01
1.7e+00
3.3e+00
—
4.0e+00
2.0e+00
1.2e+00
cases:1.71%
controls:0.69%
cases:1.62%
controls:0.29%
cases:0.94%
controls:0.03%
—
—
cases:1.62%
controls:0.03%
cases:1.65%
controls:0.24%
cases:2.46%
controls:0.73%
150
605
8629
86892
142
253
8648
87331
83
30
8707
87554
—
135
27
8215
87373
128
202
7616
84643
156
523
6191
70856
DNA double strand Ab [Units/volume] in Serum
5130-0 [3023420]
5130-0 [3023420]
8.4e-01
1.8e+00
3.3e+00
—
3.9e+00
2.0e+00
1.3e+00
cases:1.57%
controls:0.69%
cases:1.47%
controls:0.25%
cases:0.60%
controls:0.02%
—
—
cases:1.40%
controls:0.03%
cases:1.78%
controls:0.25%
cases:2.74%
controls:0.74%
138
601
8641
86896
129
223
8661
87361
53
20
8737
87564
—
117
25
8233
87375
138
209
7606
84636
174
525
6173
70854
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
29760-6 [3005772]
7.1e-01
1.3e+00
2.0e+00
4.1e+00
2.6e+00
1.4e+00
9.3e-01
cases:3.92%
controls:1.96%
cases:2.82%
controls:0.76%
cases:1.05%
controls:0.14%
cases:0.41%
controls:0.01%
cases:1.49%
controls:0.11%
cases:3.36%
controls:0.83%
cases:5.44%
controls:2.21%
344
1714
8435
85783
248
668
8542
86916
92
123
8698
87461
36
6
8754
87578
124
97
8226
87303
260
707
7484
84138
345
1577
6002
69802
Other overlap syndromes
M35.1 [45553172]
M35.1 [45553172]
1.9e+00
2.3e+00
2.8e+00
1.0e+50
2.1e+00
2.3e+00
1.8e+00
cases:0.25%
controls:0.04%
cases:0.25%
controls:0.03%
cases:0.11%
controls:0.01%
cases:0.10%
controls:0.00%
cases:0.07%
controls:0.01%
cases:0.28%
controls:0.03%
cases:0.32%
controls:0.05%
22
34
8757
87463
22
22
8768
87562
10
6
8780
87578
9
0
8781
87584
6
8
8344
87392
22
25
7722
84820
20
37
6327
71342
Vancomycin [Mass/volume] in Serum or Plasma
20578-1 [3005715]
20578-1 [3005715]
1.0e+00
1.6e+00
2.8e+00
—
4.6e+00
2.2e+00
8.3e-01
cases:0.56%
controls:0.20%
cases:0.43%
controls:0.09%
cases:0.22%
controls:0.01%
—
—
cases:0.54%
controls:0.01%
cases:0.76%
controls:0.08%
cases:0.61%
controls:0.27%
49
173
8730
87324
38
76
8752
87508
19
11
8771
87573
—
45
5
8305
87395
59
70
7685
84775
39
192
6308
71187
Procalcitonin [Mass/volume] in Serum or Plasma
33959-8 [3046279]
33959-8 [3046279]
1.0e+00
1.7e+00
3.4e+00
—
4.2e+00
2.0e+00
7.1e-01
cases:1.26%
controls:0.46%
cases:1.33%
controls:0.24%
cases:0.78%
controls:0.03%
—
—
cases:1.63%
controls:0.02%
cases:1.68%
controls:0.22%
cases:1.81%
controls:0.90%
111
404
8668
87093
117
206
8673
87378
69
24
8721
87560
—
136
21
8214
87379
130
190
7614
84655
115
641
6232
70738
One hour or less
ZXE00 [2001311394]
ZXE00 [2001311394]
5.4e-01
1.1e+00
1.7e+00
5.0e+00
2.0e+00
1.6e+00
1.1e+00
cases:10.59%
controls:6.46%
cases:4.88%
controls:1.69%
cases:0.96%
controls:0.17%
cases:1.23%
controls:0.01%
cases:1.11%
controls:0.15%
cases:6.03%
controls:1.30%
cases:11.19%
controls:4.07%
930
5649
7849
81848
429
1481
8361
86103
84
148
8706
87436
108
7
8682
87577
93
133
8257
87267
467
1104
7277
83741
710
2908
5637
68471
Supine thorax X-ray examination
GD1QA [2001303648]
GD1QA [2001303648]
5.8e-01
9.8e-01
2.5e+00
5.6e+00
2.0e+00
9.1e-01
5.6e-01
cases:3.21%
controls:1.82%
cases:2.28%
controls:0.87%
cases:1.24%
controls:0.11%
cases:1.51%
controls:0.01%
cases:0.77%
controls:0.11%
cases:2.32%
controls:0.95%
cases:5.01%
controls:2.91%
282
1591
8497
85906
200
759
8590
86825
109
93
8681
87491
133
5
8657
87579
64
93
8286
87307
180
804
7564
84041
318
2079
6029
69300
CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
14135-8 [3001405]
14135-8 [3001405]
1.1e+00
1.6e+00
2.7e+00
—
3.3e+00
2.3e+00
2.1e+00
cases:0.41%
controls:0.14%
cases:0.41%
controls:0.08%
cases:0.11%
controls:0.01%
—
—
cases:0.25%
controls:0.01%
cases:0.70%
controls:0.07%
cases:1.17%
controls:0.14%
36
123
8743
87374
36
74
8754
87510
10
7
8780
87577
—
21
8
8329
87392
54
58
7690
84787
74
100
6273
71279
Hepatitis B virus core IgM Ab [Presence] in Serum
31204-1 [3013527]
31204-1 [3013527]
8.2e-01
1.8e+00
3.6e+00
—
4.2e+00
1.7e+00
9.4e-01
cases:0.55%
controls:0.24%
cases:0.73%
controls:0.12%
cases:0.42%
controls:0.01%
—
—
cases:0.75%
controls:0.01%
cases:0.72%
controls:0.14%
cases:1.21%
controls:0.48%
48
212
8731
87285
64
107
8726
87477
37
10
8753
87574
—
63
10
8287
87390
56
115
7688
84730
77
340
6270
71039
Medical Oncology
90 [38004507]
90 [38004507]
6.2e-01
1.3e+00
2.2e+00
4.4e+00
2.2e+00
1.4e+00
8.7e-01
cases:6.69%
controls:3.71%
cases:9.12%
controls:2.62%
cases:7.35%
controls:0.87%
cases:5.48%
controls:0.07%
cases:7.11%
controls:0.83%
cases:9.34%
controls:2.53%
cases:9.11%
controls:4.01%
587
3244
8192
84253
802
2291
7988
85293
646
765
8144
86819
482
60
8308
87524
594
729
7756
86671
723
2147
7021
82698
578
2862
5769
68517
Acute myeloblastic leukaemia [AML]
C92.0 [45600565]
C92.0 [45600565]
8.2e-01
1.7e+00
2.6e+00
1.0e+50
3.4e+00
3.0e+00
2.3e+00
cases:0.06%
controls:0.03%
cases:0.11%
controls:0.02%
cases:0.14%
controls:0.01%
cases:0.24%
controls:0.00%
cases:0.41%
controls:0.01%
cases:0.52%
controls:0.03%
cases:0.38%
controls:0.04%
5
22
8774
87475
10
18
8780
87566
12
9
8778
87575
21
0
8769
87584
34
12
8316
87388
40
22
7704
84823
24
26
6323
71353
Systemic involvement of connective tissue, unspecified
M35.9 [45553174]
M35.9 [45553174]
1.5e+00
1.7e+00
2.8e+00
1.0e+50
2.5e+00
2.4e+00
2.2e+00
cases:0.40%
controls:0.09%
cases:0.24%
controls:0.05%
cases:0.13%
controls:0.01%
cases:0.09%
controls:0.00%
cases:0.11%
controls:0.01%
cases:0.49%
controls:0.04%
cases:0.72%
controls:0.08%
35
79
8744
87418
21
40
8769
87544
11
7
8779
87577
8
0
8782
87584
9
8
8341
87392
38
37
7706
84808
46
57
6301
71322
Glomerular basement membrane Ab [Units/volume] in Serum
49774-3 [3032700]
49774-3 [3032700]
1.1e+00
1.8e+00
3.2e+00
1.0e+50
4.1e+00
2.0e+00
7.9e-01
cases:0.40%
controls:0.14%
cases:0.39%
controls:0.07%
cases:0.20%
controls:0.01%
cases:0.07%
controls:0.00%
cases:0.55%
controls:0.01%
cases:0.40%
controls:0.05%
cases:0.50%
controls:0.23%
35
120
8744
87377
34
59
8756
87525
18
7
8772
87577
6
0
8784
87584
46
8
8304
87392
31
45
7713
84800
32
163
6315
71216
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
2465-3 [3005719]
1.0e+00
1.8e+00
3.1e+00
—
3.4e+00
2.2e+00
1.6e+00
cases:3.47%
controls:1.29%
cases:3.87%
controls:0.69%
cases:2.34%
controls:0.11%
—
—
cases:2.96%
controls:0.10%
cases:4.98%
controls:0.61%
cases:6.59%
controls:1.45%
305
1133
8474
86364
340
600
8450
86984
206
97
8584
87487
—
247
89
8103
87311
386
514
7358
84331
418
1037
5929
70342
Erythropoietin (EPO) [Units/volume] in Serum or Plasma
15061-5 [3024172]
15061-5 [3024172]
7.4e-01
1.4e+00
3.2e+00
1.0e+50
4.2e+00
2.4e+00
1.1e+00
cases:0.49%
controls:0.23%
cases:0.35%
controls:0.09%
cases:0.22%
controls:0.01%
cases:0.09%
controls:0.00%
cases:0.61%
controls:0.01%
cases:1.01%
controls:0.09%
cases:1.04%
controls:0.35%
43
205
8736
87292
31
79
8759
87505
19
8
8771
87576
8
0
8782
87584
51
8
8299
87392
78
80
7666
84765
66
247
6281
71132
Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
55774-4 [40758895]
55774-4 [40758895]
1.6e+00
2.7e+00
4.1e+00
1.0e+50
—
2.7e+00
1.8e+00
cases:0.34%
controls:0.07%
cases:0.36%
controls:0.03%
cases:0.40%
controls:0.01%
cases:0.16%
controls:0.00%
—
—
cases:0.54%
controls:0.04%
cases:0.58%
controls:0.09%
30
59
8749
87438
32
22
8758
87562
35
6
8755
87578
14
0
8776
87584
—
42
30
7702
84815
37
66
6310
71313
Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
55776-9 [40758897]
55776-9 [40758897]
1.6e+00
2.7e+00
4.1e+00
1.0e+50
—
2.7e+00
1.8e+00
cases:0.34%
controls:0.07%
cases:0.36%
controls:0.03%
cases:0.40%
controls:0.01%
cases:0.16%
controls:0.00%
—
—
cases:0.54%
controls:0.04%
cases:0.58%
controls:0.09%
30
59
8749
87438
32
22
8758
87562
35
6
8755
87578
14
0
8776
87584
—
42
30
7702
84815
37
66
6310
71313
Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
14278-6 [3003284]
14278-6 [3003284]
9.1e-01
1.6e+00
3.6e+00
1.0e+50
3.6e+00
2.0e+00
1.1e+00
cases:0.83%
controls:0.34%
cases:0.60%
controls:0.12%
cases:0.39%
controls:0.01%
cases:0.22%
controls:0.00%
cases:0.57%
controls:0.02%
cases:0.61%
controls:0.08%
cases:0.90%
controls:0.29%
73
295
8706
87202
53
103
8737
87481
34
9
8756
87575
19
0
8771
87584
48
14
8302
87386
47
68
7697
84777
57
206
6290
71173
Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
14277-8 [3004383]
14277-8 [3004383]
9.1e-01
1.6e+00
3.6e+00
1.0e+50
3.6e+00
2.0e+00
1.1e+00
cases:0.84%
controls:0.34%
cases:0.60%
controls:0.12%
cases:0.39%
controls:0.01%
cases:0.22%
controls:0.00%
cases:0.57%
controls:0.02%
cases:0.61%
controls:0.08%
cases:0.88%
controls:0.29%
74
297
8705
87200
53
104
8737
87480
34
9
8756
87575
19
0
8771
87584
48
14
8302
87386
47
68
7697
84777
56
206
6291
71173
Cystostatic therapy of methastized malignancy
WD105 [2001310678]
WD105 [2001310678]
1.6e+00
2.3e+00
2.9e+00
—
2.4e+00
2.5e+00
1.2e+00
cases:1.03%
controls:0.21%
cases:1.68%
controls:0.17%
cases:1.08%
controls:0.06%
—
—
cases:0.59%
controls:0.06%
cases:1.78%
controls:0.14%
cases:0.96%
controls:0.28%
90
181
8689
87316
148
149
8642
87435
95
54
8695
87530
—
49
49
8301
87351
138
123
7606
84722
61
200
6286
71179
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1995-0 [3021347]
4.7e-01
1.1e+00
2.3e+00
4.8e+00
2.5e+00
1.2e+00
7.0e-01
cases:14.11%
controls:9.29%
cases:13.52%
controls:4.90%
cases:6.88%
controls:0.77%
cases:3.22%
controls:0.03%
cases:8.50%
controls:0.78%
cases:13.53%
controls:4.72%
cases:20.45%
controls:11.30%
1239
8126
7540
79371
1188
4294
7602
83290
605
677
8185
86907
283
25
8507
87559
710
685
7640
86715
1048
4005
6696
80840
1298
8068
5049
63311
rituximab
L01FA01 [955167]
L01FA01 [955167]
1.1e+00
1.6e+00
3.3e+00
—
2.6e+00
2.3e+00
1.9e+00
cases:0.36%
controls:0.12%
cases:0.34%
controls:0.07%
cases:0.27%
controls:0.01%
—
—
cases:0.26%
controls:0.02%
cases:0.58%
controls:0.06%
cases:0.74%
controls:0.11%
32
102
8747
87395
30
61
8760
87523
24
9
8766
87575
—
22
17
8328
87383
45
48
7699
84797
47
76
6300
71303
Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
34720-3 [3030558]
34720-3 [3030558]
1.0e+00
2.1e+00
2.8e+00
—
3.2e+00
2.2e+00
1.5e+00
cases:0.22%
controls:0.08%
cases:0.18%
controls:0.02%
cases:0.13%
controls:0.01%
—
—
cases:0.14%
controls:0.01%
cases:0.23%
controls:0.02%
cases:0.32%
controls:0.07%
19
70
8760
87427
16
19
8774
87565
11
7
8779
87577
—
12
5
8338
87395
18
21
7726
84824
20
48
6327
71331
Chronic kidney disease, unspecified
N18.9 [45553438]
N18.9 [45553438]
9.9e-01
1.2e+00
1.6e+00
4.9e+00
1.9e+00
1.2e+00
1.0e+00
cases:1.86%
controls:0.70%
cases:1.54%
controls:0.47%
cases:0.69%
controls:0.14%
cases:0.80%
controls:0.01%
cases:0.91%
controls:0.14%
cases:1.83%
controls:0.53%
cases:2.98%
controls:1.09%
163
613
8616
86884
135
416
8655
87168
61
125
8729
87459
70
5
8720
87579
76
119
8274
87281
142
453
7602
84392
189
779
6158
70600
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
30383-4 [3000850]
4.1e-01
8.8e-01
2.0e+00
5.6e+00
2.2e+00
1.0e+00
7.3e-01
cases:6.28%
controls:4.24%
cases:4.73%
controls:2.01%
cases:2.12%
controls:0.29%
cases:1.74%
controls:0.01%
cases:2.41%
controls:0.26%
cases:4.98%
controls:1.83%
cases:9.53%
controls:4.85%
551
3712
8228
83785
416
1761
8374
85823
186
253
8604
87331
153
6
8637
87578
201
231
8149
87169
386
1549
7358
83296
605
3462
5742
67917
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1751-7 [3024561]
5.5e-01
1.2e+00
2.4e+00
4.1e+00
2.5e+00
1.3e+00
7.6e-01
cases:14.49%
controls:8.91%
cases:14.06%
controls:4.81%
cases:8.15%
controls:0.78%
cases:1.77%
controls:0.03%
cases:8.86%
controls:0.76%
cases:15.47%
controls:4.75%
cases:21.62%
controls:11.38%
1272
7798
7507
79699
1236
4216
7554
83368
716
687
8074
86897
156
26
8634
87558
740
665
7610
86735
1198
4027
6546
80818
1372
8126
4975
63253
Immunofixation for Serum or Plasma
25700-6 [3037756]
25700-6 [3037756]
1.3e+00
1.9e+00
2.9e+00
1.0e+50
3.6e+00
1.9e+00
1.3e+00
cases:1.15%
controls:0.32%
cases:1.01%
controls:0.15%
cases:0.50%
controls:0.03%
cases:0.10%
controls:0.00%
cases:0.77%
controls:0.02%
cases:0.76%
controls:0.12%
cases:1.43%
controls:0.41%
101
279
8678
87218
89
134
8701
87450
44
24
8746
87560
9
0
8781
87584
64
18
8286
87382
59
102
7685
84743
91
294
6256
71085
Lymphocytic lymphoma
C83.00 [2000501222]
C83.00 [2000501222]
1.9e+00
1.7e+00
2.5e+00
—
3.1e+00
2.1e+00
1.6e+00
cases:0.13%
controls:0.02%
cases:0.11%
controls:0.02%
cases:0.08%
controls:0.01%
—
—
cases:0.13%
controls:0.01%
cases:0.18%
controls:0.02%
cases:0.14%
controls:0.03%
11
17
8768
87480
10
18
8780
87566
7
6
8783
87578
—
11
5
8339
87395
14
19
7730
84826
9
21
6338
71358
Mycobacterium sp identified in Specimen
40699-1 [3042631]
40699-1 [3042631]
9.7e-01
1.7e+00
2.8e+00
—
3.3e+00
2.1e+00
1.8e+00
cases:0.52%
controls:0.20%
cases:0.49%
controls:0.09%
cases:0.15%
controls:0.01%
—
—
cases:0.23%
controls:0.01%
cases:0.56%
controls:0.07%
cases:1.04%
controls:0.17%
46
175
8733
87322
43
75
8747
87509
13
8
8777
87576
—
19
7
8331
87393
43
56
7701
84789
66
118
6281
71261
Centromere protein B Ab [Units/volume] in Serum
53982-5 [3039162]
53982-5 [3039162]
9.5e-01
2.0e+00
3.2e+00
1.0e+50
3.9e+00
1.7e+00
1.1e+00
cases:0.48%
controls:0.19%
cases:0.53%
controls:0.08%
cases:0.14%
controls:0.01%
cases:0.06%
controls:0.00%
cases:0.34%
controls:0.01%
cases:0.39%
controls:0.07%
cases:0.74%
controls:0.24%
42
162
8737
87335
47
66
8743
87518
12
5
8778
87579
5
0
8785
87584
28
6
8322
87394
30
62
7714
84783
47
174
6300
71205
Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
9654-5 [3007847]
9654-5 [3007847]
1.0e+00
1.7e+00
2.5e+00
—
3.5e+00
2.4e+00
1.6e+00
cases:0.25%
controls:0.09%
cases:0.28%
controls:0.05%
cases:0.11%
controls:0.01%
—
—
cases:0.30%
controls:0.01%
cases:0.43%
controls:0.04%
cases:0.66%
controls:0.14%
22
77
8757
87420
25
46
8765
87538
10
8
8780
87576
—
25
8
8325
87392
33
32
7711
84813
42
97
6305
71282
Sepsis, unspecified
A41.9 [45585911]
A41.9 [45585911]
1.1e+00
2.0e+00
3.2e+00
—
3.4e+00
1.8e+00
1.2e+00
cases:0.75%
controls:0.24%
cases:0.48%
controls:0.06%
cases:0.27%
controls:0.01%
—
—
cases:0.40%
controls:0.01%
cases:0.57%
controls:0.09%
cases:1.09%
controls:0.32%
66
211
8713
87286
42
56
8748
87528
24
10
8766
87574
—
33
12
8317
87388
44
78
7700
84767
69
228
6278
71151
Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
20444-6 [3028369]
20444-6 [3028369]
5.8e-01
2.0e+00
3.1e+00
—
4.3e+00
2.3e+00
9.9e-01
cases:0.27%
controls:0.15%
cases:0.40%
controls:0.05%
cases:0.15%
controls:0.01%
—
—
cases:0.51%
controls:0.01%
cases:0.68%
controls:0.07%
cases:0.55%
controls:0.21%
24
134
8755
87363
35
48
8755
87536
13
6
8777
87578
—
43
6
8307
87394
53
56
7691
84789
35
147
6312
71232
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
2075-0 [3014576]
6.3e-01
1.1e+00
2.3e+00
4.7e+00
2.3e+00
1.2e+00
4.7e-01
cases:3.54%
controls:1.92%
cases:2.99%
controls:1.00%
cases:1.44%
controls:0.14%
cases:0.96%
controls:0.01%
cases:1.40%
controls:0.14%
cases:3.33%
controls:1.04%
cases:5.10%
controls:3.25%
311
1678
8468
85819
263
880
8527
86704
127
125
8663
87459
84
8
8706
87576
117
123
8233
87277
258
880
7486
83965
324
2323
6023
69056
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
50554-5 [3029287]
4.4e-01
9.6e-01
2.0e+00
5.2e+00
2.3e+00
1.1e+00
6.9e-01
cases:11.13%
controls:7.50%
cases:9.41%
controls:3.82%
cases:4.04%
controls:0.55%
cases:2.98%
controls:0.02%
cases:4.93%
controls:0.52%
cases:10.15%
controls:3.63%
cases:17.05%
controls:9.30%
977
6558
7802
80939
827
3343
7963
84241
355
482
8435
87102
262
15
8528
87569
412
456
7938
86944
786
3083
6958
81762
1082
6640
5265
64739
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
2021-4 [3021447]
6.0e-01
1.1e+00
2.2e+00
4.7e+00
2.3e+00
1.2e+00
5.1e-01
cases:2.77%
controls:1.54%
cases:2.72%
controls:0.90%
cases:1.30%
controls:0.14%
cases:0.96%
controls:0.01%
cases:1.51%
controls:0.15%
cases:3.10%
controls:0.93%
cases:4.73%
controls:2.90%
243
1351
8536
86146
239
789
8551
86795
114
122
8676
87462
84
8
8706
87576
126
130
8224
87270
240
791
7504
84054
300
2072
6047
69307
Acute renal failure, unspecified
N17.9 [45567829]
N17.9 [45567829]
1.4e+00
1.7e+00
2.9e+00
—
3.5e+00
2.0e+00
1.1e+00
cases:0.88%
controls:0.22%
cases:0.65%
controls:0.12%
cases:0.40%
controls:0.02%
—
—
cases:0.57%
controls:0.02%
cases:1.08%
controls:0.15%
cases:1.31%
controls:0.42%
77
195
8702
87302
57
103
8733
87481
35
19
8755
87565
—
48
15
8302
87385
84
128
7660
84717
83
299
6264
71080
Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
61365-3 [40764126]
61365-3 [40764126]
1.0e+00
2.5e+00
—
1.0e+50
4.3e+00
2.8e+00
2.1e+00
cases:0.35%
controls:0.13%
cases:0.48%
controls:0.04%
—
—
cases:0.11%
controls:0.00%
cases:0.41%
controls:0.01%
cases:0.79%
controls:0.05%
cases:0.85%
controls:0.11%
31
114
8748
87383
42
34
8748
87550
—
10
0
8780
87584
34
5
8316
87395
61
42
7683
84803
54
78
6293
71301
ABO and Rh group [Type] in Blood
882-1 [3003694]
882-1 [3003694]
2.7e-01
1.1e+00
2.4e+00
5.2e+00
2.3e+00
9.8e-01
3.8e-01
cases:6.34%
controls:4.91%
cases:4.87%
controls:1.71%
cases:1.84%
controls:0.16%
cases:1.21%
controls:0.01%
cases:1.43%
controls:0.15%
cases:3.59%
controls:1.38%
cases:7.37%
controls:5.18%
557
4293
8222
83204
428
1496
8362
86088
162
142
8628
87442
106
6
8684
87578
119
132
8231
87268
278
1169
7466
83676
468
3699
5879
67680
Iron deficiency anaemia, unspecified
D50.9 [45605373]
D50.9 [45605373]
8.7e-01
1.2e+00
1.8e+00
4.6e+00
2.1e+00
1.3e+00
6.7e-01
cases:1.94%
controls:0.82%
cases:1.25%
controls:0.37%
cases:0.43%
controls:0.07%
cases:0.66%
controls:0.01%
cases:0.50%
controls:0.06%
cases:1.32%
controls:0.38%
cases:2.17%
controls:1.12%
170
717
8609
86780
110
325
8680
87259
38
61
8752
87523
58
6
8732
87578
42
53
8308
87347
102
322
7642
84523
138
800
6209
70579
Whole body extensive metabolic PET with CT
JN4JR [2001310913]
JN4JR [2001310913]
1.6e+00
3.3e+00
—
—
1.0e+50
4.8e+00
2.8e+00
cases:0.17%
controls:0.03%
cases:0.39%
controls:0.01%
—
—
—
—
cases:0.19%
controls:0.00%
cases:0.85%
controls:0.01%
cases:0.41%
controls:0.03%
15
30
8764
87467
34
12
8756
87572
—
—
16
0
8334
87400
66
6
7678
84839
26
18
6321
71361
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
51483-6 [3030467]
4.7e-01
9.6e-01
2.0e+00
5.2e+00
2.2e+00
1.0e+00
6.6e-01
cases:8.49%
controls:5.48%
cases:7.50%
controls:3.00%
cases:3.17%
controls:0.45%
cases:2.32%
controls:0.01%
cases:3.65%
controls:0.42%
cases:7.50%
controls:2.89%
cases:13.23%
controls:7.30%
745
4798
8034
82699
659
2628
8131
84956
279
391
8511
87193
204
11
8586
87573
305
365
8045
87035
581
2454
7163
82391
840
5214
5507
66165
pH of Venous blood
2746-6 [3012544]
2746-6 [3012544]
6.0e-01
1.1e+00
2.3e+00
4.4e+00
2.3e+00
1.2e+00
5.0e-01
cases:2.86%
controls:1.59%
cases:2.81%
controls:0.92%
cases:1.30%
controls:0.13%
cases:0.86%
controls:0.01%
cases:1.54%
controls:0.15%
cases:3.09%
controls:0.94%
cases:4.74%
controls:2.93%
251
1390
8528
86107
247
802
8543
86782
114
118
8676
87466
76
9
8714
87575
129
131
8221
87269
239
801
7505
84044
301
2088
6046
69291
Base excess in Venous blood by calculation
1927-3 [3002032]
1927-3 [3002032]
5.8e-01
1.1e+00
2.2e+00
4.5e+00
2.3e+00
1.2e+00
5.3e-01
cases:2.75%
controls:1.55%
cases:2.72%
controls:0.88%
cases:1.24%
controls:0.14%
cases:0.84%
controls:0.01%
cases:1.49%
controls:0.15%
cases:3.01%
controls:0.93%
cases:4.73%
controls:2.83%
241
1359
8538
86138
239
775
8551
86809
109
121
8681
87463
74
8
8716
87576
124
130
8226
87270
233
787
7511
84058
300
2020
6047
69359
Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
17792-3 [3023939]
17792-3 [3023939]
9.1e-01
1.8e+00
3.1e+00
1.0e+50
4.1e+00
1.6e+00
1.0e+00
cases:0.74%
controls:0.30%
cases:0.75%
controls:0.13%
cases:0.24%
controls:0.01%
cases:0.08%
controls:0.00%
cases:0.48%
controls:0.01%
cases:0.59%
controls:0.12%
cases:1.13%
controls:0.41%
65
261
8714
87236
66
114
8724
87470
21
9
8769
87575
7
0
8783
87584
40
7
8310
87393
46
106
7698
84739
72
296
6275
71083
Folate [Moles/volume] in Serum or Plasma
14732-2 [3021960]
14732-2 [3021960]
5.9e-01
9.5e-01
2.1e+00
4.8e+00
2.8e+00
8.2e-01
3.4e-01
cases:5.46%
controls:3.11%
cases:5.47%
controls:2.19%
cases:2.28%
controls:0.29%
cases:0.85%
controls:0.01%
cases:3.54%
controls:0.21%
cases:5.19%
controls:2.35%
cases:9.96%
controls:7.29%
479
2720
8300
84777
481
1915
8309
85669
200
250
8590
87334
75
6
8715
87578
296
186
8054
87214
402
1991
7342
82854
632
5200
5715
66179
Bacteria [Presence] in Urine
87829-8 [36304419]
87829-8 [36304419]
4.8e-01
9.6e-01
2.0e+00
5.2e+00
2.2e+00
9.9e-01
6.9e-01
cases:8.24%
controls:5.24%
cases:7.06%
controls:2.83%
cases:2.89%
controls:0.41%
cases:2.20%
controls:0.01%
cases:3.37%
controls:0.39%
cases:6.92%
controls:2.69%
cases:12.81%
controls:6.87%
723
4589
8056
82908
621
2476
8169
85108
254
360
8536
87224
193
11
8597
87573
281
341
8069
87059
536
2283
7208
82562
813
4907
5534
66472
Malignant neoplasm: Fallopian tube
C57.0 [45542616]
C57.0 [45542616]
1.8e+00
2.6e+00
3.0e+00
1.0e+50
2.6e+00
2.5e+00
1.2e+00
cases:0.08%
controls:0.01%
cases:0.15%
controls:0.01%
cases:0.14%
controls:0.01%
cases:0.14%
controls:0.00%
cases:0.12%
controls:0.01%
cases:0.17%
controls:0.01%
cases:0.08%
controls:0.02%
7
11
8772
87486
13
10
8777
87574
12
6
8778
87578
12
0
8778
87584
10
8
8340
87392
13
12
7731
84833
5
17
6342
71362
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
16128-1 [3017143]
7.7e-01
1.7e+00
3.5e+00
—
3.6e+00
1.8e+00
1.0e+00
cases:4.16%
controls:1.98%
cases:4.08%
controls:0.74%
cases:2.22%
controls:0.07%
—
—
cases:2.84%
controls:0.08%
cases:3.65%
controls:0.63%
cases:5.50%
controls:2.10%
365
1731
8414
85766
359
652
8431
86932
195
58
8595
87526
—
237
69
8113
87331
283
533
7461
84312
349
1502
5998
69877
Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
35559-4 [3035797]
35559-4 [3035797]
1.0e+00
1.9e+00
2.8e+00
—
3.4e+00
2.0e+00
1.2e+00
cases:1.33%
controls:0.48%
cases:1.33%
controls:0.21%
cases:0.63%
controls:0.04%
—
—
cases:1.01%
controls:0.03%
cases:1.39%
controls:0.19%
cases:1.89%
controls:0.55%
117
422
8662
87075
117
180
8673
87404
55
32
8735
87552
—
84
30
8266
87370
108
162
7636
84683
120
393
6227
70986
Ammonium ion [Moles/volume] in Plasma
1845-7 [3023183]
1845-7 [3023183]
6.8e-01
1.5e+00
2.8e+00
—
4.0e+00
1.9e+00
1.5e+00
cases:0.56%
controls:0.28%
cases:0.60%
controls:0.13%
cases:0.27%
controls:0.02%
—
—
cases:0.49%
controls:0.01%
cases:0.88%
controls:0.14%
cases:1.62%
controls:0.36%
49
249
8730
87248
53
113
8737
87471
24
15
8766
87569
—
41
8
8309
87392
68
115
7676
84730
103
257
6244
71122
Lactate [Moles/volume] in Capillary blood
19239-3 [3028271]
19239-3 [3028271]
7.9e-01
1.7e+00
3.6e+00
1.0e+50
3.2e+00
1.7e+00
1.4e+00
cases:0.54%
controls:0.24%
cases:0.51%
controls:0.10%
cases:0.20%
controls:0.01%
cases:0.22%
controls:0.00%
cases:0.26%
controls:0.01%
cases:0.46%
controls:0.09%
cases:0.93%
controls:0.23%
47
213
8732
87284
45
85
8745
87499
18
5
8772
87579
19
0
8771
87584
22
9
8328
87391
36
75
7708
84770
59
162
6288
71217
Protein [Mass] in Urine collected for unspecified duration
32551-4 [3017817]
32551-4 [3017817]
6.8e-01
1.7e+00
2.9e+00
—
4.1e+00
1.9e+00
1.1e+00
cases:0.33%
controls:0.17%
cases:0.33%
controls:0.06%
cases:0.18%
controls:0.01%
—
—
cases:0.35%
controls:0.01%
cases:0.36%
controls:0.06%
cases:0.60%
controls:0.19%
29
146
8750
87351
29
53
8761
87531
16
9
8774
87575
—
29
5
8321
87395
28
48
7716
84797
38
138
6309
71241
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
19072-8 [3016431]
4.6e-01
1.0e+00
2.2e+00
4.6e+00
2.4e+00
1.1e+00
6.2e-01
cases:15.38%
controls:10.29%
cases:14.63%
controls:5.71%
cases:7.63%
controls:0.93%
cases:3.40%
controls:0.04%
cases:9.49%
controls:0.94%
cases:14.82%
controls:5.53%
cases:22.28%
controls:13.40%
1350
9001
7429
78496
1286
4999
7504
82585
671
811
8119
86773
299
32
8491
87552
792
823
7558
86577
1148
4696
6596
80149
1414
9562
4933
61817
cyclophosphamide
L01AA01 [21601390]
L01AA01 [21601390]
1.9e+00
2.5e+00
2.6e+00
—
—
3.0e+00
2.4e+00
cases:0.34%
controls:0.05%
cases:0.27%
controls:0.02%
cases:0.08%
controls:0.01%
—
—
—
—
cases:0.37%
controls:0.02%
cases:0.36%
controls:0.03%
30
47
8749
87450
24
20
8766
87564
7
5
8783
87579
—
—
29
16
7715
84829
23
24
6324
71355
Hepatitis B virus core and surface Ab and surface Ag panel - Serum
77190-7 [46237023]
77190-7 [46237023]
7.9e-01
1.7e+00
3.2e+00
—
3.8e+00
1.8e+00
1.1e+00
cases:1.13%
controls:0.52%
cases:0.97%
controls:0.18%
cases:0.55%
controls:0.02%
—
—
cases:0.96%
controls:0.02%
cases:1.02%
controls:0.17%
cases:1.56%
controls:0.55%
99
452
8680
87045
85
161
8705
87423
48
19
8742
87565
—
80
19
8270
87381
79
144
7665
84701
99
390
6248
70989
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
30391-7 [3002582]
4.5e-01
9.4e-01
2.0e+00
5.2e+00
2.2e+00
9.8e-01
6.2e-01
cases:9.56%
controls:6.30%
cases:8.45%
controls:3.48%
cases:3.58%
controls:0.51%
cases:2.72%
controls:0.02%
cases:4.28%
controls:0.50%
cases:8.66%
controls:3.42%
cases:15.13%
controls:8.76%
839
5508
7940
81989
743
3051
8047
84533
315
448
8475
87136
239
14
8551
87570
357
438
7993
86962
671
2904
7073
81941
960
6254
5387
65125
Parainfluenza type 2 nucleic acid detection
222351000000102 [44790048]
222351000000102 [44790048]
7.5e-01
1.4e+00
3.0e+00
—
3.7e+00
2.2e+00
1.2e+00
cases:0.36%
controls:0.17%
cases:0.34%
controls:0.09%
cases:0.26%
controls:0.01%
—
—
cases:0.38%
controls:0.01%
cases:0.59%
controls:0.07%
cases:0.99%
controls:0.29%
32
151
8747
87346
30
76
8760
87508
23
11
8767
87573
—
32
8
8318
87392
46
58
7698
84787
63
206
6284
71173
Parainfluenza type 1 nucleic acid detection
222341000000100 [44790047]
222341000000100 [44790047]
7.5e-01
1.4e+00
3.0e+00
—
3.7e+00
2.2e+00
1.2e+00
cases:0.36%
controls:0.17%
cases:0.34%
controls:0.09%
cases:0.26%
controls:0.01%
—
—
cases:0.38%
controls:0.01%
cases:0.59%
controls:0.07%
cases:0.99%
controls:0.29%
32
151
8747
87346
30
76
8760
87508
23
11
8767
87573
—
32
8
8318
87392
46
58
7698
84787
63
206
6284
71173
Parainfluenza type 3 nucleic acid detection
222361000000104 [44790049]
222361000000104 [44790049]
7.5e-01
1.4e+00
3.0e+00
—
3.7e+00
2.2e+00
1.2e+00
cases:0.36%
controls:0.17%
cases:0.34%
controls:0.09%
cases:0.26%
controls:0.01%
—
—
cases:0.38%
controls:0.01%
cases:0.59%
controls:0.07%
cases:0.99%
controls:0.29%
32
151
8747
87346
30
76
8760
87508
23
11
8767
87573
—
32
8
8318
87392
46
58
7698
84787
63
206
6284
71173
Parainfluenza type 4 nucleic acid detection
810871000000102 [44806118]
810871000000102 [44806118]
7.5e-01
1.4e+00
3.0e+00
—
3.7e+00
2.2e+00
1.2e+00
cases:0.36%
controls:0.17%
cases:0.34%
controls:0.09%
cases:0.26%
controls:0.01%
—
—
cases:0.38%
controls:0.01%
cases:0.59%
controls:0.07%
cases:0.99%
controls:0.29%
32
151
8747
87346
30
76
8760
87508
23
11
8767
87573
—
32
8
8318
87392
46
58
7698
84787
63
206
6284
71173
darbepoetin alfa; parenteral
B03XA02 [21601134]
B03XA02 [21601134]
1.9e+00
2.1e+00
2.1e+00
—
2.2e+00
2.2e+00
1.8e+00
cases:0.92%
controls:0.14%
cases:1.09%
controls:0.13%
cases:0.44%
controls:0.05%
—
—
cases:0.50%
controls:0.06%
cases:1.46%
controls:0.16%
cases:1.56%
controls:0.25%
81
125
8698
87372
96
116
8694
87468
39
47
8751
87537
—
42
51
8308
87349
113
138
7631
84707
99
181
6248
71198
Short blood count panel - Blood
55429-5 [40758558]
55429-5 [40758558]
4.9e-01
8.6e-01
2.1e+00
4.7e+00
2.3e+00
1.1e+00
7.4e-01
cases:8.42%
controls:5.33%
cases:6.42%
controls:2.82%
cases:4.65%
controls:0.61%
cases:2.96%
controls:0.03%
cases:5.25%
controls:0.54%
cases:7.84%
controls:2.66%
cases:12.53%
controls:6.38%
739
4664
8040
82833
564
2471
8226
85113
409
536
8381
87048
260
25
8530
87559
438
475
7912
86925
607
2253
7137
82592
795
4552
5552
66827
Atrial fibrillation and atrial flutter, unspecified
I48.9 [45755409]
I48.9 [45755409]
6.4e-01
9.9e-01
2.1e+00
5.0e+00
2.0e+00
1.0e+00
4.1e-01
cases:0.90%
controls:0.48%
cases:0.90%
controls:0.33%
cases:0.58%
controls:0.07%
cases:1.54%
controls:0.01%
cases:0.47%
controls:0.06%
cases:1.18%
controls:0.42%
cases:1.80%
controls:1.19%
79
416
8700
87081
79
293
8711
87291
51
62
8739
87522
135
9
8655
87575
39
53
8311
87347
91
357
7653
84488
114
852
6233
70527
Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
50797-0 [3029379]
50797-0 [3029379]
1.0e+00
1.9e+00
2.8e+00
—
3.3e+00
2.0e+00
1.2e+00
cases:1.23%
controls:0.45%
cases:1.25%
controls:0.19%
cases:0.57%
controls:0.03%
—
—
cases:0.89%
controls:0.03%
cases:1.28%
controls:0.17%
cases:1.73%
controls:0.51%
108
396
8671
87101
110
165
8680
87419
50
30
8740
87554
—
74
30
8276
87370
99
144
7645
84701
110
362
6237
71017
Urate [Moles/volume] in Serum or Plasma
14933-6 [3026493]
14933-6 [3026493]
4.9e-01
1.2e+00
2.3e+00
4.1e+00
2.5e+00
1.1e+00
6.4e-01
cases:8.41%
controls:5.33%
cases:6.71%
controls:2.22%
cases:2.59%
controls:0.26%
cases:0.80%
controls:0.01%
cases:2.98%
controls:0.26%
cases:6.31%
controls:2.18%
cases:10.97%
controls:6.13%
738
4660
8041
82837
590
1944
8200
85640
228
225
8562
87359
70
12
8720
87572
249
228
8101
87172
489
1849
7255
82996
696
4373
5651
67006
Myeloperoxidase Ab [Units/volume] in Serum
6969-0 [3023150]
6969-0 [3023150]
7.8e-01
1.6e+00
3.2e+00
1.0e+50
3.7e+00
1.8e+00
1.1e+00
cases:0.62%
controls:0.28%
cases:0.51%
controls:0.11%
cases:0.28%
controls:0.01%
cases:0.23%
controls:0.00%
cases:0.53%
controls:0.01%
cases:0.57%
controls:0.09%
cases:0.93%
controls:0.32%
54
248
8725
87249
45
93
8745
87491
25
10
8765
87574
20
0
8770
87584
44
11
8306
87389
44
77
7700
84768
59
227
6288
71152
Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
50796-2 [3029338]
50796-2 [3029338]
1.0e+00
1.9e+00
2.8e+00
—
3.3e+00
2.0e+00
1.2e+00
cases:1.23%
controls:0.46%
cases:1.29%
controls:0.20%
cases:0.60%
controls:0.04%
—
—
cases:0.92%
controls:0.03%
cases:1.32%
controls:0.18%
cases:1.81%
controls:0.53%
108
400
8671
87097
113
176
8677
87408
53
32
8737
87552
—
77
30
8273
87370
102
151
7642
84694
115
380
6232
70999
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
2705-2 [3024354]
5.7e-01
1.0e+00
2.1e+00
4.7e+00
2.2e+00
1.2e+00
3.9e-01
cases:2.28%
controls:1.30%
cases:1.93%
controls:0.72%
cases:0.91%
controls:0.11%
cases:0.84%
controls:0.01%
cases:1.08%
controls:0.12%
cases:2.39%
controls:0.75%
cases:3.66%
controls:2.51%
200
1134
8579
86363
170
631
8620
86953
80
94
8710
87490
74
7
8716
87577
90
101
8260
87299
185
633
7559
84212
232
1792
6115
69587
U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
59026-5 [40762119]
59026-5 [40762119]
9.6e-01
1.9e+00
2.8e+00
—
3.6e+00
1.8e+00
1.1e+00
cases:0.51%
controls:0.20%
cases:0.51%
controls:0.08%
cases:0.14%
controls:0.01%
—
—
cases:0.38%
controls:0.01%
cases:0.43%
controls:0.07%
cases:0.63%
controls:0.22%
45
172
8734
87325
45
67
8745
87517
12
7
8778
87577
—
32
9
8318
87391
33
60
7711
84785
40
156
6307
71223
Fractional oxyhemoglobin in Capillary blood
2715-1 [3022806]
2715-1 [3022806]
8.2e-01
1.7e+00
3.3e+00
1.0e+50
2.9e+00
1.9e+00
1.6e+00
cases:0.51%
controls:0.23%
cases:0.41%
controls:0.08%
cases:0.16%
controls:0.01%
cases:0.15%
controls:0.00%
cases:0.14%
controls:0.01%
cases:0.39%
controls:0.06%
cases:0.65%
controls:0.14%
45
198
8734
87299
36
68
8754
87516
14
5
8776
87579
13
0
8777
87584
12
7
8338
87393
30
50
7714
84795
41
97
6306
71282
Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
70058-3 [42868544]
70058-3 [42868544]
6.8e-01
1.4e+00
3.3e+00
1.0e+50
4.3e+00
1.4e+00
9.8e-01
cases:0.51%
controls:0.26%
cases:0.39%
controls:0.10%
cases:0.16%
controls:0.01%
cases:0.25%
controls:0.00%
cases:0.61%
controls:0.01%
cases:0.25%
controls:0.06%
cases:0.65%
controls:0.24%
45
227
8734
87270
34
87
8756
87497
14
5
8776
87579
22
0
8768
87584
51
7
8299
87393
19
51
7725
84794
41
173
6306
71206
Microscopic observation [Identifier] in Isolate by Gram stain
87975-9 [36305247]
87975-9 [36305247]
9.8e-01
1.8e+00
3.1e+00
—
3.0e+00
1.9e+00
1.4e+00
cases:1.14%
controls:0.43%
cases:0.91%
controls:0.16%
cases:0.34%
controls:0.02%
—
—
cases:0.44%
controls:0.02%
cases:0.92%
controls:0.13%
cases:1.78%
controls:0.46%
100
378
8679
87119
80
138
8710
87446
30
14
8760
87570
—
37
20
8313
87380
71
113
7673
84732
113
326
6234
71053
Smith extractable nuclear Ab [Units/volume] in Serum
11090-8 [3016921]
11090-8 [3016921]
8.1e-01
1.7e+00
3.0e+00
—
3.9e+00
1.7e+00
9.4e-01
cases:0.87%
controls:0.39%
cases:0.93%
controls:0.17%
cases:0.27%
controls:0.01%
—
—
cases:0.68%
controls:0.01%
cases:0.87%
controls:0.16%
cases:1.31%
controls:0.52%
76
338
8703
87159
82
147
8708
87437
24
12
8766
87572
—
57
12
8293
87388
67
135
7677
84710
83
369
6264
71010
Bacteria identified in Isolate by Culture
43409-2 [3042936]
43409-2 [3042936]
5.9e-01
1.1e+00
2.0e+00
3.7e+00
2.5e+00
1.4e+00
7.2e-01
cases:4.31%
controls:2.44%
cases:2.81%
controls:0.91%
cases:0.88%
controls:0.11%
cases:0.23%
controls:0.01%
cases:1.40%
controls:0.12%
cases:3.31%
controls:0.84%
cases:5.66%
controls:2.83%
378
2136
8401
85361
247
797
8543
86787
77
100
8713
87484
20
5
8770
87579
117
102
8233
87298
256
715
7488
84130
359
2020
5988
69359
CD3+CD4+ (T4 helper) cells/cells in Blood
8123-2 [3014037]
8123-2 [3014037]
1.1e+00
2.2e+00
—
—
3.8e+00
3.0e+00
1.9e+00
cases:0.28%
controls:0.09%
cases:0.48%
controls:0.05%
—
—
—
—
cases:0.26%
controls:0.01%
cases:0.79%
controls:0.04%
cases:0.76%
controls:0.11%
25
80
8754
87417
42
46
8748
87538
—
—
22
5
8328
87395
61
35
7683
84810
48
79
6299
71300
Palliative care
Z51.5 [45547323]
Z51.5 [45547323]
2.0e-01
8.4e-01
1.8e+00
4.8e+00
2.4e+00
1.6e+00
5.3e-01
cases:0.08%
controls:0.07%
cases:0.33%
controls:0.14%
cases:0.48%
controls:0.08%
cases:0.72%
controls:0.01%
cases:1.05%
controls:0.09%
cases:1.78%
controls:0.35%
cases:1.40%
controls:0.83%
7
57
8772
87440
29
125
8761
87459
42
72
8748
87512
63
5
8727
87579
88
81
8262
87319
138
297
7606
84548
89
591
6258
70788
Protein electrophoresis panel - Serum or Plasma
24351-9 [3004588]
24351-9 [3004588]
9.7e-01
1.9e+00
2.9e+00
—
3.4e+00
1.8e+00
1.1e+00
cases:2.93%
controls:1.13%
cases:3.25%
controls:0.51%
cases:1.71%
controls:0.09%
—
—
cases:1.98%
controls:0.07%
cases:2.66%
controls:0.46%
cases:3.97%
controls:1.31%
257
993
8522
86504
286
443
8504
87141
150
82
8640
87502
—
165
61
8185
87339
206
394
7538
84451
252
934
6095
70445
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
T81.0 [45599741]
T81.0 [45599741]
9.4e-01
1.8e+00
2.7e+00
—
3.7e+00
1.7e+00
1.1e+00
cases:1.37%
controls:0.54%
cases:0.92%
controls:0.15%
cases:0.32%
controls:0.02%
—
—
cases:0.47%
controls:0.01%
cases:0.66%
controls:0.12%
cases:1.39%
controls:0.47%
120
471
8659
87026
81
131
8709
87453
28
18
8762
87566
—
39
10
8311
87390
51
101
7693
84744
88
333
6259
71046
Heart failure, unspecified
I50.9 [45576879]
I50.9 [45576879]
8.3e-01
1.2e+00
1.8e+00
4.8e+00
1.9e+00
1.0e+00
5.6e-01
cases:3.85%
controls:1.72%
cases:3.15%
controls:1.00%
cases:1.34%
controls:0.22%
cases:1.37%
controls:0.01%
cases:1.43%
controls:0.23%
cases:3.25%
controls:1.23%
cases:4.70%
controls:2.74%
338
1501
8441
85996
277
877
8513
86707
118
191
8672
87393
120
10
8670
87574
119
197
8231
87203
252
1041
7492
83804
298
1958
6049
69421
Pulmonary embolism
I26 [45548014]
I26 [45548014]
1.7e+00
2.0e+00
2.6e+00
1.0e+50
2.6e+00
1.6e+00
1.4e+00
cases:0.64%
controls:0.12%
cases:0.30%
controls:0.04%
cases:0.08%
controls:0.01%
cases:0.06%
controls:0.00%
cases:0.10%
controls:0.01%
cases:0.18%
controls:0.04%
cases:0.47%
controls:0.11%
56
102
8723
87395
26
34
8764
87550
7
5
8783
87579
5
0
8785
87584
8
6
8342
87394
14
31
7730
84814
30
82
6317
71297
Thoracic and Cardiac Surgery
OMOP4822009 [45756830]
OMOP4822009 [45756830]
6.8e-01
1.1e+00
2.1e+00
3.8e+00
1.8e+00
1.6e+00
9.1e-01
cases:2.39%
controls:1.22%
cases:1.41%
controls:0.47%
cases:0.61%
controls:0.07%
cases:0.26%
controls:0.01%
cases:0.38%
controls:0.07%
cases:1.54%
controls:0.32%
cases:2.25%
controls:0.92%
210
1071
8569
86426
124
409
8666
87175
54
64
8736
87520
23
5
8767
87579
32
58
8318
87342
119
269
7625
84576
143
657
6204
70722
SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
26975-3 [3025245]
26975-3 [3025245]
8.9e-01
1.9e+00
2.8e+00
—
3.7e+00
1.7e+00
9.6e-01
cases:0.75%
controls:0.31%
cases:0.82%
controls:0.13%
cases:0.19%
controls:0.01%
—
—
cases:0.57%
controls:0.01%
cases:0.74%
controls:0.13%
cases:1.12%
controls:0.43%
66
271
8713
87226
72
113
8718
87471
17
10
8773
87574
—
48
12
8302
87388
57
112
7687
84733
71
308
6276
71071
Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
29374-6 [3006999]
29374-6 [3006999]
8.0e-01
1.7e+00
3.0e+00
—
3.9e+00
1.7e+00
9.5e-01
cases:0.87%
controls:0.39%
cases:0.91%
controls:0.16%
cases:0.27%
controls:0.01%
—
—
cases:0.66%
controls:0.01%
cases:0.80%
controls:0.15%
cases:1.31%
controls:0.51%
76
341
8703
87156
80
144
8710
87440
24
12
8766
87572
—
55
12
8295
87388
62
131
7682
84714
83
364
6264
71015
Multidisciplinary treatment meeting
WZC20 [2001310890]
WZC20 [2001310890]
7.7e-01
2.0e+00
2.9e+00
—
3.0e+00
2.1e+00
1.2e+00
cases:1.07%
controls:0.50%
cases:1.58%
controls:0.21%
cases:0.51%
controls:0.03%
—
—
cases:0.55%
controls:0.03%
cases:1.45%
controls:0.18%
cases:1.35%
controls:0.42%
94
438
8685
87059
139
185
8651
87399
45
24
8745
87560
—
46
24
8304
87376
112
155
7632
84690
86
300
6261
71079
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
29953-7 [3037522]
5.7e-01
1.5e+00
3.7e+00
—
3.8e+00
1.5e+00
9.6e-01
cases:4.18%
controls:2.40%
cases:3.62%
controls:0.82%
cases:2.54%
controls:0.07%
—
—
cases:3.14%
controls:0.08%
cases:3.34%
controls:0.75%
cases:6.30%
controls:2.50%
367
2101
8412
85396
318
719
8472
86865
223
59
8567
87525
—
262
66
8088
87334
259
635
7485
84210
400
1784
5947
69595
F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
21668-9 [3015816]
21668-9 [3015816]
2.0e+00
3.5e+00
—
1.0e+50
3.4e+00
2.0e+00
1.1e+00
cases:1.47%
controls:0.20%
cases:2.28%
controls:0.07%
—
—
cases:0.13%
controls:0.00%
cases:0.22%
controls:0.01%
cases:0.45%
controls:0.06%
cases:0.57%
controls:0.19%
129
175
8650
87322
200
63
8590
87521
—
11
0
8779
87584
18
6
8332
87394
35
54
7709
84791
36
138
6311
71241
More than one and less than three hours
ZXE10 [2001311401]
ZXE10 [2001311401]
4.9e-01
1.0e+00
1.8e+00
4.2e+00
1.9e+00
1.5e+00
1.0e+00
cases:8.71%
controls:5.52%
cases:3.78%
controls:1.36%
cases:0.78%
controls:0.13%
cases:0.52%
controls:0.01%
cases:0.81%
controls:0.12%
cases:4.22%
controls:0.94%
cases:8.82%
controls:3.41%
765
4826
8014
82671
332
1192
8458
86392
69
117
8721
87467
46
7
8744
87577
68
104
8282
87296
327
797
7417
84048
560
2434
5787
68945
prednisolone; oral, parenteral
H02AB06 [21602734]
H02AB06 [21602734]
5.7e-01
9.9e-01
1.6e+00
3.8e+00
2.5e+00
1.5e+00
8.7e-01
cases:16.79%
controls:10.22%
cases:11.77%
controls:4.71%
cases:4.19%
controls:0.84%
cases:1.15%
controls:0.03%
cases:9.65%
controls:0.83%
cases:17.34%
controls:4.57%
cases:22.33%
controls:10.71%
1474
8942
7305
78555
1035
4127
7755
83457
368
737
8422
86847
101
22
8689
87562
806
729
7544
86671
1343
3881
6401
80964
1417
7648
4930
63731
prednisolone
A07EA01 [21600653]
A07EA01 [21600653]
5.7e-01
9.9e-01
1.6e+00
3.8e+00
2.5e+00
1.5e+00
8.7e-01
cases:16.88%
controls:10.28%
cases:11.83%
controls:4.73%
cases:4.19%
controls:0.85%
cases:1.15%
controls:0.03%
cases:9.66%
controls:0.84%
cases:17.38%
controls:4.59%
cases:22.36%
controls:10.76%
1482
8991
7297
78506
1040
4146
7750
83438
368
741
8422
86843
101
22
8689
87562
807
730
7543
86670
1346
3895
6398
80950
1419
7680
4928
63699
Other extensive ultrasound examination of artery
PG1DE [2001309713]
PG1DE [2001309713]
1.0e+00
2.0e+00
3.1e+00
—
2.4e+00
2.0e+00
1.4e+00
cases:1.24%
controls:0.45%
cases:0.90%
controls:0.13%
cases:0.15%
controls:0.01%
—
—
cases:0.19%
controls:0.02%
cases:0.99%
controls:0.13%
cases:1.78%
controls:0.44%
109
393
8670
87104
79
112
8711
87472
13
6
8777
87578
—
16
15
8334
87385
77
111
7667
84734
113
316
6234
71063
Phlebitis/thrombophlebitis
K94 [2002000621]
K94 [2002000621]
1.7e+00
1.9e+00
2.2e+00
—
1.9e+00
2.1e+00
2.0e+00
cases:0.60%
controls:0.11%
cases:0.32%
controls:0.05%
cases:0.13%
controls:0.01%
—
—
cases:0.10%
controls:0.01%
cases:0.32%
controls:0.04%
cases:0.65%
controls:0.09%
53
99
8726
87398
28
40
8762
87544
11
12
8779
87572
—
8
12
8342
87388
25
33
7719
84812
41
63
6306
71316
Mycobacterium sp identified in Specimen by Organism specific culture
543-9 [3005702]
543-9 [3005702]
1.0e+00
1.8e+00
2.4e+00
—
2.9e+00
2.2e+00
1.6e+00
cases:0.82%
controls:0.30%
cases:0.77%
controls:0.13%
cases:0.18%
controls:0.02%
—
—
cases:0.26%
controls:0.01%
cases:0.81%
controls:0.09%
cases:1.54%
controls:0.33%
72
260
8707
87237
68
110
8722
87474
16
14
8774
87570
—
22
13
8328
87387
63
80
7681
84765
98
234
6249
71145
CT of torso and neck
JN6AD [2001310938]
JN6AD [2001310938]
1.3e+00
2.4e+00
—
1.0e+50
3.7e+00
2.4e+00
2.1e+00
cases:0.33%
controls:0.09%
cases:0.65%
controls:0.06%
—
—
cases:0.17%
controls:0.00%
cases:0.37%
controls:0.01%
cases:0.75%
controls:0.07%
cases:1.18%
controls:0.15%
29
79
8750
87418
57
52
8733
87532
—
15
0
8775
87584
31
8
8319
87392
58
59
7686
84786
75
106
6272
71273
Leukocytes [#/volume] in Urine
30405-5 [3018095]
30405-5 [3018095]
4.5e-01
9.2e-01
2.0e+00
4.9e+00
2.1e+00
9.6e-01
5.8e-01
cases:10.56%
controls:7.01%
cases:9.64%
controls:4.08%
cases:4.21%
controls:0.62%
cases:2.89%
controls:0.02%
cases:4.81%
controls:0.60%
cases:10.03%
controls:4.10%
cases:17.05%
controls:10.28%
927
6137
7852
81360
847
3575
7943
84009
370
543
8420
87041
254
20
8536
87564
402
523
7948
86877
777
3481
6967
81364
1082
7335
5265
64044
Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2874-6 [3023465]
2874-6 [3023465]
9.9e-01
1.8e+00
2.9e+00
—
3.2e+00
1.9e+00
1.2e+00
cases:1.58%
controls:0.60%
cases:1.46%
controls:0.25%
cases:0.74%
controls:0.04%
—
—
cases:1.04%
controls:0.04%
cases:1.47%
controls:0.23%
cases:2.14%
controls:0.69%
139
522
8640
86975
128
219
8662
87365
65
37
8725
87547
—
87
37
8263
87363
114
196
7630
84649
136
491
6211
70888
Intravenous
ZX120 [2001311495]
ZX120 [2001311495]
1.1e+00
1.8e+00
2.6e+00
—
2.6e+00
2.2e+00
1.5e+00
cases:3.12%
controls:1.01%
cases:2.37%
controls:0.40%
cases:1.15%
controls:0.09%
—
—
cases:1.20%
controls:0.09%
cases:2.87%
controls:0.34%
cases:3.69%
controls:0.81%
274
885
8505
86612
208
352
8582
87232
101
76
8689
87508
—
100
78
8250
87322
222
288
7522
84557
234
577
6113
70802
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
30248-9 [3015399]
6.1e-01
1.1e+00
2.2e+00
3.9e+00
2.3e+00
1.1e+00
6.8e-01
cases:8.50%
controls:4.82%
cases:6.81%
controls:2.43%
cases:3.00%
controls:0.34%
cases:0.59%
controls:0.01%
cases:2.98%
controls:0.30%
cases:7.05%
controls:2.49%
cases:12.73%
controls:6.88%
746
4216
8033
83281
599
2131
8191
85453
264
297
8526
87287
52
11
8738
87573
249
261
8101
87139
546
2111
7198
82734
808
4909
5539
66470
granisetron; oral, parenteral, transdermal
A04AA02 [21600494]
A04AA02 [21600494]
1.1e+00
2.2e+00
3.1e+00
—
2.7e+00
2.0e+00
7.7e-01
cases:1.48%
controls:0.50%
cases:2.42%
controls:0.27%
cases:1.00%
controls:0.05%
—
—
cases:0.59%
controls:0.04%
cases:1.28%
controls:0.18%
cases:0.88%
controls:0.41%
130
434
8649
87063
213
237
8577
87347
88
41
8702
87543
—
49
34
8301
87366
99
154
7645
84691
56
292
6291
71087
Abdominal ultrasound examination
JN3AE [2001305555]
JN3AE [2001305555]
8.5e-01
1.7e+00
2.5e+00
—
3.3e+00
2.0e+00
1.4e+00
cases:3.66%
controls:1.60%
cases:2.57%
controls:0.46%
cases:0.50%
controls:0.04%
—
—
cases:1.07%
controls:0.04%
cases:2.97%
controls:0.40%
cases:5.64%
controls:1.42%
321
1399
8458
86098
226
401
8564
87183
44
38
8746
87546
—
89
34
8261
87366
230
339
7514
84506
358
1016
5989
70363
Physiotherapy
R4110 [2001310233]
R4110 [2001310233]
6.0e-01
9.7e-01
1.6e+00
4.6e+00
1.8e+00
1.3e+00
9.3e-01
cases:7.83%
controls:4.45%
cases:4.48%
controls:1.74%
cases:1.15%
controls:0.24%
cases:1.27%
controls:0.01%
cases:1.43%
controls:0.23%
cases:5.02%
controls:1.47%
cases:9.89%
controls:4.15%
687
3896
8092
83601
394
1525
8396
86059
101
207
8689
87377
112
11
8678
87573
119
203
8231
87197
389
1248
7355
83597
628
2962
5719
68417
Sepsis due to Staphylococcus aureus
A41.0 [45532832]
A41.0 [45532832]
1.2e+00
1.8e+00
2.2e+00
—
3.2e+00
2.1e+00
1.4e+00
cases:0.36%
controls:0.11%
cases:0.22%
controls:0.04%
cases:0.11%
controls:0.01%
—
—
cases:0.25%
controls:0.01%
cases:0.36%
controls:0.04%
cases:0.66%
controls:0.17%
32
97
8747
87400
19
32
8771
87552
10
11
8780
87573
—
21
9
8329
87391
28
38
7716
84807
42
123
6305
71256
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
14749-6 [3013826]
3.3e-01
9.3e-01
2.2e+00
4.8e+00
2.2e+00
9.5e-01
4.7e-01
cases:16.70%
controls:12.60%
cases:14.48%
controls:6.23%
cases:7.47%
controls:0.89%
cases:5.05%
controls:0.05%
cases:6.91%
controls:0.84%
cases:14.44%
controls:6.13%
cases:23.49%
controls:16.10%
1466
11021
7313
76476
1273
5460
7517
82124
657
783
8133
86801
444
40
8346
87544
577
738
7773
86662
1118
5205
6626
79640
1491
11489
4856
59890
Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
78445-4 [21492711]
78445-4 [21492711]
1.4e+00
2.2e+00
—
—
4.1e+00
2.6e+00
1.6e+00
cases:0.32%
controls:0.08%
cases:0.30%
controls:0.03%
—
—
—
—
cases:0.47%
controls:0.01%
cases:0.49%
controls:0.04%
cases:0.58%
controls:0.12%
28
67
8751
87430
26
30
8764
87554
—
—
39
7
8311
87393
38
32
7706
84813
37
88
6310
71291
Phlebitis and thrombophlebitis of lower extremities, unspecified
I80.3 [45572137]
I80.3 [45572137]
1.8e+00
2.7e+00
3.9e+00
1.0e+50
—
2.1e+00
1.3e+00
cases:1.48%
controls:0.26%
cases:1.09%
controls:0.07%
cases:0.28%
controls:0.01%
cases:0.33%
controls:0.00%
—
—
cases:0.67%
controls:0.09%
cases:0.95%
controls:0.26%
130
224
8649
87273
96
62
8694
87522
25
5
8765
87579
29
0
8761
87584
—
52
73
7692
84772
60
187
6287
71192
Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
17791-5 [3027450]
17791-5 [3027450]
8.2e-01
1.7e+00
2.9e+00
—
3.8e+00
1.6e+00
9.5e-01
cases:0.96%
controls:0.42%
cases:0.92%
controls:0.17%
cases:0.27%
controls:0.01%
—
—
cases:0.67%
controls:0.01%
cases:0.81%
controls:0.17%
cases:1.37%
controls:0.54%
84
370
8695
87127
81
151
8709
87433
24
13
8766
87571
—
56
13
8294
87387
63
142
7681
84703
87
382
6260
70997
Supervision of high-risk pregnancy, unspecified
Z35.9 [45576148]
Z35.9 [45576148]
7.7e-01
1.9e+00
2.9e+00
1.0e+50
2.8e+00
2.0e+00
1.4e+00
cases:0.35%
controls:0.16%
cases:0.32%
controls:0.05%
cases:0.18%
controls:0.01%
cases:0.16%
controls:0.00%
cases:0.13%
controls:0.01%
cases:0.48%
controls:0.06%
cases:0.76%
controls:0.19%
31
144
8748
87353
28
41
8762
87543
16
9
8774
87575
14
0
8776
87584
11
7
8339
87393
37
55
7707
84790
48
139
6299
71240
Extractable nuclear Ab [Units/volume] in Serum
30342-0 [3015171]
30342-0 [3015171]
7.0e-01
1.5e+00
3.2e+00
1.0e+50
3.7e+00
1.5e+00
1.2e+00
cases:1.36%
controls:0.68%
cases:1.02%
controls:0.23%
cases:0.46%
controls:0.02%
cases:0.28%
controls:0.00%
cases:0.79%
controls:0.02%
cases:0.89%
controls:0.20%
cases:2.14%
controls:0.64%
119
591
8660
86906
90
204
8700
87380
40
17
8750
87567
25
0
8765
87584
66
18
8284
87382
69
171
7675
84674
136
456
6211
70923
Demanding therapy of methastized malignancy with biomodifiers
WD325 [2001310687]
WD325 [2001310687]
1.5e+00
1.9e+00
2.5e+00
—
2.5e+00
2.2e+00
1.1e+00
cases:0.22%
controls:0.05%
cases:0.25%
controls:0.04%
cases:0.13%
controls:0.01%
—
—
cases:0.08%
controls:0.01%
cases:0.35%
controls:0.04%
cases:0.25%
controls:0.08%
19
42
8760
87455
22
33
8768
87551
11
9
8779
87575
—
7
6
8343
87394
27
33
7717
84812
16
59
6331
71320
Cerebral infarction, unspecified
I63.9 [45596216]
I63.9 [45596216]
4.7e-01
1.1e+00
2.2e+00
4.7e+00
1.8e+00
1.0e+00
4.7e-01
cases:1.96%
controls:1.23%
cases:1.35%
controls:0.47%
cases:0.58%
controls:0.07%
cases:0.76%
controls:0.01%
cases:0.59%
controls:0.10%
cases:1.29%
controls:0.48%
cases:2.21%
controls:1.39%
172
1076
8607
86421
119
410
8671
87174
51
58
8739
87526
67
6
8723
87578
49
85
8301
87315
100
408
7644
84437
140
990
6207
70389
Normoblasts [#/volume] in Blood
715-3 [3021589]
715-3 [3021589]
4.7e-01
8.2e-01
2.1e+00
4.5e+00
2.2e+00
9.6e-01
7.1e-01
cases:13.87%
controls:9.17%
cases:15.13%
controls:7.30%
cases:11.88%
controls:1.65%
cases:7.67%
controls:0.09%
cases:12.43%
controls:1.62%
cases:17.39%
controls:7.45%
cases:23.37%
controls:13.00%
1218
8025
7561
79472
1330
6393
7460
81191
1044
1444
7746
86140
674
81
8116
87503
1038
1415
7312
85985
1347
6325
6397
78520
1483
9282
4864
62097
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
51486-9 [3029879]
5.9e-01
9.6e-01
1.9e+00
4.6e+00
2.1e+00
9.5e-01
5.1e-01
cases:4.76%
controls:2.71%
cases:4.04%
controls:1.58%
cases:1.58%
controls:0.23%
cases:1.05%
controls:0.01%
cases:2.01%
controls:0.24%
cases:4.21%
controls:1.68%
cases:7.07%
controls:4.36%
418
2370
8361
85127
355
1384
8435
86200
139
205
8651
87379
92
9
8698
87575
168
214
8182
87186
326
1424
7418
83421
449
3114
5898
68265
Pneumonia, unspecified
J18.9 [45601123]
J18.9 [45601123]
5.6e-01
1.0e+00
2.2e+00
4.5e+00
1.7e+00
1.0e+00
6.8e-01
cases:5.19%
controls:3.04%
cases:3.22%
controls:1.17%
cases:1.52%
controls:0.18%
cases:1.24%
controls:0.01%
cases:1.03%
controls:0.18%
cases:3.72%
controls:1.39%
cases:8.02%
controls:4.24%
456
2659
8323
84838
283
1029
8507
86555
134
155
8656
87429
109
12
8681
87572
86
161
8264
87239
288
1177
7456
83668
509
3030
5838
68349
Kappa light chains/Lambda light chains [Mass Ratio] in Serum
15189-4 [3007778]
15189-4 [3007778]
1.2e+00
1.7e+00
2.6e+00
—
3.4e+00
1.8e+00
1.0e+00
cases:1.57%
controls:0.50%
cases:1.38%
controls:0.26%
cases:0.75%
controls:0.06%
—
—
cases:1.19%
controls:0.04%
cases:1.43%
controls:0.25%
cases:1.89%
controls:0.67%
138
434
8641
87063
121
226
8669
87358
66
50
8724
87534
—
99
35
8251
87365
111
208
7633
84637
120
480
6227
70899
INR in Blood by Coagulation assay
34714-6 [3032080]
34714-6 [3032080]
6.5e-01
1.3e+00
1.8e+00
4.0e+00
1.9e+00
1.2e+00
7.9e-01
cases:18.45%
controls:10.58%
cases:18.25%
controls:6.00%
cases:11.24%
controls:1.98%
cases:7.13%
controls:0.14%
cases:11.44%
controls:1.92%
cases:17.37%
controls:5.77%
cases:23.40%
controls:12.21%
1620
9259
7159
78238
1604
5254
7186
82330
988
1737
7802
85847
627
122
8163
87462
955
1681
7395
85719
1345
4892
6399
79953
1485
8712
4862
62667
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
2000-8 [3015377]
4.3e-01
9.9e-01
2.3e+00
4.3e+00
2.0e+00
1.0e+00
6.2e-01
cases:9.27%
controls:6.24%
cases:7.46%
controls:2.91%
cases:4.52%
controls:0.47%
cases:0.57%
controls:0.01%
cases:3.27%
controls:0.46%
cases:7.55%
controls:2.80%
cases:13.80%
controls:7.93%
814
5464
7965
82033
656
2548
8134
85036
397
411
8393
87173
50
7
8740
87577
273
403
8077
86997
585
2376
7159
82469
876
5657
5471
65722
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
1798-8 [3016771]
3.6e-01
9.5e-01
2.0e+00
5.0e+00
2.0e+00
8.1e-01
4.7e-01
cases:8.19%
controls:5.83%
cases:6.12%
controls:2.46%
cases:2.09%
controls:0.30%
cases:1.88%
controls:0.01%
cases:2.37%
controls:0.32%
cases:5.36%
controls:2.45%
cases:11.23%
controls:7.35%
719
5104
8060
82393
538
2157
8252
85427
184
260
8606
87324
165
11
8625
87573
198
276
8152
87124
415
2081
7329
82764
713
5244
5634
66135
Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
51435-6 [3029713]
51435-6 [3029713]
9.9e-01
1.8e+00
2.7e+00
—
3.1e+00
1.9e+00
1.2e+00
cases:1.44%
controls:0.54%
cases:1.52%
controls:0.26%
cases:0.69%
controls:0.05%
—
—
cases:1.08%
controls:0.05%
cases:1.52%
controls:0.23%
cases:2.13%
controls:0.68%
126
470
8653
87027
134
225
8656
87359
61
42
8729
87542
—
90
42
8260
87358
118
199
7626
84646
135
486
6212
70893
Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection
6521-9 [3009595]
6521-9 [3009595]
1.0e+00
1.6e+00
—
—
4.1e+00
2.8e+00
2.1e+00
cases:0.30%
controls:0.10%
cases:0.26%
controls:0.05%
—
—
—
—
cases:0.36%
controls:0.01%
cases:0.61%
controls:0.04%
cases:0.95%
controls:0.12%
26
91
8753
87406
23
48
8767
87536
—
—
30
5
8320
87395
47
32
7697
84813
60
85
6287
71294
Extensive body CT
JN4BD [2001310899]
JN4BD [2001310899]
9.0e-01
1.8e+00
2.6e+00
—
2.5e+00
2.2e+00
1.6e+00
cases:2.98%
controls:1.24%
cases:2.59%
controls:0.46%
cases:0.72%
controls:0.05%
—
—
cases:0.75%
controls:0.06%
cases:2.71%
controls:0.30%
cases:3.31%
controls:0.66%
262
1082
8517
86415
228
400
8562
87184
63
48
8727
87536
—
63
53
8287
87347
210
257
7534
84588
210
473
6137
70906
Scheduled procedure
ZXD10 [2001311387]
ZXD10 [2001311387]
5.2e-01
1.0e+00
1.5e+00
4.2e+00
1.8e+00
1.6e+00
1.1e+00
cases:9.91%
controls:6.14%
cases:4.02%
controls:1.50%
cases:0.73%
controls:0.16%
cases:0.36%
controls:0.01%
cases:0.86%
controls:0.15%
cases:5.02%
controls:1.11%
cases:9.72%
controls:3.54%
870
5374
7909
82123
353
1314
8437
86270
64
140
8726
87444
32
5
8758
87579
72
130
8278
87270
389
941
7355
83904
617
2529
5730
68850
Other specified sepsis
A41.8 [45595587]
A41.8 [45595587]
7.5e-01
2.3e+00
2.8e+00
—
3.3e+00
2.0e+00
1.1e+00
cases:0.21%
controls:0.10%
cases:0.35%
controls:0.03%
cases:0.11%
controls:0.01%
—
—
cases:0.19%
controls:0.01%
cases:0.34%
controls:0.04%
cases:0.44%
controls:0.15%
18
85
8761
87412
31
30
8759
87554
10
6
8780
87578
—
16
6
8334
87394
26
38
7718
84807
28
106
6319
71273
Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2868-8 [3005229]
2868-8 [3005229]
1.0e+00
1.7e+00
2.7e+00
—
3.3e+00
1.8e+00
1.1e+00
cases:1.71%
controls:0.62%
cases:1.58%
controls:0.29%
cases:0.78%
controls:0.05%
—
—
cases:1.25%
controls:0.05%
cases:1.64%
controls:0.28%
cases:2.43%
controls:0.82%
150
544
8629
86953
139
255
8651
87329
69
48
8721
87536
—
104
41
8246
87359
127
237
7617
84608
154
584
6193
70795
Oxygen [Partial pressure] in Blood
11556-8 [3027315]
11556-8 [3027315]
8.9e-01
1.6e+00
3.0e+00
—
3.0e+00
1.7e+00
1.3e+00
cases:1.03%
controls:0.42%
cases:0.72%
controls:0.15%
cases:0.35%
controls:0.02%
—
—
cases:0.50%
controls:0.03%
cases:0.76%
controls:0.14%
cases:1.07%
controls:0.28%
90
369
8689
87128
63
127
8727
87457
31
15
8759
87569
—
42
22
8308
87378
59
118
7685
84727
68
202
6279
71177
Base excess in Blood by calculation
11555-0 [3012501]
11555-0 [3012501]
8.9e-01
1.6e+00
3.0e+00
—
3.0e+00
1.7e+00
1.4e+00
cases:1.01%
controls:0.42%
cases:0.72%
controls:0.15%
cases:0.35%
controls:0.02%
—
—
cases:0.50%
controls:0.03%
cases:0.75%
controls:0.14%
cases:1.09%
controls:0.28%
89
366
8690
87131
63
127
8727
87457
31
15
8759
87569
—
42
22
8308
87378
58
118
7686
84727
69
201
6278
71178
Carbon dioxide [Partial pressure] in Blood
11557-6 [3013290]
11557-6 [3013290]
8.9e-01
1.6e+00
3.0e+00
—
3.0e+00
1.7e+00
1.4e+00
cases:1.01%
controls:0.42%
cases:0.72%
controls:0.15%
cases:0.35%
controls:0.02%
—
—
cases:0.50%
controls:0.03%
cases:0.75%
controls:0.14%
cases:1.09%
controls:0.28%
89
366
8690
87131
63
127
8727
87457
31
15
8759
87569
—
42
22
8308
87378
58
118
7686
84727
69
202
6278
71177
Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32730-4 [3043723]
32730-4 [3043723]
1.0e+00
1.7e+00
2.7e+00
—
3.3e+00
1.8e+00
1.1e+00
cases:1.71%
controls:0.62%
cases:1.57%
controls:0.29%
cases:0.78%
controls:0.05%
—
—
cases:1.25%
controls:0.05%
cases:1.64%
controls:0.28%
cases:2.43%
controls:0.82%
150
544
8629
86953
138
256
8652
87328
69
48
8721
87536
—
104
41
8246
87359
127
237
7617
84608
154
583
6193
70796
Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32731-2 [3043747]
32731-2 [3043747]
1.0e+00
1.7e+00
2.7e+00
—
3.3e+00
1.8e+00
1.1e+00
cases:1.71%
controls:0.62%
cases:1.57%
controls:0.29%
cases:0.78%
controls:0.05%
—
—
cases:1.25%
controls:0.05%
cases:1.61%
controls:0.28%
cases:2.43%
controls:0.82%
150
543
8629
86954
138
254
8652
87330
69
48
8721
87536
—
104
41
8246
87359
125
236
7619
84609
154
583
6193
70796
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
6768-6 [3035995]
3.8e-01
8.8e-01
2.2e+00
4.3e+00
2.2e+00
1.0e+00
6.1e-01
cases:25.38%
controls:18.93%
cases:23.69%
controls:11.37%
cases:16.36%
controls:2.20%
cases:6.55%
controls:0.09%
cases:15.98%
controls:2.12%
cases:26.25%
controls:11.34%
cases:35.94%
controls:23.31%
2228
16562
6551
70935
2082
9955
6708
77629
1438
1926
7352
85658
576
81
8214
87503
1334
1853
7016
85547
2033
9625
5711
75220
2281
16639
4066
54740
Other vasculitis limited to skin
L95.8 [45601251]
L95.8 [45601251]
1.7e+00
3.1e+00
—
1.0e+50
—
3.8e+00
2.9e+00
cases:0.11%
controls:0.02%
cases:0.20%
controls:0.01%
—
—
cases:0.11%
controls:0.00%
—
—
cases:0.43%
controls:0.01%
cases:0.33%
controls:0.02%
10
18
8769
87479
18
8
8772
87576
—
10
0
8780
87584
—
33
8
7711
84837
21
13
6326
71366
Rheumatology
66 [38004491]
66 [38004491]
7.2e-01
9.2e-01
1.2e+00
4.6e+00
1.6e+00
1.3e+00
1.1e+00
cases:6.03%
controls:3.04%
cases:4.47%
controls:1.83%
cases:1.18%
controls:0.35%
cases:1.15%
controls:0.01%
cases:1.75%
controls:0.36%
cases:6.26%
controls:1.75%
cases:9.06%
controls:3.07%
529
2661
8250
84836
393
1604
8397
85980
104
308
8686
87276
101
10
8689
87574
146
315
8204
87085
485
1484
7259
83361
575
2193
5772
69186
Protein [Mass/volume] in Serum or Plasma
2885-2 [3020630]
2885-2 [3020630]
9.3e-01
1.7e+00
2.8e+00
—
3.3e+00
1.7e+00
1.0e+00
cases:3.34%
controls:1.34%
cases:3.50%
controls:0.64%
cases:1.99%
controls:0.12%
—
—
cases:2.42%
controls:0.09%
cases:3.28%
controls:0.60%
cases:4.52%
controls:1.70%
293
1172
8486
86325
308
563
8482
87021
175
103
8615
87481
—
202
80
8148
87320
254
508
7490
84337
287
1213
6060
70166
Lambda light chains.free [Mass/volume] in Serum or Plasma
33944-0 [3047169]
33944-0 [3047169]
1.2e+00
1.6e+00
2.5e+00
—
3.4e+00
1.8e+00
1.0e+00
cases:1.59%
controls:0.51%
cases:1.47%
controls:0.29%
cases:0.84%
controls:0.07%
—
—
cases:1.33%
controls:0.04%
cases:1.63%
controls:0.27%
cases:2.10%
controls:0.75%
140
442
8639
87055
129
250
8661
87334
74
63
8716
87521
—
111
39
8239
87361
126
233
7618
84612
133
535
6214
70844
tinzaparin; parenteral
B01AB10 [21600981]
B01AB10 [21600981]
1.1e+00
1.6e+00
2.6e+00
—
3.0e+00
2.0e+00
1.1e+00
cases:2.27%
controls:0.78%
cases:2.25%
controls:0.44%
cases:1.24%
controls:0.09%
—
—
cases:1.75%
controls:0.09%
cases:2.96%
controls:0.39%
cases:3.66%
controls:1.29%
199
686
8580
86811
198
386
8592
87198
109
78
8681
87506
—
146
75
8204
87325
229
334
7515
84511
232
919
6115
70460
Teaching
WZC30 [2001310891]
WZC30 [2001310891]
5.0e-01
1.2e+00
1.9e+00
4.3e+00
1.9e+00
1.2e+00
4.6e-01
cases:3.01%
controls:1.84%
cases:2.75%
controls:0.83%
cases:0.82%
controls:0.13%
cases:0.43%
controls:0.01%
cases:0.74%
controls:0.11%
cases:2.57%
controls:0.81%
cases:3.62%
controls:2.31%
264
1611
8515
85886
242
727
8548
86857
72
111
8718
87473
38
5
8752
87579
62
94
8288
87306
199
685
7545
84160
230
1647
6117
69732
Vascular Surgery
77 [38004496]
77 [38004496]
6.8e-01
1.2e+00
1.7e+00
4.2e+00
1.7e+00
1.3e+00
7.5e-01
cases:5.18%
controls:2.69%
cases:3.53%
controls:1.09%
cases:1.11%
controls:0.20%
cases:0.51%
controls:0.01%
cases:1.03%
controls:0.19%
cases:3.72%
controls:1.09%
cases:6.18%
controls:3.02%
455
2353
8324
85144
310
952
8480
86632
98
172
8692
87412
45
7
8745
87577
86
165
8264
87235
288
923
7456
83922
392
2156
5955
69223
Mitochondria Ab [Titer] in Serum
20483-4 [3034770]
20483-4 [3034770]
1.0e+00
1.7e+00
2.3e+00
—
3.2e+00
2.0e+00
1.2e+00
cases:1.10%
controls:0.41%
cases:0.81%
controls:0.15%
cases:0.18%
controls:0.02%
—
—
cases:0.32%
controls:0.01%
cases:0.92%
controls:0.12%
cases:1.53%
controls:0.45%
97
356
8682
87141
71
128
8719
87456
16
16
8774
87568
—
27
11
8323
87389
71
106
7673
84739
97
324
6250
71055
Kappa light chains.free [Mass/volume] in Serum
36916-5 [3034860]
36916-5 [3034860]
1.1e+00
1.7e+00
2.5e+00
—
3.4e+00
1.8e+00
1.0e+00
cases:1.57%
controls:0.51%
cases:1.48%
controls:0.29%
cases:0.84%
controls:0.07%
—
—
cases:1.33%
controls:0.04%
cases:1.61%
controls:0.28%
cases:2.10%
controls:0.75%
138
443
8641
87054
130
250
8660
87334
74
63
8716
87521
—
111
39
8239
87361
125
234
7619
84611
133
536
6214
70843
Ultrasound examination of upper part of abdomen
JN1AE [2001305517]
JN1AE [2001305517]
9.3e-01
1.6e+00
2.7e+00
1.0e+50
2.8e+00
1.9e+00
1.5e+00
cases:2.07%
controls:0.83%
cases:1.32%
controls:0.26%
cases:0.25%
controls:0.02%
cases:1.21%
controls:0.00%
cases:0.41%
controls:0.03%
cases:1.59%
controls:0.24%
cases:3.66%
controls:0.81%
182
723
8597
86774
116
231
8674
87353
22
15
8768
87569
106
0
8684
87584
34
22
8316
87378
123
204
7621
84641
232
581
6115
70798
Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2865-4 [3015322]
2865-4 [3015322]
9.8e-01
1.7e+00
2.6e+00
—
3.3e+00
1.8e+00
1.1e+00
cases:1.54%
controls:0.58%
cases:1.50%
controls:0.28%
cases:0.69%
controls:0.05%
—
—
cases:1.15%
controls:0.04%
cases:1.59%
controls:0.27%
cases:2.32%
controls:0.75%
135
510
8644
86987
132
243
8658
87341
61
47
8729
87537
—
96
39
8254
87361
123
226
7621
84619
147
538
6200
70841
Smooth muscle Ab [Titer] in Serum
8095-2 [3007566]
8095-2 [3007566]
1.0e+00
1.7e+00
2.5e+00
—
3.1e+00
1.9e+00
1.2e+00
cases:1.12%
controls:0.41%
cases:0.83%
controls:0.15%
cases:0.18%
controls:0.01%
—
—
cases:0.32%
controls:0.01%
cases:0.89%
controls:0.13%
cases:1.56%
controls:0.48%
98
360
8681
87137
73
128
8717
87456
16
13
8774
87571
—
27
13
8323
87387
69
112
7675
84733
99
346
6248
71033
Serous epithelial malignant tumor of the ovary
C56.71 [2000501075]
C56.71 [2000501075]
1.8e+00
1.9e+00
2.4e+00
—
2.4e+00
1.9e+00
1.1e+00
cases:0.39%
controls:0.07%
cases:0.42%
controls:0.06%
cases:0.36%
controls:0.03%
—
—
cases:0.40%
controls:0.04%
cases:0.39%
controls:0.06%
cases:0.22%
controls:0.07%
34
58
8745
87439
37
56
8753
87528
32
30
8758
87554
—
33
31
8317
87369
30
49
7714
84796
14
53
6333
71326
CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
20607-8 [3020073]
20607-8 [3020073]
1.7e+00
2.7e+00
—
—
—
4.2e+00
2.8e+00
cases:0.27%
controls:0.05%
cases:0.31%
controls:0.02%
—
—
—
—
—
—
cases:0.96%
controls:0.01%
cases:0.93%
controls:0.06%
24
44
8755
87453
27
18
8763
87566
—
—
—
74
12
7670
84833
59
41
6288
71338
tranexamic acid; oral, parenteral
B02AA02 [21601036]
B02AA02 [21601036]
9.1e-01
1.5e+00
2.0e+00
—
3.4e+00
2.0e+00
1.5e+00
cases:2.88%
controls:1.19%
cases:1.76%
controls:0.40%
cases:0.56%
controls:0.08%
—
—
cases:1.53%
controls:0.05%
cases:2.89%
controls:0.39%
cases:5.67%
controls:1.26%
253
1037
8526
86460
155
349
8635
87235
49
68
8741
87516
—
128
44
8222
87356
224
335
7520
84510
360
900
5987
70479
Emergency Medicine
93 [38004510]
93 [38004510]
3.7e-01
8.8e-01
2.0e+00
5.4e+00
1.6e+00
7.3e-01
3.4e-01
cases:18.57%
controls:13.66%
cases:16.33%
controls:7.46%
cases:7.77%
controls:1.11%
cases:11.25%
controls:0.06%
cases:5.20%
controls:1.07%
cases:15.02%
controls:7.87%
cases:26.55%
controls:20.40%
1630
11949
7149
75548
1435
6534
7355
81050
683
976
8107
86608
989
49
7801
87535
434
935
7916
86465
1163
6678
6581
78167
1685
14558
4662
56821
Extensive CT examination of arteria pulmonalis
FB1BD [2001302407]
FB1BD [2001302407]
1.0e+00
1.6e+00
2.9e+00
1.0e+50
2.8e+00
1.9e+00
1.2e+00
cases:1.86%
controls:0.69%
cases:1.11%
controls:0.22%
cases:0.42%
controls:0.02%
cases:0.43%
controls:0.00%
cases:0.29%
controls:0.02%
cases:1.08%
controls:0.17%
cases:2.03%
controls:0.62%
163
606
8616
86891
98
194
8692
87390
37
20
8753
87564
38
0
8752
87584
24
16
8326
87384
84
144
7660
84701
129
441
6218
70938
Myelocytes/Leukocytes in Blood
26498-6 [3017181]
26498-6 [3017181]
9.2e-01
1.6e+00
2.8e+00
—
3.3e+00
1.7e+00
1.0e+00
cases:2.65%
controls:1.08%
cases:3.92%
controls:0.84%
cases:2.49%
controls:0.16%
—
—
cases:3.95%
controls:0.15%
cases:5.11%
controls:0.95%
cases:5.39%
controls:2.03%
233
942
8546
86555
345
733
8445
86851
219
136
8571
87448
—
330
129
8020
87271
396
809
7348
84036
342
1446
6005
69933
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
6262
43243
2.33
315.77
11.8
6.5
12.55
11.65
umol/l
4.88
6066
41193
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
975
2669
3.96
310.76
4.8
3.4
0.32
0.34
iu/ml
0.98
565
1446
632
1230
5.43
308.59
1.1
1.1
—
—
—
0
0
6551
42886
2.72
307.65
11.4
6.4
0.58
0.59
e9/l
0.24
5849
36780
6560
43001
2.72
307.65
11.4
6.4
0.04
0.04
e9/l
10.59
5857
36884
1415
3819
4.18
307.65
2.4
1.7
1.31
1.54
g/l
14.70
1223
3296
2559
11952
2.56
307.65
1.6
1.4
651.39
497.45
titre
3.01
626
2522
3065
9610
4.24
307.65
7.0
4.3
259.54
239.29
u/l
6.78
2973
9103
706
1358
5.54
307.65
3.7
3.2
10923.49
1679.94
u/ml
0.49
57
71
2469
11124
2.65
307.65
9.8
6.2
1.06
1.05
mmol/l
1.31
2353
10370
2341
7425
3.86
307.65
4.7
2.5
76.48
68.04
e9/l
10.65
1689
5400
988
1762
6.14
307.65
2.1
1.6
—
—
—
0
0
329
223
15.25
307.65
1.3
1.1
88.74
92.32
%
0.52
174
105
241
73
33.85
307.65
1.5
1.2
—
—
—
0
0
4099
21127
2.66
307.65
7.5
4.2
84.51
89.38
%
22.01
3991
20676
5675
37155
2.32
307.65
8.5
5.1
34.72
35.71
g/l
29.93
5427
34806
493
225
23.06
307.65
3.5
1.3
134.23
184.18
%
6.68
474
216
3194
13961
2.94
307.65
6.1
3.5
0.80
0.82
mmol/l
9.95
3066
13156
270
151
18.37
307.65
1.9
1.1
98.50
109.27
%
2.76
262
144
5826
37585
2.43
307.65
30.4
14.9
1.45
1.26
inr
92.28
5083
31481
1692
5085
3.83
307.65
2.3
1.9
1.25
1.32
g/l
0.75
1583
4672
6174
39803
2.59
307.65
11.5
6.4
57.38
57.34
%
0.08
6024
38027
1551
2573
7.01
307.65
4.0
2.7
94.41
92.53
%
2.06
1504
2479
773
1232
6.74
307.65
1.7
1.2
7.96
3.66
u/ml
5.13
438
548
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
359
231
16.11
307.65
1.4
1.1
101.47
110.33
%
1.82
338
207
2814
12677
2.74
307.65
3.8
2.7
23.91
22.42
%
4.73
2710
11769
825
1257
7.09
307.65
1.7
1.2
8.14
3.05
u/ml
5.48
396
444
875
1745
5.42
307.65
7.3
5.8
2306.27
1192.87
iu/ml
0.27
132
239
6885
47787
2.62
307.65
18.6
9.6
3.95
4.16
e9/l
8.07
6207
41346
993
2561
4.21
307.65
2.7
1.7
0.22
0.23
g/l
6.72
935
2439
6304
40546
2.67
307.65
12.0
6.6
27.28
27.82
%
2.99
6120
38420
1810
6925
3.00
307.65
3.0
2.6
65.51
66.36
g/l
4.20
1712
6324
3551
18466
2.48
307.65
3.2
1.8
1.70
1.21
mg/l
7.75
2877
14258
6657
44306
2.70
307.65
12.0
6.6
0.17
0.19
e9/l
22.04
6009
38681
2912
9695
3.90
307.65
4.6
2.6
1.93
1.74
%
13.01
2715
8606
1052
1215
9.62
307.65
1.9
1.6
—
—
—
0
0
1642
2346
8.26
307.65
5.0
2.6
167.23
192.52
%
18.12
1570
2236
6260
39555
2.73
307.65
12.1
6.7
9.15
8.81
%
10.98
6044
37099
450
453
10.38
307.65
1.9
2.7
97.69
97.99
%
0.05
427
424
3446
12679
3.70
307.65
4.2
2.1
31.36
29.61
s
26.40
3354
12327
2006
6525
3.63
307.65
4.0
2.8
10.29
10.55
g/l
1.50
1898
6018
3050
14818
2.56
307.65
3.8
2.6
13.20
13.06
umol/l
0.44
2941
13795
1000
2638
4.12
307.65
2.7
1.7
1.14
1.19
g/l
4.24
952
2515
6242
39467
2.71
307.65
11.9
6.6
2.59
2.84
%
15.83
6034
36987
326
229
14.71
307.65
1.2
1.1
89.56
90.65
%
0.17
168
105
2931
13784
2.63
307.65
3.7
2.6
2.27
2.33
g/l
7.69
2789
12737
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
659
312
22.63
307.65
3.5
1.3
128.09
155.51
%
5.61
634
298
1691
2451
8.18
307.65
4.1
2.8
3.37
3.57
g/l
5.20
1616
2335
6614
43888
2.69
307.65
11.6
6.4
1.78
1.92
e9/l
8.79
6000
38605
610
1165
5.53
304.04
1.2
1.1
111.87
116.55
%
2.11
564
1050
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
245
143
17.56
299.17
1.3
1.1
82.43
75.49
%
0.53
82
35
244
143
17.49
297.35
1.4
1.1
88.54
84.34
%
0.34
90
35
5539
37102
2.19
290.10
11.8
6.7
1.21
1.21
mmol/l
7.34
5281
34378
5972
41578
2.19
278.35
13.0
7.3
1.21
1.21
mmol/l
8.49
5190
35988
1799
7678
2.66
269.36
11.6
7.6
10.70
9.78
mmol/l
4.91
1727
7364
1080
3524
3.33
262.43
1.7
1.6
9.40
17.40
iu/ml
1.44
38
100
487
891
5.71
253.72
1.2
1.1
90.35
97.05
%
4.60
457
832
3773
22921
2.08
241.36
3.2
2.4
3.06
2.77
mg/l
8.62
3397
19846
452
812
5.80
239.97
3.1
2.5
1025.81
1208.48
e6/l
3.63
390
697
2651
14150
2.21
236.81
2.6
1.9
—
—
—
0
0
1031
3483
3.20
235.55
2.8
1.8
12.70
6.72
iu/ml
4.53
270
844
394
633
6.45
234.33
2.6
2.4
—
—
—
0
0
5343
37111
2.01
231.56
21.3
11.4
0.01
0.00
e9/l
2.14
4401
30148
308
385
8.23
229.74
2.3
1.6
—
—
—
0
0
308
385
8.23
229.74
2.3
1.6
—
—
—
0
0
1632
7166
2.54
227.19
6.8
4.2
0.79
0.72
%
0.62
875
2100
788
2306
3.64
225.84
1.6
1.4
12.65
13.23
iu/ml
0.04
20
46
384
636
6.25
221.51
2.6
2.3
14.64
14.74
%
0.05
373
619
668
1775
3.97
220.05
1.5
1.4
13.07
20.49
u/ml
—
10
37
3800
23836
1.99
216.03
4.7
3.4
0.46
0.41
e6/l
0.47
2948
17542
3019
17490
2.07
214.05
2.0
1.5
2.51
2.36
g/l
3.03
2160
10844
4220
27555
1.96
212.41
4.9
3.5
65.64
82.93
e6/l
0.60
3385
21061
300
402
7.67
210.86
1.4
1.2
—
—
—
0
0
2074
10462
2.26
209.35
2.3
1.8
—
—
—
0
0
3644
22729
1.98
208.71
4.5
3.3
21.78
151.10
estimate
0.50
13
103
619
1625
4.01
207.14
1.6
1.5
147.16
145.52
au/ml
0.11
174
480
1974
9810
2.28
206.21
2.3
1.9
—
—
—
0
0
4645
31548
1.93
205.71
5.9
4.1
79.47
94.24
e6/l
0.59
3515
22185
3483
21640
1.97
199.60
4.4
2.7
346.46
341.29
umol/l
1.86
3185
19139
833
2732
3.25
198.79
3.4
3.3
35.21
51.73
mg/l
1.98
690
2345
948
3360
3.02
198.11
2.5
2.3
4.15
4.21
g/l
1.33
888
3063
947
3356
3.02
197.95
2.5
2.3
3.67
3.72
g/l
0.35
887
3060
948
3363
3.02
197.79
2.5
2.3
6.95
7.45
g/l
15.26
888
3063
832
2736
3.24
197.64
3.5
3.3
109.30
73.31
mg/l
0.25
690
2351
1698
8053
2.35
197.09
3.1
2.3
0.20
0.21
g/l
6.57
1598
7525
7647
62248
2.20
193.08
15.6
8.2
82.72
79.15
u/l
7.91
7418
59160
724
2224
3.44
191.83
2.3
1.6
—
—
—
0
0
710
2157
3.48
191.40
2.2
1.6
—
—
—
0
0
851
2892
3.13
191.08
2.6
2.4
0.67
0.87
g/l
0.90
746
2477
893
3150
3.03
187.85
2.5
2.3
2.94
2.92
g/l
0.34
833
2853
558
1461
4.00
187.11
2.4
1.7
—
—
—
0
0
133
57
23.65
185.48
1.4
1.2
0.75
0.05
u/ml
1.26
23
13
532
1354
4.10
185.45
5.4
3.5
1.32
1.65
%
1.52
480
1205
2774
16321
1.99
182.94
4.0
3.0
515.52
533.23
mosm/kgh2o
4.45
2512
14337
1379
6151
2.45
182.65
2.2
1.7
—
—
—
0
0
619
1775
3.66
182.03
1.4
1.3
262.36
263.44
u/ml
0.03
410
1097
753
2447
3.26
182.01
3.4
3.2
6.85
3.46
ratio
0.58
392
1436
5593
41390
1.86
179.58
4.6
3.2
204.62
118.14
ug/l
18.13
5341
38763
748
2464
3.21
176.63
2.5
2.3
0.06
0.04
g/l
0.25
690
2209
829
2900
3.04
176.61
2.4
2.3
10.50
10.19
g/l
1.04
767
2573
1890
9850
2.15
172.04
4.5
2.8
10.11
8.24
umol/l
2.49
1690
8576
718
2367
3.20
169.15
2.5
2.3
0.00
0.00
g/l
0.68
649
2069
686
2209
3.27
168.00
2.5
2.3
0.00
0.00
g/l
-0.00
649
2063
6290
48807
1.86
167.83
8.8
5.1
6.61
6.66
mmol/l
1.41
6086
46001
3058
19155
1.88
163.56
3.8
2.8
5.27
5.63
e6/l
0.89
2851
17431
4126
28460
1.80
160.32
4.8
3.4
2.34
2.35
mmol/l
9.58
3849
25923
436
1074
4.21
158.53
1.8
1.5
—
—
—
0
0
5265
39180
1.78
156.13
4.7
2.8
—
—
estimate
—
0
0
432
1120
3.99
146.42
1.9
1.6
—
—
—
0
0
853
3360
2.69
144.74
2.5
1.9
2.96
2.45
ug/l
0.28
775
2967
3177
20817
1.79
142.42
4.2
2.4
—
—
—
0
0
764
2877
2.80
141.34
1.4
1.4
—
—
—
0
0
3512
23755
1.76
140.71
2.0
1.7
19.18
20.05
nmol/l
3.14
3151
20324
717
2649
2.85
137.39
6.2
4.7
1.62
1.50
mg/l
2.64
679
2425
583
1921
3.17
136.85
1.7
1.4
—
—
—
0
0
829
3321
2.64
135.72
1.4
1.3
1.69
1.16
u/ml
0.27
42
276
289
581
5.10
135.02
1.4
1.5
12.52
12.59
umol/l
0.05
284
541
1218
5850
2.24
133.29
10.6
8.8
24.28
24.80
mmol/l
5.16
1207
5819
1551
8205
2.06
132.31
2.4
2.3
364.37
377.45
nmol/l
1.50
1462
7610
3508
24038
1.73
132.03
4.1
3.3
1758.71
1457.18
ng/l
3.53
3093
20727
6691
54664
1.77
130.76
6.3
4.8
362.43
1901.86
e6/l
5.12
113
747
3948
27993
1.70
130.76
4.8
3.3
36.86
34.31
u/l
0.98
3746
26446
6877
56699
1.78
129.36
6.6
4.6
1.55
2.32
0.54
13
79
510
1603
3.31
129.32
1.7
1.4
—
—
—
0
0
2255
13658
1.85
128.65
4.2
3.2
2.79
2.64
e6/l
0.29
1157
6694
254
477
5.44
128.10
1.4
1.1
1.12
1.06
ratio
3.91
224
382
1115
5260
2.27
127.08
7.2
4.5
24.03
24.13
mmol/l
0.49
1100
5202
7212
60521
1.81
125.01
6.6
4.4
14.53
11.85
mm/h
33.55
6893
56781
2550
16213
1.78
123.05
3.7
3.0
2.45
2.45
mmol/l
0.37
2333
14480
280
594
4.83
122.77
3.2
2.6
505.27
510.78
e6/l
0.05
201
471
2376
14898
1.79
119.65
3.9
3.1
0.99
1.12
e6/l
0.71
1289
7943
368
983
3.85
119.40
2.5
2.5
16.93
28.93
iu/ml
1.59
52
90
264
546
4.94
119.29
3.4
2.5
0.55
0.70
e9/l
4.14
251
523
1589
8787
1.97
118.52
6.9
4.2
5.75
5.82
kpa
1.82
1548
8559
1441
7713
2.02
117.88
10.5
7.8
1.44
1.32
mmol/l
2.62
1418
7545
527
1800
3.04
115.99
4.7
2.7
38.78
33.49
umol/l
3.82
490
1629
284
639
4.55
115.85
1.3
1.3
83.70
79.06
0.46
26
34
1547
8551
1.97
115.24
7.0
4.2
1.43
1.74
mmol/l
2.59
1367
7457
111
87
12.90
115.20
11.6
11.5
0.34
0.36
umol/l
0.14
104
81
275
612
4.60
113.72
3.4
2.7
201.58
223.45
e6/l
0.75
212
510
280
634
4.52
113.31
1.9
1.8
3.98
4.22
mg/l
0.29
267
607
209
367
5.80
113.25
1.4
1.1
34.64
13.71
u/ml
0.72
39
35
4783
36573
1.62
111.74
2.6
2.1
93.83
95.88
pmol/l
2.37
2947
19688
627
2405
2.72
111.30
2.0
1.7
—
—
—
0
0
3570
25454
1.65
110.21
2.8
2.2
229.82
209.92
u/l
0.30
3432
24094
1229
6366
2.07
109.44
5.8
4.0
106.15
89.16
ng/l
5.37
1099
5492
616
2369
2.71
108.74
1.4
1.3
7.45
4.25
u/ml
0.40
85
217
652
2589
2.63
107.97
1.6
1.3
—
—
—
0
0
3676
26522
1.63
107.47
3.4
2.7
56.52
62.70
u/l
1.30
3456
24647
274
640
4.38
106.56
1.7
1.6
—
—
—
0
0
187
318
5.98
104.76
5.1
3.4
1.41
1.28
%
0.37
187
318
1467
8225
1.93
103.84
5.3
3.4
—
—
—
0
0
606
2374
2.66
103.02
1.5
1.3
13.80
8.13
u/ml
0.84
115
347
490
1721
2.95
102.46
1.6
1.6
—
—
—
0
0
252
571
4.51
101.86
1.5
1.2
—
—
—
0
0
2193
13988
1.74
101.48
2.0
1.7
1182.98
1159.30
nmol/l
0.52
1756
10610
631
2550
2.58
100.66
1.4
1.3
46.66
37.67
u/ml
0.33
52
136
470
1629
2.98
100.62
1.7
1.4
—
—
—
0
0
400
1265
3.26
100.14
1.8
1.4
—
—
—
0
0
604
2404
2.62
99.38
1.3
1.3
93.77
130.85
titre
0.72
53
224
267
647
4.22
98.96
1.9
1.5
—
—
—
0
0
443
1507
3.03
97.99
1.4
1.3
217.74
360.34
titre
0.75
42
118
443
1514
3.02
97.19
1.4
1.3
105.45
187.43
titre
0.49
11
35
597
2391
2.60
96.94
1.3
1.2
677.14
901.59
titre
0.45
14
69
1623
9623
1.83
95.72
10.3
7.7
0.59
0.89
mmol/l
2.00
1364
7874
424
1427
3.06
95.53
1.5
1.3
85.31
30.72
u/l
4.46
390
1239
524
1983
2.74
95.22
1.4
1.3
2.76
3.53
u/ml
0.24
34
128
267
666
4.10
95.19
1.2
1.2
—
—
—
0
0
266
666
4.08
94.35
1.2
1.2
—
—
—
0
0
273
697
4.00
94.28
1.2
1.2
—
—
—
0
0
260
641
4.14
94.17
1.2
1.2
—
—
—
0
0
289
773
3.82
93.49
1.2
1.2
—
—
—
0
0
1625
9710
1.81
93.17
10.4
7.7
4.98
5.08
kpa
4.11
1571
9347
1623
9708
1.81
92.69
10.4
7.7
12.48
12.44
kpa
0.09
1566
9342
5508
44654
1.56
92.15
5.3
3.9
12.34
3.51
estimate
1.89
1449
9510
361
1129
3.28
91.99
7.0
6.5
11.65
11.84
mg/l
0.29
340
1046
5457
44174
1.56
91.70
5.3
3.9
0.00
0.00
estimate
2.33
1420
9324
258
647
4.07
91.31
1.2
1.2
—
—
—
0
0
682
2988
2.38
91.18
2.9
2.3
521.36
588.97
ug/l
0.24
650
2828
1411
8121
1.87
91.15
3.1
2.5
47.44
44.64
u/l
0.07
1222
6865
1310
7368
1.90
90.89
5.7
3.7
4.77
4.56
kpa
2.79
1270
7156
1004
5162
2.06
90.24
2.1
1.7
—
—
—
0
0
2374
15947
1.65
88.59
4.9
3.9
349.74
485.17
ng/l
0.80
1873
12254
5514
44959
1.54
87.88
5.3
4.0
0.01
0.16
estimate
0.70
1376
9000
494
1889
2.70
87.87
1.4
1.3
48.20
40.94
u/ml
0.44
72
180
4037
30770
1.54
87.65
5.1
3.8
40.66
77.48
ng/l
1.48
2977
20973
186
371
5.09
87.64
41.8
40.8
7.11
7.25
ug/l
0.40
173
335
152
252
6.11
87.38
1.3
1.1
12.71
4.78
u/ml
—
7
9
182
359
5.15
86.85
32.7
28.8
120.03
112.33
ug/l
0.73
155
292
65
31
21.10
86.60
1.2
1.1
—
—
—
0
0
302
880
3.51
86.03
5.2
3.4
54.82
57.76
%
1.32
261
753
528
2111
2.59
85.86
1.3
1.3
2.94
19.81
u/ml
—
7
21
4773
37905
1.52
84.53
3.2
2.5
75.95
76.63
nmol/l
0.95
4448
34542
209
474
4.49
84.38
1.9
1.4
—
—
—
0
0
298
874
3.49
84.04
2.6
1.7
—
—
—
0
0
222
532
4.25
83.49
1.9
1.4
—
—
—
0
0
1447
8625
1.80
82.74
10.9
8.1
95.53
95.60
%
0.14
1397
8337
210
497
4.30
80.28
1.9
1.4
—
—
—
0
0
1167
6566
1.89
80.20
8.1
3.8
1.22
1.23
mmol/l
7.36
1072
5672
863
4385
2.07
79.66
1.7
1.5
—
—
—
0
0
176
364
4.91
79.51
2.5
2.5
32.76
27.91
%
3.26
165
347
631
2837
2.31
79.23
2.9
2.6
—
—
—
0
0
535
2236
2.48
79.14
2.0
2.1
12.54
11.62
mg/l
0.95
501
2084
197
456
4.39
77.50
3.7
2.5
35.07
41.53
%
3.86
109
262
273
799
3.49
77.23
2.7
1.7
—
—
—
0
0
245
676
3.69
75.75
1.3
1.2
199.23
196.38
titre
0.02
39
116
245
676
3.69
75.75
1.3
1.2
414.29
161.43
titre
—
7
21
538
2314
2.40
74.66
3.7
3.2
2.92
2.15
index
1.09
297
1216
315
1032
3.12
74.23
1.3
1.2
—
—
—
0
0
1339
8037
1.78
74.11
11.7
8.5
115.81
121.28
g/l
17.04
1312
7860
1048
5856
1.89
73.18
5.8
4.1
5.06
5.14
kpa
2.37
1004
5605
930
5041
1.94
71.12
12.2
9.7
23.83
24.25
mmol/l
3.38
912
4933
722
3584
2.10
70.66
2.1
1.9
42.08
39.21
u/l
2.39
647
3192
390
1482
2.70
70.08
1.8
1.6
0.72
0.79
g/l
0.51
307
1155
368
1363
2.77
69.49
1.5
1.4
12.64
13.40
u/ml
—
7
28
920
5019
1.92
68.92
5.7
4.1
1.74
1.72
mmol/l
0.07
677
3689
423
1695
2.57
68.28
5.4
4.1
2.33
2.47
mmol/l
0.45
295
1129
423
1696
2.56
68.20
5.5
4.1
4.82
4.99
kpa
4.99
412
1665
304
1025
3.03
68.16
2.5
2.5
1.30
1.30
g/24h
0.01
182
613
424
1705
2.56
67.94
5.5
4.2
8.62
8.62
kpa
0.02
413
1673
308
1053
2.99
67.38
1.4
1.3
53.97
55.95
u/ml
0.04
23
62
1116
6555
1.80
65.96
3.7
2.7
67.45
67.63
ml/min/173m2
0.05
649
2738
1620
10662
1.63
62.65
4.1
3.1
5.81
4.53
e9/l
3.10
1448
9242
321
1170
2.80
62.46
1.3
1.2
16.00
12.67
u/ml
0.11
16
46
171
422
4.11
61.88
1.2
1.2
—
—
—
0
0
963
5511
1.83
61.81
13.3
9.8
93.91
93.99
%
0.14
956
5492
345
1315
2.68
61.58
1.2
1.2
0.57
1.05
—
5
46
312
1134
2.81
61.03
3.7
2.7
286.28
556.01
u/ml
0.38
307
1120
223
669
3.39
60.71
2.8
1.6
—
—
—
0
0
223
669
3.39
60.71
2.8
1.6
—
—
—
0
0
223
669
3.39
60.71
2.8
1.6
—
—
—
0
0
933
5333
1.83
60.04
13.6
9.9
0.65
0.64
%
0.24
922
5301
416
1761
2.42
59.66
3.6
2.6
15.56
16.49
%
6.84
404
1724
105
177
5.99
59.41
1.3
1.1
41.90
21.33
u/ml
—
10
6
526
2475
2.19
58.85
5.5
4.3
8.30
8.45
kpa
1.25
507
2422
952
5508
1.81
58.81
13.2
9.7
1.35
1.31
%
0.49
941
5476
146
332
4.45
58.80
1.1
1.2
986.05
950.00
titre
0.12
43
68
267
924
2.94
57.16
1.6
1.4
0.38
0.40
g/l
0.22
202
664
267
924
2.94
57.16
1.6
1.4
6.59
6.66
g/l
0.10
203
668
267
925
2.94
57.05
1.6
1.4
2.60
2.91
g/l
2.22
202
670
87
128
6.85
56.19
1.5
1.3
—
—
—
0
0
330
1289
2.62
56.08
2.5
1.9
1.82
1.68
mmol/l
1.48
316
1257
8558
79809
1.77
55.65
33.5
16.0
23.74
24.28
mg/l
0.90
7746
65989
396
1692
2.40
55.60
1.7
1.6
—
—
—
0
0
7428
67030
1.51
55.13
40.2
19.5
14.14
13.59
%
145.73
7377
66159
136
308
4.46
55.07
2.0
1.9
5168.29
14736.22
u/ml
0.40
21
41
395
1695
2.39
54.93
1.4
1.3
—
—
—
0
0
395
1695
2.39
54.93
1.4
1.3
—
—
—
0
0
150
371
4.09
54.15
5.0
4.2
118.00
64.52
mg/l
0.55
130
262
139
330
4.26
52.99
1.1
1.1
89.35
93.16
%
0.70
113
258
2700
20484
1.45
52.33
4.8
3.8
0.00
0.41
1.07
21
214
122
267
4.62
51.57
1.3
1.1
—
—
—
0
0
404
1800
2.30
51.52
4.1
3.0
89.63
89.91
%
0.33
389
1755
211
679
3.16
51.27
3.2
1.7
—
—
—
0
0
124
284
4.41
49.53
2.6
2.7
0.61
0.61
mmol/l
0.31
124
284
606
3215
1.95
48.82
1.6
1.6
19.44
15.65
u/ml
0.62
107
793
575
3004
1.97
48.44
4.4
3.1
24.26
24.74
mmol/l
2.00
560
2954
85
149
5.75
46.24
1.6
1.6
3885.00
6570.00
u/ml
—
10
14
217
757
2.91
45.83
3.4
3.0
—
—
—
0
0
203
683
3.02
45.73
1.1
1.1
—
—
—
0
0
117
275
4.29
45.24
1.4
1.4
—
—
—
0
0
2096
15532
1.45
44.82
1.4
1.3
33.30
31.49
iu/ml
0.17
628
4602
8535
80245
1.66
44.70
35.8
18.7
139.32
139.64
mmol/l
27.08
8435
78684
8544
80428
1.65
43.57
36.5
18.9
3.96
3.97
mmol/l
0.94
8434
78708
101
219
4.65
43.23
1.2
1.1
—
—
—
0
0
539
2863
1.94
43.18
4.5
3.4
424.63
412.60
mg/l
0.05
328
1301
142
398
3.61
43.00
3.4
1.8
—
—
—
0
0
142
398
3.61
43.00
3.4
1.8
—
—
—
0
0
142
398
3.61
43.00
3.4
1.8
—
—
—
0
0
142
398
3.61
43.00
3.4
1.8
—
—
—
0
0
802
4817
1.73
42.99
13.3
10.1
15.27
16.00
%
9.96
774
4653
3031
24116
1.38
42.65
3.8
3.0
0.10
0.06
0.38
59
557
2595
20127
1.40
42.58
1.4
1.3
2.01
1.79
u/ml
0.32
688
5486
856
5253
1.69
42.38
5.7
3.4
120.42
129.43
g/l
22.35
834
5111
3054
24412
1.37
41.46
5.6
4.1
0.00
0.00
estimate
4.09
1306
8587
50
56
8.97
40.65
2.3
4.5
—
—
—
0
0
6212
55417
1.35
39.96
4.6
3.3
59.52
45.95
u/l
21.21
5905
52227
996
6452
1.61
39.72
3.6
3.1
279.23
196.28
ng/l
5.82
908
5898
74
132
5.64
39.56
1.5
1.6
—
—
—
0
0
145
437
3.35
39.30
1.2
1.1
—
—
—
0
0
113
291
3.92
38.70
3.9
2.0
—
—
—
0
0
98
229
4.31
38.23
4.6
2.8
1.49
1.97
ratio
1.91
90
206
112
290
3.90
38.07
3.9
2.0
—
—
—
0
0
112
290
3.90
38.07
3.9
2.0
—
—
—
0
0
56
78
7.22
38.05
1.1
1.1
—
—
—
0
0
408
2069
2.02
37.31
3.0
2.3
123.41
130.05
g/l
5.22
323
1601
267
1154
2.35
36.54
1.2
1.1
1.54
1.51
g/l
0.35
255
1050
1569
11394
1.45
36.40
2.6
2.5
138.02
132.56
ug/g
0.25
1293
9118
56
83
6.78
35.97
1.2
1.6
—
—
—
0
0
131
393
3.37
35.80
1.1
1.1
8.29
3.73
iu/ml
—
7
22
509
2825
1.85
35.54
1.6
1.6
1.13
4.38
iu/ml
0.64
112
525
319
1520
2.14
34.48
1.6
1.4
59.80
63.52
mmol/l
0.80
249
1229
875
5693
1.59
34.03
1.5
1.3
249.65
237.66
u/ml
0.12
796
5288
91
220
4.17
33.99
1.8
1.9
15.23
44.16
u/l
1.72
83
201
461
2517
1.87
33.88
1.8
1.3
—
—
—
0
0
203
805
2.55
33.53
1.4
1.3
—
—
titre
—
0
0
8037
75440
1.44
33.10
29.9
15.5
80.93
82.21
ml/min/173m2
5.11
7633
69555
212
864
2.49
33.06
1.3
1.2
63.78
68.82
u/l
0.27
203
760
87
215
4.07
31.59
1.9
1.4
12.48
13.56
g/l
0.41
57
165
457
2553
1.83
31.22
1.5
1.4
285.23
272.24
ug/g
0.65
261
1478
92
240
3.86
31.01
2.8
1.6
3791.50
17418.55
e6/l
0.96
56
127
1873
14381
1.38
31.01
1.3
1.3
14.13
10.77
u/ml
0.54
622
5635
98
268
3.68
30.88
1.1
1.1
—
—
—
0
0
2923
23999
1.32
30.85
4.7
3.3
0.03
0.20
estimate
1.74
1172
7436
1182
8377
1.47
30.70
3.9
4.3
11.93
27.41
ug/l
2.07
936
6801
2192
17274
1.35
30.69
1.8
1.7
3933644.66
29664313.13
pmol/l
5.05
1856
14489
56
99
5.68
30.27
1.7
1.9
—
—
—
0
0
3904
33394
1.29
30.00
5.3
3.9
0.01
0.20
estimate
1.38
1223
7727
3373
28340
1.30
29.68
4.6
3.5
7.14
7.63
mmol/l
8.78
2930
24064
67
142
4.74
29.57
6.5
6.7
3530.43
3534.50
iu/ml
—
7
14
587
3592
1.68
29.10
1.9
1.6
0.34
0.30
mg/l
0.68
273
1633
360
1907
1.92
29.03
2.1
1.5
36.60
24.73
e6/l
0.26
278
1393
99
286
3.49
28.77
2.9
1.8
1067.77
3499.80
e6/l
0.42
77
195
363
1934
1.91
28.77
2.1
1.6
837.21
3374.68
e6/l
0.67
294
1508
5829
52576
1.28
28.73
3.6
3.2
—
—
—
0
0
3155
26376
1.29
28.54
5.4
4.2
15.00
9.71
mg/mmol
4.56
2171
16681
201
858
2.37
28.37
1.2
1.2
61.36
41.13
u/ml
0.55
14
50
1365
10078
1.41
28.25
1.9
1.8
1.58
1.45
%
6.07
1162
8882
249
1166
2.17
28.18
1.5
1.5
31.08
32.38
g/l
0.87
225
1059
153
576
2.68
28.13
1.1
1.1
—
0.62
—
0
5
217
966
2.28
27.80
1.1
1.1
—
—
—
0
0
165
658
2.53
27.01
1.1
1.0
290.40
288.31
mg/l
0.11
152
601
157
612
2.59
26.94
1.6
1.5
16.15
12.79
u/l
3.16
152
589
52
96
5.44
26.87
1.1
1.1
368.60
306.46
u/ml
—
10
26
971
6790
1.48
26.80
2.6
2.3
8.72
7.25
ug/l
1.09
847
5934
532
3247
1.68
26.61
6.9
4.5
24.75
24.71
mmol/l
0.11
499
2992
396
2244
1.80
25.81
1.3
1.2
—
—
—
0
0
3081
25928
1.28
25.78
4.5
3.5
92.34
50.15
mg/l
6.18
2194
16780
394
2234
1.80
25.63
1.3
1.2
—
—
—
0
0
190
831
2.31
25.41
1.6
1.5
—
—
—
0
0
979
6927
1.46
25.38
3.6
2.5
0.46
0.44
e6/l
0.09
945
6629
184
799
2.33
25.03
4.0
3.3
12.05
13.64
index
1.21
133
474
68
167
4.09
24.97
1.6
1.3
—
—
—
0
0
6837
63380
1.28
24.72
5.0
4.4
14.76
14.71
pmol/l
0.87
6401
58466
640
4167
1.57
24.60
5.5
4.1
50.44
47.37
%
2.41
632
4098
386
2208
1.78
24.38
1.9
1.4
542.48
526.01
mg/l
0.20
370
2108
750
5077
1.52
24.17
9.8
6.8
24.54
24.48
mmol/l
0.15
718
4872
140
549
2.57
23.78
1.9
1.3
—
—
—
0
0
482
2959
1.66
23.57
3.7
3.6
508.72
2283.30
u/ml
1.12
412
2548
180
797
2.28
23.42
1.3
1.3
380.80
342.35
u/l
0.37
169
759
208
978
2.15
23.37
6.8
13.0
7.48
7.30
mmol/l
0.10
179
822
137
537
2.57
23.30
1.9
1.3
—
—
—
0
0
128
487
2.65
23.12
1.7
1.5
6.37
6.52
u/l
0.04
102
391
346
1948
1.81
23.06
1.9
1.4
3.76
3.74
mmol/l
0.17
321
1838
68
178
3.84
22.91
1.3
1.3
—
—
—
0
0
40
67
5.99
22.89
1.6
1.5
2.26
2.00
mg/l
0.10
27
49
40
67
5.99
22.89
1.6
1.5
1.14
1.08
mg/l
0.04
26
44
40
67
5.99
22.89
1.6
1.5
2.54
2.21
mg/l
0.12
29
46
40
67
5.99
22.89
1.6
1.5
3.58
2.32
mg/l
0.62
30
42
40
67
5.99
22.89
1.6
1.5
1.68
2.38
mg/l
0.36
30
46
40
67
5.99
22.89
1.6
1.5
2.15
1.46
mg/l
0.31
25
38
40
67
5.99
22.89
1.6
1.5
4.53
3.98
mg/l
0.14
25
41
40
67
5.99
22.89
1.6
1.5
2.29
1.44
mg/l
0.32
23
42
40
67
5.99
22.89
1.6
1.5
2.95
1.74
mg/l
0.44
27
46
107
375
2.87
22.61
2.0
1.4
—
—
—
0
0
107
375
2.87
22.61
2.0
1.4
—
—
—
0
0
297
1606
1.88
22.54
3.1
3.2
0.78
0.82
nmol/l
0.97
222
1276
52
114
4.58
22.11
10.0
12.4
7.01
5.58
mmol/l
0.78
52
114
107
381
2.83
21.97
3.9
6.0
1655.17
9544.93
u/ml
—
6
67
40
70
5.73
21.90
1.6
1.5
2.83
1.54
mg/l
0.62
25
46
115
427
2.71
21.82
1.7
1.6
251430.00
1281918.48
iu/ml
—
5
23
519
3314
1.60
21.66
3.1
2.0
—
—
—
0
0
60
150
4.02
21.56
1.3
1.2
113.60
91.33
titre
—
10
21
128
505
2.56
21.52
1.3
1.2
121.15
93.13
u/l
1.08
123
426
67
182
3.70
21.43
1.4
1.3
18.88
26.75
g/l
3.62
50
143
431
2637
1.66
21.35
5.7
3.9
1.40
1.39
mmol/l
0.04
417
2596
111
414
2.70
20.90
2.4
2.1
2.02
1.86
umol/l
0.80
104
382
200
978
2.07
20.33
1.3
1.1
—
—
—
0
0
639
4346
1.50
20.07
1.2
1.1
1.82
2.54
u/ml
—
6
46
122
492
2.50
19.63
1.3
1.2
26.46
26.57
u/l
0.01
117
408
76
238
3.21
19.57
1.8
1.3
16.02
17.04
umol/l
0.99
70
202
40
78
5.14
19.52
1.4
1.2
1.46
1.45
iu/ml
0.01
25
37
205
1029
2.01
19.42
1.4
1.5
3325.33
3174.40
e6/l
0.03
158
719
176
838
2.12
19.22
1.4
1.4
6.16
6.33
mmol/l
0.30
165
782
561
3764
1.52
18.79
5.6
3.4
24.86
25.23
mmol/l
1.87
543
3633
455
2926
1.58
18.43
1.3
1.3
206.56
228.90
miu/ml
0.61
171
1346
7814
74418
1.29
18.42
6.2
5.4
1.91
1.89
mu/l
0.65
7396
69276
28
41
6.85
18.22
1.4
1.2
—
—
—
0
0
141
630
2.26
18.06
1.3
1.2
40.77
52.40
u/ml
0.20
11
42
183
910
2.03
17.83
1.4
1.4
101550.26
63863.85
e6/l
0.38
114
512
25
33
7.59
17.80
4.6
5.3
—
—
—
0
0
207
1077
1.94
17.74
2.4
1.4
—
—
—
0
0
480
3155
1.55
17.67
1.8
1.7
—
—
—
0
0
155
727
2.15
17.63
1.3
1.2
67.18
69.52
u/ml
0.04
11
25
129
563
2.31
17.48
1.4
1.5
—
—
—
0
0
48
120
4.01
17.31
2.7
3.2
44.99
24.67
mg/l
—
10
29
330
1995
1.68
17.16
1.3
1.3
—
—
—
0
0
199
1034
1.94
17.13
2.5
1.4
—
—
—
0
0
355
2191
1.64
17.04
1.5
1.4
—
—
—
0
0
34
65
5.25
16.98
1.4
1.2
0.50
0.48
iu/ml
0.04
16
34
24
32
7.52
16.94
1.1
1.1
—
—
—
0
0
8676
84036
1.39
16.93
39.4
20.5
83.46
77.22
umol/l
26.02
8608
83041
205
1082
1.91
16.85
2.5
1.4
—
—
—
0
0
1060
8125
1.34
16.83
2.5
2.1
0.02
0.01
estimate
0.18
233
1690
333
2029
1.66
16.81
1.7
1.6
17833.55
13136.82
e6/l
0.93
231
1413
199
1041
1.93
16.80
2.5
1.4
—
—
—
0
0
199
1043
1.93
16.71
2.5
1.4
—
—
—
0
0
207
1101
1.90
16.63
2.4
1.4
—
—
—
0
0
27
18
15.03
16.61
1.1
1.1
—
—
—
0
0
8618
83428
1.37
16.46
21.6
11.9
27.06
26.03
u/l
2.73
8475
81104
748
5441
1.41
16.44
3.4
3.5
4.39
4.51
pmol/l
2.07
679
4892
1971
16462
1.25
16.05
1.7
1.6
—
—
—
0
0
32
61
5.26
16.04
3.0
1.7
67.67
57.63
%
0.54
18
41
146
697
2.11
15.92
1.5
1.3
2.32
2.04
mmol/l
0.88
130
652
43
106
4.07
15.82
5.8
5.9
69.44
46.89
ug/min
0.78
36
77
287
1712
1.70
15.72
3.3
3.6
474.09
820.38
u/ml
0.49
248
1566
178
925
1.94
15.37
1.5
1.4
281.38
279.19
mosm/kgh2o
0.60
141
695
250
1450
1.74
15.17
1.9
1.9
4.82
4.89
mmol/24h
0.12
225
1291
454
3059
1.51
14.92
2.4
1.8
—
—
—
0
0
82
321
2.57
14.17
1.7
1.7
2980.00
3041.60
titre
0.03
16
50
30
62
4.85
13.76
1.2
1.4
—
—
—
0
0
154
794
1.95
13.66
3.4
3.8
—
—
—
0
0
141
707
2.01
13.54
1.6
1.6
26.13
30.71
%
0.82
91
433
173
931
1.87
13.50
1.6
1.6
61.56
57.74
%
0.65
113
595
588
4253
1.41
13.34
1.2
1.1
115.77
171.51
titre
0.50
13
136
338
2194
1.56
13.22
6.5
4.1
3.89
3.89
mmol/l
0.00
331
2176
815
6236
1.34
13.00
1.6
1.4
—
—
—
0
0
572
4137
1.41
12.99
2.7
2.1
0.03
0.21
estimate
0.46
194
1312
102
460
2.23
12.92
1.3
1.1
96.13
82.60
u/l
0.88
97
412
349
2297
1.54
12.84
1.2
1.2
3.59
4.06
0.35
35
309
113
535
2.13
12.68
2.0
1.6
14.11
22.23
umol/l
4.29
106
492
125
620
2.03
12.41
1.3
1.3
14.28
12.51
u/l
0.56
117
573
100
456
2.21
12.35
1.3
1.1
32.18
24.20
u/l
0.48
92
409
117
572
2.06
12.09
1.8
1.2
34.55
35.04
mmol/l
0.07
105
506
559
4084
1.39
11.97
1.4
1.4
—
—
—
0
0
23
23
10.02
11.95
1.0
1.1
—
—
—
0
0
26
54
4.82
11.87
3.2
1.6
9.58
19.97
%
0.94
12
31
73
297
2.47
11.71
1.6
1.4
60.93
66.34
%
0.66
61
243
29
67
4.34
11.66
1.7
2.0
178.00
157.70
ug/g
0.34
24
60
526
3823
1.40
11.62
2.4
2.3
4151.31
6108.14
u/l
1.04
202
1507
53
184
2.89
11.60
1.2
1.1
—
—
—
0
0
31
76
4.09
11.56
1.5
3.3
1.74
1.55
mg/l
0.09
18
56
108
522
2.08
11.53
1.8
1.5
5.29
6.02
u/l
0.80
90
448
91
413
2.21
11.40
1.6
1.3
59.61
65.28
%
0.27
18
47
22
41
5.38
11.33
4.0
5.7
30712.50
1132076.11
u/ml
—
8
9
22
41
5.38
11.33
3.9
5.2
—
—
—
0
0
762
5894
1.32
11.25
2.5
2.4
20.08
20.57
au/ml
0.04
58
671
99
472
2.11
10.98
1.1
1.1
—
—
—
0
0
708
5448
1.32
10.84
1.4
1.3
58.88
52.79
au/ml
0.23
31
351
26
61
4.27
10.28
1.1
1.3
1.49
1.11
ml/s/173m2
0.70
17
44
395
2791
1.43
10.27
1.5
1.4
11.05
9.78
u/l
0.92
309
2233
15
8
18.77
10.24
1.4
1.3
—
—
—
0
0
101
504
2.01
9.96
2.3
1.7
—
—
—
0
0
556
4196
1.35
9.74
5.5
3.4
62.66
61.25
u/ml
0.04
539
4045
146
831
1.77
9.63
1.1
1.1
—
—
—
0
0
98
495
1.99
9.37
1.1
1.1
1558.73
1497.39
miu/ml
0.22
98
495
34
104
3.28
9.27
1.3
1.3
—
—
—
0
0
63
268
2.36
9.26
1.4
1.2
31.67
21.97
%
0.52
18
32
40
136
2.95
9.15
1.3
1.7
584382.14
169033.16
nmol/l
0.31
32
113
117
633
1.86
9.13
1.8
1.5
29.08
24.83
u/ml
0.34
24
116
38
126
3.02
9.08
1.7
1.4
12.19
8.92
%
0.30
26
66
546
4164
1.33
8.93
4.1
3.4
1.02
1.02
ratio
1.03
503
3740
109
583
1.88
8.83
2.4
2.3
801.22
632.86
ml
2.60
77
389
32
98
3.27
8.72
1.1
1.0
—
—
—
0
0
203
1298
1.58
8.63
2.4
2.3
7.19
7.05
umol/l
0.06
159
955
196
1244
1.59
8.60
1.3
1.4
—
—
—
0
0
108
590
1.84
8.22
1.3
1.2
—
—
—
0
0
753
6063
1.26
8.14
1.3
1.2
153.22
138.36
u/ml
0.41
270
2285
18
24
7.51
8.14
3.1
4.0
—
—
—
0
0
67
310
2.17
8.13
1.3
1.3
—
—
—
0
0
153
928
1.66
8.09
1.2
1.1
1.10
2.31
iu/ml
—
6
12
2211
19708
1.16
8.06
5.2
4.1
1.02
1.17
kg/l
0.81
1615
13160
77
378
2.05
8.03
1.4
1.6
4.21
4.01
%
0.05
19
85
32
104
3.08
7.95
1.8
1.8
—
—
—
0
0
106
584
1.82
7.87
1.3
1.2
—
—
—
0
0
67
316
2.13
7.77
2.2
1.8
39.26
40.06
g/l
0.46
67
316
131
773
1.70
7.70
1.4
1.4
—
—
—
0
0
489
3764
1.32
7.53
6.9
4.9
1.69
1.61
%
0.93
455
3561
66
314
2.11
7.50
1.0
1.1
—
—
—
0
0
454
3466
1.33
7.42
7.3
5.2
0.87
0.87
%
0.06
424
3279
113
650
1.75
7.30
1.5
1.3
1.78
2.56
u/ml
0.41
70
367
224
1521
1.48
7.29
1.2
1.1
11.06
15.94
au/ml
0.63
37
372
102
574
1.79
7.11
3.1
3.3
19.70
26.38
mu/l
1.54
95
542
71
355
2.01
7.09
2.5
2.5
46.95
53.20
umol/l
0.79
57
317
186
1223
1.53
7.07
1.1
1.1
1.46
2.84
1.47
22
206
18
30
6.01
7.05
1.0
1.1
—
—
—
0
0
98
548
1.80
6.99
1.3
1.2
0.63
0.61
ratio
0.08
58
323
44
182
2.42
6.97
7.0
6.8
61.74
70.77
%
1.07
34
140
37
141
2.63
6.94
1.6
1.6
112.75
119.71
ug/l
0.16
28
123
52
233
2.24
6.89
1.1
1.1
—
—
—
0
0
51
227
2.25
6.86
1.5
1.6
10.56
8.91
ug/l
1.15
51
227
53
240
2.21
6.85
1.3
1.3
3.96
3.42
mmol/l
0.44
47
219
114
671
1.71
6.82
3.0
2.6
25.92
28.51
mg/l
0.36
87
483
47
204
2.31
6.71
1.8
1.6
0.38
0.36
ug/l
0.10
39
137
157
1008
1.57
6.66
1.3
1.3
0.31
0.18
nmol/l
0.56
121
799
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
80
427
1.88
6.64
1.1
1.1
—
—
—
0
0
38
151
2.52
6.57
1.6
1.2
822.33
83.06
mg/l
2.65
32
107
27
90
3.01
6.48
1.0
1.2
34.46
20.99
u/l
0.67
13
60
58
279
2.09
6.46
1.2
1.1
—
—
—
0
0
161
1049
1.54
6.42
2.1
2.1
21.24
25.01
ug/l
0.62
155
1031
18
47
3.83
6.25
1.1
1.3
160.33
1684.63
u/l
0.51
18
41
118
720
1.65
6.20
1.2
1.2
110.32
107.23
pmol/l
0.26
118
720
176
1180
1.50
6.16
5.8
5.2
387.65
359.06
umol/l
1.79
157
1027
200
2860
0.69
6.15
1.1
1.1
0.62
0.63
ratio
0.08
25
342
83
463
1.80
6.03
2.1
2.0
8.13
7.94
mmol/l
0.17
83
463
38
158
2.41
6.00
1.1
1.1
—
—
—
0
0
119
737
1.62
5.92
1.2
1.1
45.86
40.71
mg/l
0.55
98
622
52
249
2.09
5.90
1.1
1.3
92.19
129.52
nmol/l
1.34
35
185
16
40
4.00
5.88
9.4
5.7
99.81
103.57
g/l
0.44
16
40
40
172
2.33
5.88
3.4
2.6
277.82
244.46
ug/l
0.04
40
172
28
101
2.78
5.87
1.2
1.1
—
—
—
0
0
93
544
1.72
5.76
1.5
1.3
95.00
60.50
titre
—
8
40
148
972
1.53
5.74
3.2
2.2
0.12
0.54
mmol/l
0.58
142
931
114
712
1.61
5.51
1.1
1.1
257.31
258.83
mg/l
0.02
97
629
176
1209
1.46
5.51
1.3
1.3
0.26
0.25
nmol/l
0.05
11
71
85
495
1.72
5.38
1.1
1.1
1.09
1.15
u/l
0.43
32
200
18
53
3.40
5.29
1.1
1.1
—
—
—
0
0
764
8995
0.84
5.26
1.9
1.9
3.47
3.46
ratio
0.07
569
6808
73
410
1.79
5.24
1.4
1.3
237.33
329.40
u/l
0.95
66
377
28
108
2.60
5.20
1.0
1.0
—
—
—
0
0
93
563
1.66
5.12
1.5
1.3
287.50
418.04
titre
—
8
46
226
1651
1.38
5.05
3.0
1.9
1.02
0.85
nmol/l
2.56
193
1411
69
386
1.79
5.03
1.7
1.7
1.43
3.20
u/field
1.62
58
272
72
408
1.77
5.03
4.1
4.1
—
—
—
0
0
425
3400
1.26
4.96
1.6
1.7
307.14
298.68
mu/l
0.20
385
3085
105
662
1.59
4.93
1.1
1.1
—
—
—
0
0
63
348
1.82
4.81
1.2
1.1
1556.30
321.78
ng/l
0.71
27
88
294
2255
1.31
4.78
1.1
1.1
2.84
7.77
eliau/ml
2.53
30
281
8780
86574
1.20
4.78
49.8
24.3
6.82
6.79
e9/l
0.44
8653
84615
8778
86558
1.20
4.74
49.6
24.2
91.44
90.92
fl
17.80
8721
85688
7559
73771
1.12
4.74
7.1
6.2
39.04
39.03
mmol/mol
0.03
7109
69292
8778
86560
1.20
4.73
50.9
24.7
38.91
40.80
%
26.26
8720
85649
8778
86563
1.20
4.71
49.7
24.2
4.32
4.48
e12/l
130.14
8648
84642
8779
86580
1.20
4.67
50.2
24.4
129.28
134.84
g/l
185.88
8724
85729
8775
86539
1.19
4.66
49.9
24.3
217.94
252.55
e9/l
251.04
8655
84859
224
1675
1.35
4.38
9.7
7.0
11.57
11.32
mmol/l
0.46
194
1503
224
1676
1.34
4.36
9.7
7.0
104.63
105.08
mmol/l
0.62
194
1505
42
210
2.00
4.34
7.6
6.7
5.81
5.96
kpa
0.41
36
188
129
879
1.47
4.30
3.7
2.3
1.20
1.20
mmol/l
0.12
129
868
576
4837
1.20
4.28
1.5
1.4
24.47
25.05
iu/l
0.17
476
4097
131
902
1.46
4.16
3.7
2.3
4.12
4.06
mmol/l
0.88
131
891
131
902
1.46
4.16
3.7
2.3
105.73
105.55
mmol/l
0.18
131
891
9
13
6.93
4.16
1.0
1.0
—
—
—
0
0
51
278
1.84
4.11
1.5
1.2
—
—
—
0
0
70
421
1.67
4.04
2.4
2.5
41.78
38.54
umol/l
0.06
11
43
104
689
1.51
4.00
1.8
1.5
1.11
1.21
promille
0.31
88
547
81
514
1.58
3.80
2.8
1.9
134.44
110.31
ng/l
0.47
81
514
113
771
1.47
3.79
2.5
2.6
18.87
19.61
nmol/l
0.35
105
735
70
429
1.64
3.78
1.6
1.4
—
—
—
0
0
7499
73394
1.10
3.72
4.7
4.2
1.32
1.27
mmol/l
6.27
6980
67905
20
78
2.57
3.70
1.1
1.1
108.80
84.92
titre
0.73
20
78
7691
75378
1.11
3.68
5.6
5.0
5.94
5.90
mmol/l
1.59
7131
69614
295
2349
1.26
3.68
1.9
2.0
6.92
6.15
iu/l
0.07
113
996
15
50
3.00
3.68
1.0
1.1
—
—
—
0
0
57
335
1.71
3.62
1.0
1.1
—
—
—
0
0
45
247
1.83
3.60
1.3
1.3
150.18
375.11
ug/l
0.54
27
123
14
40
3.50
3.59
5.8
8.2
—
—
—
0
0
46
255
1.81
3.57
3.3
2.9
26.16
28.22
umol/l
0.60
31
191
256
2014
1.28
3.54
4.5
3.1
1.52
1.59
mmol/l
0.72
251
1953
579
6734
0.85
3.50
1.7
1.6
3.35
3.45
mmol/l
1.32
386
4580
71
448
1.59
3.44
2.4
1.7
6.29
6.28
nmol/l
0.00
64
358
35
180
1.95
3.42
1.2
1.2
—
—
—
0
0
36
187
1.93
3.41
7.9
6.9
5.89
5.43
kpa
0.45
36
187
12
32
3.75
3.38
1.2
1.1
—
—
—
0
0
161
1199
1.35
3.33
1.1
1.1
4.49
3.60
eliau/ml
0.17
53
557
74
476
1.56
3.32
2.1
1.6
104.17
410.18
pmol/l
0.73
14
69
63
390
1.62
3.32
1.2
1.3
152.24
162.19
mmol/24h
0.34
63
390
117
829
1.42
3.27
1.3
1.3
1.50
1.51
nmol/l
0.01
107
743
6
7
8.57
3.26
1.2
1.1
3.17
1.00
%
—
6
7
134
973
1.38
3.26
3.8
3.4
6.35
11.32
nmol/l
0.39
129
942
9
19
4.74
3.23
4.2
8.8
—
—
—
0
0
56
341
1.65
3.16
1.2
1.2
—
—
—
0
0
15
55
2.73
3.14
1.6
2.3
—
—
—
0
0
227
1795
1.27
3.06
2.8
2.4
170.51
94.70
ug/min
1.54
143
1071
9
21
4.29
2.99
1.0
1.0
—
—
—
0
0
230
1829
1.26
2.98
1.5
1.5
134.97
148.17
pmol/l
0.26
224
1779
156
1184
1.32
2.89
1.5
1.5
—
—
—
0
0
150
1137
1.32
2.82
1.4
1.3
390.41
346.61
pmol/l
0.22
131
956
34
186
1.83
2.81
1.4
1.9
0.17
0.21
nmol/l
0.27
22
136
27
138
1.96
2.74
1.1
1.3
1.70
1.69
mmol/l
0.00
19
95
62
403
1.54
2.72
1.7
2.3
66.47
142.90
umol/l
3.59
30
214
21
98
2.15
2.70
1.0
1.0
—
—
—
0
0
8
19
4.21
2.67
1.0
1.0
—
—
—
0
0
8
19
4.21
2.67
1.0
1.0
—
—
—
0
0
24
119
2.02
2.65
1.7
1.4
30.81
812.78
ng/l
0.56
19
75
105
763
1.38
2.62
1.4
1.4
9.24
8.49
mmol/l
0.83
100
730
530
4628
1.15
2.58
1.6
1.6
909.57
1015.49
mu/l
2.00
431
3908
34
192
1.77
2.57
1.3
1.1
—
—
—
0
0
9
25
3.60
2.57
1.2
1.2
—
—
—
0
0
5
7
7.14
2.55
1.0
1.0
—
—
—
0
0
61
402
1.52
2.54
2.9
2.3
—
—
—
0
0
44
269
1.64
2.51
1.2
1.3
—
—
—
0
0
44
269
1.64
2.51
5.4
6.5
24.94
24.77
mmol/l
0.08
38
246
15
63
2.38
2.45
2.3
5.6
—
—
—
0
0
13
51
2.55
2.44
1.1
1.0
—
—
—
0
0
194
1555
1.25
2.42
1.8
1.5
0.45
0.40
nmol/l
0.18
151
1206
6
12
5.00
2.40
1.2
1.0
1.17
1.25
u/field
—
6
12
171
1352
1.27
2.39
1.6
1.4
3.38
3.84
ug/l
0.47
155
1213
32
182
1.76
2.38
1.4
1.4
22.38
24.06
%
0.12
26
148
49
313
1.57
2.37
2.1
1.4
91.55
289.85
nmol/24h
1.30
49
313
24
125
1.92
2.34
1.1
1.1
—
—
—
0
0
101
748
1.35
2.28
1.4
1.4
211003.67
97355.70
e6/l
0.57
79
494
10
34
2.94
2.27
1.1
1.1
223.28
264.44
nmol/l
—
10
34
16
72
2.22
2.27
1.0
1.2
1.52
1.69
umol/24h
0.51
16
72
31
178
1.74
2.25
1.1
1.2
336.42
282.44
pmol/l
0.43
26
126
25
135
1.85
2.21
2.6
2.0
—
—
—
0
0
6884
67569
1.07
2.20
40.6
20.3
331.18
332.33
g/l
20.12
6848
67172
86
625
1.38
2.20
2.2
2.0
1.66
1.55
u/field
0.10
56
335
19
94
2.02
2.15
1.2
1.1
—
—
—
0
0
11
43
2.56
2.07
1.4
2.0
1.28
0.73
umol/l
—
6
31
48
316
1.52
2.07
1.3
1.2
0.31
0.30
g/l
0.48
36
252
9
32
2.81
1.99
1.0
1.1
—
—
—
0
0
36
224
1.61
1.98
1.3
1.3
10.89
13.55
pmol/l
0.36
16
86
37
233
1.59
1.95
1.2
1.1
—
—
—
0
0
41
265
1.55
1.94
4.1
4.0
5.09
4.86
kpa
0.58
41
265
41
266
1.54
1.91
4.1
4.0
9.75
10.28
kpa
0.37
41
266
44
291
1.51
1.88
1.9
2.3
7.90
9.43
mg/l
1.40
37
251
6
17
3.53
1.83
1.0
1.0
—
—
—
0
0
32
198
1.62
1.82
1.1
1.1
—
—
—
0
0
64
460
1.39
1.80
1.4
1.5
1.30
1.29
nmol/l
0.04
54
338
12
53
2.27
1.80
8.3
5.1
—
—
—
0
0
8
29
2.76
1.79
5.6
5.8
331.38
428.24
umol/l
—
8
29
8
29
2.76
1.79
9.0
8.3
—
—
—
0
0
19
102
1.86
1.75
1.1
1.2
—
—
—
0
0
255
2188
1.17
1.68
1.6
1.6
—
—
—
0
0
83
1080
0.77
1.65
3.9
2.7
13.28
13.15
%
0.37
83
1068
7
25
2.80
1.65
5.0
4.4
4.16
4.33
mg/l
—
7
16
33
212
1.56
1.64
1.4
1.8
164.00
118.73
au/ml
—
6
27
73
546
1.34
1.64
1.4
1.3
5.43
5.01
umol/l
0.35
67
495
43
293
1.47
1.64
1.3
1.3
110.49
109.25
%
0.11
37
257
2610
25072
1.06
1.62
5.2
5.6
2.87
3.14
ug/l
0.36
2330
22698
19
105
1.81
1.62
1.1
1.0
0.01
0.51
u/ml
—
9
59
38
253
1.50
1.62
1.1
1.2
0.50
18.72
u/ml
0.83
28
150
5
14
3.57
1.61
1.2
1.1
2.82
1.16
mg/l
—
5
14
300
2616
1.15
1.61
1.5
1.5
61.22
60.96
ug/l
0.02
242
2186
24
143
1.68
1.60
2.6
1.9
—
—
—
0
0
233
1996
1.17
1.58
1.9
1.8
—
—
—
0
0
344
3033
1.14
1.58
1.5
1.4
—
—
—
0
0
33
215
1.54
1.56
1.2
1.1
—
—
—
0
0
17
92
1.85
1.55
1.1
1.1
—
—
—
0
0
82
633
1.30
1.50
1.1
1.1
16.68
17.72
u/ml
0.15
28
260
11
51
2.16
1.50
1.1
1.1
—
—
—
0
0
38
259
1.47
1.47
1.1
1.0
0.40
0.98
u/ml
0.76
38
254
87
680
1.28
1.46
1.1
1.1
10.77
8.93
iu/ml
0.29
25
176
46
326
1.41
1.46
3.1
4.1
9.85
8.91
mg/l
0.35
32
265
744
6879
1.09
1.43
2.4
2.3
12.01
12.67
nmol/l
1.31
658
6176
54
396
1.37
1.41
1.1
1.2
11.22
9.98
mm/h
0.30
54
396
1145
10772
1.07
1.41
2.4
2.2
—
—
—
0
0
23
141
1.63
1.41
1.9
2.4
1.14
1.50
mmol/l
0.41
14
98
46
330
1.40
1.38
2.2
2.9
1.36
1.17
ug/l
0.22
46
313
42
298
1.41
1.34
2.2
3.1
147.88
143.79
au/ml
—
8
47
68
522
1.30
1.33
1.8
1.5
88.18
81.05
umol/l
0.88
68
522
160
1354
1.18
1.31
1.1
1.1
110.64
8751.90
iu/ml
0.63
36
308
153
1290
1.19
1.31
1.2
1.3
—
—
—
0
0
17
98
1.74
1.30
1.1
1.1
—
—
—
0
0
26
169
1.54
1.28
1.1
1.2
1.51
1.58
mmol/l
0.12
18
110
11
55
2.00
1.27
1.2
1.2
—
—
—
0
0
9
44
2.05
1.26
1.0
1.0
—
—
—
0
0
7831
77542
1.06
1.26
5.5
5.0
4.40
4.60
mmol/l
58.08
7356
72834
34
236
1.44
1.24
1.3
1.1
—
—
—
0
0
14
78
1.80
1.20
2.4
2.5
0.36
0.56
u/field
0.65
14
78
321
2877
1.12
1.20
1.5
1.5
—
—
—
0
0
33
230
1.44
1.19
1.2
1.1
—
—
—
0
0
5
20
2.50
1.15
2.2
6.4
—
—
—
0
0
120
1004
1.20
1.15
3.1
2.0
24.95
24.39
mg/l
0.04
40
357
18
110
1.64
1.15
1.2
1.1
—
—
—
0
0
123
1032
1.19
1.14
1.2
1.3
—
—
—
0
0
29
199
1.46
1.14
1.3
1.3
33.40
37.13
%
0.24
20
133
1042
9857
1.06
1.12
2.3
2.1
—
—
—
0
0
157
1348
1.17
1.12
1.5
1.4
22.05
25.05
u/l
0.57
129
1119
11
58
1.90
1.12
1.0
1.1
—
—
—
0
0
712
6651
1.08
1.11
2.2
2.1
—
—
—
0
0
23
151
1.52
1.11
1.1
1.1
0.69
0.67
umol/24h
0.07
16
72
67
530
1.27
1.09
2.4
2.7
—
—
—
0
0
12
66
1.82
1.08
2.0
2.4
0.71
0.63
ug/l
0.23
12
66
503
4654
1.09
1.02
1.1
1.1
—
—
—
0
0
14
83
1.69
1.01
1.0
1.1
—
—
—
0
0
10
53
1.89
1.01
1.0
1.1
—
—
—
0
0
273
2457
1.11
0.99
1.5
1.5
1.15
1.15
ratio
0.01
167
1488
9
49
1.84
0.98
5.6
3.3
—
—
—
0
0
29
206
1.41
0.98
3.5
3.0
130.34
122.62
ng/l
0.08
20
117
269
2422
1.11
0.98
1.5
1.5
—
—
—
0
0
273
2464
1.11
0.95
1.5
1.5
1.23
1.21
ratio
0.08
168
1506
273
2464
1.11
0.95
1.5
1.5
0.97
0.95
ratio
0.26
167
1496
6
27
2.22
0.93
1.2
1.1
194.00
251.68
pmol/l
—
6
22
191
1695
1.13
0.91
1.5
1.5
56.72
60.13
ug/l
0.61
191
1695
7771
77091
1.04
0.89
5.4
4.9
1.39
1.45
mmol/l
35.77
7248
71989
243
2684
0.90
0.85
1.5
1.5
—
—
—
0
0
18
120
1.50
0.85
1.0
1.1
—
—
—
0
0
11
65
1.69
0.82
1.1
1.1
5.73
13.69
u/l
1.06
11
65
74
616
1.20
0.82
1.2
1.2
—
—
—
0
0
7921
78651
1.04
0.81
6.1
5.6
2.54
2.69
mmol/l
45.46
7420
73582
21
147
1.43
0.79
2.1
1.6
—
—
—
0
0
0
24
0.00
0.79
0.0
1.0
—
0.22
—
0
8
1955
20110
0.96
0.74
4.2
4.6
23.25
22.14
%
2.16
908
10051
9
54
1.67
0.74
1.9
1.6
325.89
322.41
umol/24h
—
9
54
29
219
1.32
0.73
1.1
1.1
—
—
—
0
0
12
76
1.58
0.71
4.2
2.9
—
—
—
0
0
5
26
1.92
0.70
1.2
1.3
1.40
1.34
%
—
5
26
40
318
1.26
0.70
1.9
1.8
—
—
—
0
0
17
118
1.44
0.69
1.0
1.1
—
—
—
0
0
62
519
1.20
0.68
1.0
1.1
1.66
11.21
nmol/l
1.81
17
101
48
392
1.23
0.67
2.3
2.1
175.75
159.14
ug/min
—
8
100
15
102
1.47
0.67
1.3
1.0
—
—
—
0
0
3380
33193
1.03
0.66
2.1
1.9
1.40
1.35
mmol/l
2.06
2894
28153
15
103
1.46
0.64
1.0
1.1
—
—
—
0
0
1370
13267
1.04
0.64
1.6
1.5
—
—
—
0
0
15
104
1.44
0.62
1.3
1.0
—
—
—
0
0
915
9509
0.96
0.61
4.7
4.8
31.56
32.56
%
1.84
668
6461
31
244
1.27
0.60
1.3
1.2
39.17
39.32
g/l
0.02
19
123
185
1689
1.10
0.60
5.2
3.5
27.58
27.45
mg/l
0.02
143
1164
15
105
1.43
0.59
1.1
1.3
69.86
52.33
%
—
7
46
15
105
1.43
0.59
1.0
1.0
0.25
4.53
u/ml
—
7
44
577
5492
1.05
0.59
2.1
2.0
—
—
—
0
0
91
800
1.14
0.57
4.4
5.3
130.51
77.09
u/ml
0.29
33
265
20
150
1.33
0.55
1.7
2.4
—
—
—
0
0
39
469
0.83
0.52
1.5
1.4
5.49
5.67
mmol/l
0.72
39
443
280
2984
0.94
0.50
1.8
1.7
5.61
4.45
mg/l
0.59
212
2196
9
65
1.38
0.50
1.3
1.1
—
—
—
0
0
164
1511
1.09
0.47
1.8
1.7
—
—
—
0
0
25
310
0.81
0.46
2.9
2.5
167.55
151.12
nmol/l
0.24
20
275
12
86
1.40
0.44
1.0
1.1
0.44
0.20
u/ml
0.35
12
86
35
293
1.20
0.43
1.1
1.5
14.68
15.38
pmol/l
0.35
29
239
21
167
1.26
0.41
1.9
1.9
3.98
1.90
ug/l
0.59
15
92
8
58
1.38
0.41
1.1
1.1
0.99
1.28
mom
—
8
58
203
1906
1.07
0.39
2.0
1.9
189.18
200.79
pmol/l
0.76
192
1803
11
80
1.38
0.38
2.1
1.7
—
—
—
0
0
12
89
1.35
0.37
1.0
1.1
—
—
—
0
0
14
107
1.31
0.37
1.0
1.0
0.01
0.78
u/ml
—
6
48
47
534
0.88
0.36
1.2
1.3
150.57
182.20
pmol/l
0.72
47
534
59
526
1.12
0.35
1.0
1.0
302.39
322.03
ng/l
0.23
44
369
103
1118
0.92
0.35
1.4
1.3
7.19
7.15
mmol/l
0.06
92
994
59
529
1.12
0.33
1.0
1.0
810.23
720.33
ng/l
0.58
43
362
116
1247
0.93
0.32
1.1
1.1
0.13
0.41
u/ml
1.55
41
424
15
187
0.80
0.32
1.1
1.4
1.22
1.17
mmol/l
0.98
15
187
59
531
1.11
0.31
1.0
1.0
40.62
42.00
ng/l
0.10
42
367
118
1099
1.07
0.31
1.9
1.7
361.83
358.48
mu/l
0.03
96
873
23
194
1.19
0.29
1.0
1.1
0.09
12.97
u/ml
2.19
15
130
1512
14875
1.02
0.28
3.1
3.3
0.80
0.78
ug/l
0.15
1022
9886
188
1792
1.05
0.26
1.1
1.1
5.37
5.54
u/ml
0.03
115
986
9
72
1.25
0.25
1.3
1.1
—
—
—
0
0
10
78
1.28
0.24
2.6
1.7
43.50
46.68
umol/l
—
10
78
58
532
1.09
0.24
1.4
1.5
29.40
37.53
nmol/l
0.90
52
477
66
611
1.08
0.22
1.3
1.5
—
—
—
0
0
931
9145
1.02
0.22
11.7
6.9
—
—
—
0
0
57
525
1.09
0.22
1.1
1.1
0.14
2.36
u/ml
1.25
17
144
139
1459
0.95
0.21
1.1
1.1
2.33
3.79
u/ml
0.51
66
748
12
98
1.22
0.21
1.0
1.0
0.36
0.81
u/ml
—
5
45
0
14
0.00
0.20
0.0
5.9
—
0.27
—
0
14
19
164
1.16
0.20
1.1
1.1
—
—
—
0
0
17
197
0.86
0.19
2.9
2.2
15.47
16.66
umol/l
0.17
17
197
50
465
1.08
0.17
1.2
1.3
—
—
—
0
0
33
303
1.09
0.15
1.8
1.6
0.47
0.49
e9/l
0.22
33
303
8
100
0.80
0.13
1.1
1.2
6.14
5.75
mmol/l
—
8
100
37
395
0.94
0.12
1.2
1.8
0.98
2.51
u/ml
—
5
115
210
2050
1.02
0.12
1.2
1.1
1.20
2.18
u/ml
1.70
127
1124
15
167
0.90
0.10
1.2
1.2
91.87
67.42
ug/l
0.79
15
167
172
1685
1.02
0.08
1.1
1.1
0.65
1.59
u/ml
3.34
86
889
7
81
0.86
0.07
1.1
1.1
—
—
—
0
0
18
168
1.07
0.06
4.6
6.4
9.94
8.14
%
0.54
18
168
18
168
1.07
0.06
2.3
3.2
42.39
45.18
%
0.22
18
168
27
283
0.95
0.05
1.1
1.0
4.39
11.43
u/ml
—
10
191
17
159
1.07
0.05
3.3
2.2
7.83
7.46
mmol/l
—
10
95
49
504
0.97
0.04
7.0
7.1
27.59
94.17
ug/l
0.82
29
336
300
2974
1.01
0.04
1.7
1.9
—
32.21
—
0
6
13
121
1.07
0.03
1.0
1.1
6.48
6.41
u/ml
0.01
13
121
12
129
0.93
0.03
3.3
6.4
9.69
8.30
mmol/l
0.80
12
129
36
349
1.03
0.03
1.1
1.1
2.83
6.90
u/ml
1.76
11
61
172
1737
0.99
0.03
1.1
1.1
0.92
1.12
u/ml
0.25
85
800
59
578
1.02
0.03
1.1
1.1
1.28
8.76
u/ml
0.69
23
164
138
1367
1.01
0.02
1.1
1.1
2.85
4.48
u/ml
0.59
63
633
11
117
0.94
0.01
1.5
1.1
—
—
—
0
0
21
203
1.03
0.01
1.0
1.1
46.20
37.62
iu/ml
0.18
21
203
25
248
1.01
0.00
1.0
1.1
54.66
59.59
u/ml
0.15
25
241
14
141
0.99
0.00
6.9
7.2
10.05
10.47
%
0.33
14
141
12
117
1.03
0.00
1.0
1.0
8.23
8.89
mu/l
0.16
12
102
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
19.20
—
0
5
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
8.2
—
15.00
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint D3_COAGDEF_PURPUR_HAEMORRHAGIC and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_COAGDEF_PURPUR_HAEMORRHAGIC | 2.476 [2.24, 2.74] | < 0.001 |
| Birth year | 0.996 [0.99, 1.0] | 0.297 |
During the follow-up period (1.1.1998 — 31.12.2019), 5469 out of 25138 females with D3_COAGDEF_PURPUR_HAEMORRHAGIC died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_COAGDEF_PURPUR_HAEMORRHAGIC | 2.664 [2.39, 2.98] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.003 |
During the follow-up period (1.1.1998 — 31.12.2019), 6555 out of 21267 males with D3_COAGDEF_PURPUR_HAEMORRHAGIC died.
Mortality risk
Mortality risk for people of age
years, who have D3_COAGDEF_PURPUR_HAEMORRHAGIC.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.194% | 0.486% |
| 5 | 1.425% | 2.986% |
| 10 | 3.355% | 7.221% |
| 15 | 6.616% | 13.413% |
| 20 | 11.192% | 21.612% |
Relationships between endpoints
↥Index endpoint: D3_COAGDEF_PURPUR_HAEMORRHAGIC – Coagulation defects, purpura and other haemorrhagic conditions
GWS hits: 10
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data